| 1 | hypertensive | 8,415 |
| 2 | hypercholesterolemic | 1,701 |
| 3 | asthmatic | 1,502 |
| 4 | nondiabetic | 1,061 |
| 5 | non-diabetic | 999 |
| 6 | hyperlipidemic | 518 |
| 7 | treatment-naive | 499 |
| 8 | neutropenic | 458 |
| 9 | schizophrenic | 404 |
| 10 | uremic | 401 |
| 11 | hypercholesterolaemic | 351 |
| 12 | treatment-naïve | 343 |
| 13 | hypothyroid | 333 |
| 14 | dyslipidemic | 315 |
| 15 | hyperglycemic | 303 |
| 16 | treatment-experienced | 224 |
| 17 | insulin-resistant | 211 |
| 18 | statin-treated | 204 |
| 19 | hyperthyroid | 193 |
| 20 | hypertriglyceridemic | 192 |
| 21 | drug-naïve | 157 |
| 22 | insulin-treated | 148 |
| 23 | proteinuric | 146 |
| 24 | hbeag-positive | 142 |
| 25 | hcv-infected | 140 |
| 26 | normoalbuminuric | 126 |
| 27 | hypomagnesemic | 125 |
| 28 | prediabetic | 114 |
| 29 | chemotherapy-naive | 108 |
| 30 | drug-naive | 104 |
| 31 | acromegalic | 99 |
| 32 | duloxetine-treated | 91 |
| 33 | hbeag-negative | 86 |
| 34 | microalbuminuric | 85 |
| 35 | hyperglycaemic | 83 |
| 36 | olanzapine-treated | 82 |
| 37 | hyperlipidaemic | 81 |
| 38 | uraemic | 78 |
| 39 | antiretroviral-naive | 77 |
| 40 | atorvastatin-treated | 62 |
| 41 | chemotherapy-naïve | 62 |
| 42 | fluoxetine-treated | 62 |
| 43 | simvastatin-treated | 62 |
| 44 | dyslipidaemic | 61 |
| 45 | hyperuricemic | 56 |
| 46 | metformin-treated | 55 |
| 47 | cyclosporine-treated | 53 |
| 48 | pre-diabetic | 52 |
| 49 | hemodialyzed | 51 |
| 50 | anuric | 49 |
| 51 | aspirin-treated | 49 |
| 52 | antiretroviral-naïve | 48 |
| 53 | bronchitic | 47 |
| 54 | super-obese | 47 |
| 55 | non-cirrhotic | 46 |
| 56 | non-dialysis | 46 |
| 57 | medication-naïve | 45 |
| 58 | non-japanese | 44 |
| 59 | nondialysis | 44 |
| 60 | csa-treated | 41 |
| 61 | thyrotoxic | 41 |
| 62 | cardiomyopathic | 40 |
| 63 | critically-ill | 40 |
| 64 | granulocytopenic | 39 |
| 65 | hyponatremic | 39 |
| 66 | insulin-naïve | 39 |
| 67 | adalimumab-treated | 38 |
| 68 | brain-injured | 38 |
| 69 | pravastatin-treated | 38 |
| 70 | statin-naive | 38 |
| 71 | insulin-naive | 37 |
| 72 | thalassemic | 37 |
| 73 | sertraline-treated | 36 |
| 74 | bevacizumab-treated | 34 |
| 75 | dysphagic | 34 |
| 76 | hypoalbuminemic | 34 |
| 77 | splenectomized | 34 |
| 78 | antipsychotic-naïve | 33 |
| 79 | gly/gly | 33 |
| 80 | infliximab-treated | 33 |
| 81 | statin-intolerant | 33 |
| 82 | medication-naive | 32 |
| 83 | non-neutropenic | 32 |
| 84 | haemophilic | 30 |
| 85 | risperidone-treated | 30 |
| 86 | steroid-naive | 30 |
| 87 | therapy-naive | 30 |
| 88 | hyperlipemic | 29 |
| 89 | noncirrhotic | 28 |
| 90 | tacrolimus-treated | 28 |
| 91 | ustekinumab-treated | 28 |
| 92 | warfarin-treated | 28 |
| 93 | chemonaive | 27 |
| 94 | non-insulin-treated | 27 |
| 95 | normocholesterolaemic | 27 |
| 96 | rituximab-treated | 27 |
| 97 | amoxicillin-treated | 26 |
| 98 | clopidogrel-treated | 26 |
| 99 | clozapine-treated | 26 |
| 100 | dyspneic | 26 |
| 101 | alcohol-treated | 25 |
| 102 | clarithromycin-treated | 25 |
| 103 | hbv-infected | 25 |
| 104 | telmisartan-treated | 25 |
| 105 | antipsychotic-naive | 24 |
| 106 | macroalbuminuric | 24 |
| 107 | statin-naïve | 24 |
| 108 | autoantibody-positive | 23 |
| 109 | cachectic | 23 |
| 110 | haemodialysed | 23 |
| 111 | acpa-positive | 22 |
| 112 | cell-treated | 22 |
| 113 | hypertriglyceridaemic | 22 |
| 114 | lithium-treated | 22 |
| 115 | pioglitazone-treated | 22 |
| 116 | abatacept-treated | 21 |
| 117 | pre-hypertensive | 21 |
| 118 | escitalopram-treated | 20 |
| 119 | normotriglyceridemic | 20 |
| 120 | tube-fed | 20 |
| 121 | gastrectomized | 19 |
| 122 | laryngectomized | 19 |
| 123 | levodopa-treated | 19 |
| 124 | non-hd | 19 |
| 125 | presbyopic | 19 |
| 126 | arb-treated | 18 |
| 127 | belatacept-treated | 18 |
| 128 | cefaclor-treated | 18 |
| 129 | etanercept-treated | 18 |
| 130 | head-injured | 18 |
| 131 | hiv/hcv-coinfected | 18 |
| 132 | paroxetine-treated | 18 |
| 133 | pregabalin-treated | 18 |
| 134 | sunitinib-treated | 18 |
| 135 | aspirin-resistant | 17 |
| 136 | non-transplanted | 17 |
| 137 | nucleoside-naive | 17 |
| 138 | opioid-tolerant | 17 |
| 139 | pacemaker-dependent | 17 |
| 140 | brain-damaged | 16 |
| 141 | comparator-treated | 16 |
| 142 | non-ambulatory | 16 |
| 143 | opioid-naive | 16 |
| 144 | vancomycin-treated | 16 |
| 145 | atenolol-treated | 15 |
| 146 | dmard-naïve | 15 |
| 147 | donepezil-treated | 15 |
| 148 | everolimus-treated | 15 |
| 149 | fluvastatin-treated | 15 |
| 150 | hypertensive-diabetic | 15 |
| 151 | igad | 15 |
| 152 | insomniac | 15 |
| 153 | nonneutropenic | 15 |
| 154 | opioid-naïve | 15 |
| 155 | orlistat-treated | 15 |
| 156 | propranolol-treated | 15 |
| 157 | amiodarone-treated | 14 |
| 158 | atomoxetine-treated | 14 |
| 159 | erythromycin-treated | 14 |
| 160 | hyperandrogenic | 14 |
| 161 | mirtazapine-treated | 14 |
| 162 | nephropathic | 14 |
| 163 | omalizumab-treated | 14 |
| 164 | opioid-experienced | 14 |
| 165 | sevelamer-treated | 14 |
| 166 | ticagrelor-treated | 14 |
| 167 | venlafaxine-treated | 14 |
| 168 | vka-experienced | 14 |
| 169 | 2,331 | 13 |
| 170 | acpa-negative | 13 |
| 171 | golimumab-treated | 13 |
| 172 | heparin-treated | 13 |
| 173 | hyperprolactinemic | 13 |
| 174 | liver-transplanted | 13 |
| 175 | methotrexate-treated | 13 |
| 176 | neutropaenic | 13 |
| 177 | trastuzumab-treated | 13 |
| 178 | 10,001 | 12 |
| 179 | albuminuric | 12 |
| 180 | celecoxib-treated | 12 |
| 181 | exenatide-treated | 12 |
| 182 | hyperlipoproteinemic | 12 |
| 183 | iron-overloaded | 12 |
| 184 | lomefloxacin-treated | 12 |
| 185 | mtx-naïve | 12 |
| 186 | oligozoospermic | 12 |
| 187 | omeprazole-treated | 12 |
| 188 | onabotulinumtoxina-treated | 12 |
| 189 | tadalafil-treated | 12 |
| 190 | thalassaemic | 12 |
| 191 | therapy-naïve | 12 |
| 192 | trial-eligible | 12 |
| 193 | xerostomic | 12 |
| 194 | acl-injured | 11 |
| 195 | biologics-naive | 11 |
| 196 | chemo-naive | 11 |
| 197 | chemonaïve | 11 |
| 198 | cilostazol-treated | 11 |
| 199 | difficult-to-wean | 11 |
| 200 | hp-positive | 11 |
| 201 | low-functioning | 11 |
| 202 | memantine-treated | 11 |
| 203 | non-splenectomized | 11 |
| 204 | nondialyzed | 11 |
| 205 | ssri-treated | 11 |
| 206 | varenicline-treated | 11 |
| 207 | aza-treated | 10 |
| 208 | cabg-treated | 10 |
| 209 | chemo-naïve | 10 |
| 210 | doxorubicin-treated | 10 |
| 211 | egg-allergic | 10 |
| 212 | hahd | 10 |
| 213 | hmpv-infected | 10 |
| 214 | hyperlipoproteinaemic | 10 |
| 215 | lam-resistant | 10 |
| 216 | lipodystrophic | 10 |
| 217 | mmf-treated | 10 |
| 218 | non-nephrotic | 10 |
| 219 | non-shock | 10 |
| 220 | polymedicated | 10 |
| 221 | rivaroxaban-treated | 10 |
| 222 | rosiglitazone-treated | 10 |
| 223 | sildenafil-treated | 10 |
| 224 | sirolimus-treated | 10 |
| 225 | tegaserod-treated | 10 |
| 226 | troponin-positive | 10 |
| 227 | vagotomised | 10 |
| 228 | weight-losing | 10 |
| 229 | 9014 | 9 |
| 230 | abciximab-treated | 9 |
| 231 | antipsychotic-treated | 9 |
| 232 | antiretroviral-treated | 9 |
| 233 | aprotinin-treated | 9 |
| 234 | aviremic | 9 |
| 235 | bisphosphonate-treated | 9 |
| 236 | ceftriaxone-treated | 9 |
| 237 | cfs/fm | 9 |
| 238 | divalproex-treated | 9 |
| 239 | gabapentin-treated | 9 |
| 240 | hiv-coinfected | 9 |
| 241 | hyperphosphatemic | 9 |
| 242 | imatinib-treated | 9 |
| 243 | immuno-compromised | 9 |
| 244 | insulin-deficient | 9 |
| 245 | linezolid-treated | 9 |
| 246 | lipoatrophic | 9 |
| 247 | low-potassium | 9 |
| 248 | non-rvr | 9 |
| 249 | olmesartan-treated | 9 |
| 250 | onco-hematological | 9 |
| 251 | opioid-treated | 9 |
| 252 | rivastigmine-treated | 9 |
| 253 | rt-pa-treated | 9 |
| 254 | sjögren׳s | 9 |
| 255 | amoxicillin/clavulanate-treated | 8 |
| 256 | azathioprine-treated | 8 |
| 257 | bcg-treated | 8 |
| 258 | bed-bound | 8 |
| 259 | cinacalcet-treated | 8 |
| 260 | czp-treated | 8 |
| 261 | furosemide-treated | 8 |
| 262 | glucocorticoid-treated | 8 |
| 263 | hcv-monoinfected | 8 |
| 264 | ifn-treated | 8 |
| 265 | interferon-treated | 8 |
| 266 | laryngectomised | 8 |
| 267 | lqt1 | 8 |
| 268 | moxifloxacin-treated | 8 |
| 269 | naltrexone-treated | 8 |
| 270 | nesb | 8 |
| 271 | non-constipated | 8 |
| 272 | non-regenerative | 8 |
| 273 | nonanticoagulated | 8 |
| 274 | nonhypercholesterolemic | 8 |
| 275 | ofc-treated | 8 |
| 276 | pazopanib-treated | 8 |
| 277 | prasugrel-treated | 8 |
| 278 | rtx-treated | 8 |
| 279 | sitagliptin-treated | 8 |
| 280 | teriparatide-treated | 8 |
| 281 | well-hydrated | 8 |
| 282 | 1,591 | 7 |
| 283 | 13,819 | 7 |
| 284 | 2,466 | 7 |
| 285 | 4732 | 7 |
| 286 | ace-intolerant | 7 |
| 287 | adv-treated | 7 |
| 288 | ampicillin-treated | 7 |
| 289 | arv-treated | 7 |
| 290 | budesonide-treated | 7 |
| 291 | carvedilol-treated | 7 |
| 292 | cediranib-treated | 7 |
| 293 | cefonicid-treated | 7 |
| 294 | cidb | 7 |
| 295 | cip-treated | 7 |
| 296 | cs-treated | 7 |
| 297 | ddavp-treated | 7 |
| 298 | dirithromycin-treated | 7 |
| 299 | efalizumab-treated | 7 |
| 300 | erlotinib-treated | 7 |
| 301 | etv-treated | 7 |
| 302 | flt3-itd-negative | 7 |
| 303 | glargine-treated | 7 |
| 304 | hbo-treated | 7 |
| 305 | high-anxiety | 7 |
| 306 | hip-fractured | 7 |
| 307 | hypotension-prone | 7 |
| 308 | lamivudine-refractory | 7 |
| 309 | lapatinib-treated | 7 |
| 310 | maraviroc-treated | 7 |
| 311 | mtx-naive | 7 |
| 312 | non-vap | 7 |
| 313 | nondialysis-dependent | 7 |
| 314 | nonmalnourished | 7 |
| 315 | normonatremic | 7 |
| 316 | pbo-treated | 7 |
| 317 | penicillin-allergic | 7 |
| 318 | pentoxifylline-treated | 7 |
| 319 | polypathological | 7 |
| 320 | polytransfused | 7 |
| 321 | pump-treated | 7 |
| 322 | ramipril-treated | 7 |
| 323 | rhinitic | 7 |
| 324 | ruxolitinib-treated | 7 |
| 325 | rv-paced | 7 |
| 326 | ses-treated | 7 |
| 327 | sorafenib-treated | 7 |
| 328 | stimulant-naïve | 7 |
| 329 | tac-treated | 7 |
| 330 | telaprevir-treated | 7 |
| 331 | transplant-eligible | 7 |
| 332 | troponin-negative | 7 |
| 333 | 14,703 | 6 |
| 334 | 18,201 | 6 |
| 335 | 2439 | 6 |
| 336 | 3,544 | 6 |
| 337 | 3,687 | 6 |
| 338 | 3838 | 6 |
| 339 | aat-deficient | 6 |
| 340 | busulfan-treated | 6 |
| 341 | clindamycin-treated | 6 |
| 342 | designer-drug-abusing | 6 |
| 343 | early-treated | 6 |
| 344 | eltrombopag-treated | 6 |
| 345 | entecavir-switch | 6 |
| 346 | erythropoietin-treated | 6 |
| 347 | esa-treated | 6 |
| 348 | fingolimod-treated | 6 |
| 349 | hepatectomized | 6 |
| 350 | hyperoh | 6 |
| 351 | hypertense | 6 |
| 352 | inotrope-dependent | 6 |
| 353 | iv-treated | 6 |
| 354 | ketorolac-treated | 6 |
| 355 | l-dopa-treated | 6 |
| 356 | met-treated | 6 |
| 357 | methylprednisolone-treated | 6 |
| 358 | narcoleptic | 6 |
| 359 | nevirapine-treated | 6 |
| 360 | non-ami | 6 |
| 361 | non-azotemic | 6 |
| 362 | non-malnourished | 6 |
| 363 | non-relapsing | 6 |
| 364 | pamidronate-treated | 6 |
| 365 | pitavastatin-treated | 6 |
| 366 | post-gastrectomy | 6 |
| 367 | premanifest | 6 |
| 368 | slit-treated | 6 |
| 369 | tca-treated | 6 |
| 370 | tracheotomized | 6 |
| 371 | virologically-suppressed | 6 |
| 372 | ziprasidone-treated | 6 |
| 373 | -seronegative | 5 |
| 374 | 1,792 | 5 |
| 375 | 3779 | 5 |
| 376 | 8164 | 5 |
| 377 | adrc-treated | 5 |
| 378 | amio-on | 5 |
| 379 | an-fep | 5 |
| 380 | asian-region | 5 |
| 381 | biologic-naïve | 5 |
| 382 | bromocriptine-treated | 5 |
| 383 | cetuximab-treated | 5 |
| 384 | csf-treated | 5 |
| 385 | cya-treated | 5 |
| 386 | cyclophosphamide-treated | 5 |
| 387 | dyslipoproteinemic | 5 |
| 388 | ecmo-referred | 5 |
| 389 | efavirenz-treated | 5 |
| 390 | elca-treated | 5 |
| 391 | etravirine-treated | 5 |
| 392 | ezetimibe-treated | 5 |
| 393 | fcm-treated | 5 |
| 394 | fleroxacin-treated | 5 |
| 395 | g-csf-treated | 5 |
| 396 | gastroparetic | 5 |
| 397 | gemfibrozil-treated | 5 |
| 398 | goserelin-treated | 5 |
| 399 | guselkumab-treated | 5 |
| 400 | hbv-monoinfected | 5 |
| 401 | hctz-treated | 5 |
| 402 | hiv-monoinfected | 5 |
| 403 | hqd | 5 |
| 404 | hydrocephalic | 5 |
| 405 | hypersecretive | 5 |
| 406 | immunocompromized | 5 |
| 407 | insulin-using | 5 |
| 408 | ip-treated | 5 |
| 409 | kikyo | 5 |
| 410 | linaclotide-treated | 5 |
| 411 | mesalazine-treated | 5 |
| 412 | modafinil-treated | 5 |
| 413 | multiple-trauma | 5 |
| 414 | nefazodone-treated | 5 |
| 415 | nesiritide-treated | 5 |
| 416 | non-cachectic | 5 |
| 417 | non-crai | 5 |
| 418 | non-dialyzed | 5 |
| 419 | non-ecmo-referred | 5 |
| 420 | non-edda | 5 |
| 421 | non-progressing | 5 |
| 422 | non-rd | 5 |
| 423 | non-sdldl | 5 |
| 424 | non-statin-treated | 5 |
| 425 | non-transfer | 5 |
| 426 | noninducible | 5 |
| 427 | nontraumatized | 5 |
| 428 | norfloxacin-treated | 5 |
| 429 | nucleoside-naïve | 5 |
| 430 | octreotide-treated | 5 |
| 431 | pen-naïve | 5 |
| 432 | phenylketonuric | 5 |
| 433 | propofol-treated | 5 |
| 434 | r-tof | 5 |
| 435 | ribavirin-treated | 5 |
| 436 | rimonabant-treated | 5 |
| 437 | rygb-1 | 5 |
| 438 | rygb-2 | 5 |
| 439 | tb-hiv-coinfected | 5 |
| 440 | thrombolysis-treated | 5 |
| 441 | tocilizumab-treated | 5 |
| 442 | tpa-treated | 5 |
| 443 | verapamil-treated | 5 |
| 444 | vildagliptin-treated | 5 |
| 445 | zibotentan-treated | 5 |
| 446 | zofenopril-treated | 5 |
| 447 | 1,476 | 4 |
| 448 | 1,628 | 4 |
| 449 | 1,653 | 4 |
| 450 | 1,664 | 4 |
| 451 | 15,939 | 4 |
| 452 | 19,185 | 4 |
| 453 | 2,231 | 4 |
| 454 | 2,662 | 4 |
| 455 | 26,449 | 4 |
| 456 | 3,340 | 4 |
| 457 | 6780 | 4 |
| 458 | 9461 | 4 |
| 459 | acas-eligible | 4 |
| 460 | allicor-treated | 4 |
| 461 | alloxan-diabetic | 4 |
| 462 | ambrisentan-treated | 4 |
| 463 | amio-off | 4 |
| 464 | ams-susceptible | 4 |
| 465 | appendectomised | 4 |
| 466 | as-tga | 4 |
| 467 | bivalirudin-treated | 4 |
| 468 | brcaness | 4 |
| 469 | c-peptide-negative | 4 |
| 470 | c-peptide-positive | 4 |
| 471 | calcitriol-resistant | 4 |
| 472 | carumonam-treated | 4 |
| 473 | cefdinir-treated | 4 |
| 474 | cefepime-treated | 4 |
| 475 | ceftibuten-treated | 4 |
| 476 | clr-treated | 4 |
| 477 | co-poisoned | 4 |
| 478 | cryoglobulinaemic | 4 |
| 479 | dapagliflozin-treated | 4 |
| 480 | direct-admit | 4 |
| 481 | disulfiram-treated | 4 |
| 482 | dothiepin-treated | 4 |
| 483 | dyslipemic | 4 |
| 484 | enprofylline-treated | 4 |
| 485 | evolocumab-treated | 4 |
| 486 | fhl3 | 4 |
| 487 | first-biopsy | 4 |
| 488 | first-episodic | 4 |
| 489 | flt3-itd-positive | 4 |
| 490 | formoterol-randomised | 4 |
| 491 | front-door | 4 |
| 492 | galantamine-treated | 4 |
| 493 | genotype-positive | 4 |
| 494 | guanfacine-treated | 4 |
| 495 | hd- | 4 |
| 496 | hdv-infected | 4 |
| 497 | hemodialysed | 4 |
| 498 | high-cardiovascular-risk | 4 |
| 499 | hp-negative | 4 |
| 500 | hypoparathyroid | 4 |
| 501 | hypozincemic | 4 |
| 502 | immuno-suppressed | 4 |
| 503 | immunodiscordant | 4 |
| 504 | inh-susceptible | 4 |
| 505 | kidney-transplanted | 4 |
| 506 | lamivudine-maintained | 4 |
| 507 | lipodystrophy-positive | 4 |
| 508 | lisinopril-treated | 4 |
| 509 | lorcaserin-treated | 4 |
| 510 | ly2605541-treated | 4 |
| 511 | medication-experienced | 4 |
| 512 | met-comt | 4 |
| 513 | met-negative | 4 |
| 514 | metoclopramide-treated | 4 |
| 515 | mpa-treated | 4 |
| 516 | myelosuppressed | 4 |
| 517 | naftifine-treated | 4 |
| 518 | nicardipine-treated | 4 |
| 519 | non-hct | 4 |
| 520 | non-hemodialyzed | 4 |
| 521 | non-laba-treated | 4 |
| 522 | normophosphatemic | 4 |
| 523 | normotriglyceridaemic | 4 |
| 524 | oac-treated | 4 |
| 525 | ocd-bipolar | 4 |
| 526 | olz-treated | 4 |
| 527 | ondansetron-treated | 4 |
| 528 | overweight+obese | 4 |
| 529 | peach-allergic | 4 |
| 530 | pramlintide-treated | 4 |
| 531 | riluzole-treated | 4 |
| 532 | rlai-treated | 4 |
| 533 | s-ipf | 4 |
| 534 | scd-heft-like | 4 |
| 535 | simeprevir-treated | 4 |
| 536 | sln-positive | 4 |
| 537 | sputum-positive | 4 |
| 538 | sulfasalazine-treated | 4 |
| 539 | tamsulosin-treated | 4 |
| 540 | tcm-treated | 4 |
| 541 | thalidomide-exposed | 4 |
| 542 | thalidomide-naive | 4 |
| 543 | therapy-experienced | 4 |
| 544 | tigecycline-treated | 4 |
| 545 | tmz-treated | 4 |
| 546 | treatment-option | 4 |
| 547 | vvir-randomized | 4 |
| 548 | young-to-middle-age | 4 |
| 549 | zanamivir-treated | 4 |
| 550 | 'non-trial | 3 |
| 551 | -ineligible | 3 |
| 552 | 131i-treated | 3 |
| 553 | 19,193 | 3 |
| 554 | 2,065 | 3 |
| 555 | 2,181 | 3 |
| 556 | 2,364 | 3 |
| 557 | 2,769 | 3 |
| 558 | 27,492 | 3 |
| 559 | 3,202 | 3 |
| 560 | 4,016 | 3 |
| 561 | 4,081 | 3 |
| 562 | 4043 | 3 |
| 563 | 41,021 | 3 |
| 564 | 4468 | 3 |
| 565 | 4503 | 3 |
| 566 | 4892 | 3 |
| 567 | 5,552 | 3 |
| 568 | 5380 | 3 |
| 569 | 54,696 | 3 |
| 570 | 5747 | 3 |
| 571 | 6,797 | 3 |
| 572 | 6216 | 3 |
| 573 | 6323 | 3 |
| 574 | 6906 | 3 |
| 575 | 7,599 | 3 |
| 576 | 7,754 | 3 |
| 577 | 7950 | 3 |
| 578 | 9779 | 3 |
| 579 | acei/arb-treated | 3 |
| 580 | ada-treated | 3 |
| 581 | alemtuzumab-treated | 3 |
| 582 | alitretinoin-treated | 3 |
| 583 | am/amp-treated | 3 |
| 584 | anakinra-treated | 3 |
| 585 | antipsychotic-stabilized | 3 |
| 586 | argatroban-treated | 3 |
| 587 | arv-experienced | 3 |
| 588 | axitinib-treated | 3 |
| 589 | azt-naive | 3 |
| 590 | b-thalassemic | 3 |
| 591 | candiduric | 3 |
| 592 | cdc-treated | 3 |
| 593 | cerivastatin-treated | 3 |
| 594 | cetirizine-treated | 3 |
| 595 | cisplatin-ineligible | 3 |
| 596 | clazosentan-treated | 3 |
| 597 | clopidogrel-naive | 3 |
| 598 | clotrimazole-treated | 3 |
| 599 | co-amoxiclav-treated | 3 |
| 600 | controlled-hypertensive | 3 |
| 601 | cryptozoospermic | 3 |
| 602 | csc-treated | 3 |
| 603 | degludec-treated | 3 |
| 604 | dfo-treated | 3 |
| 605 | digoxin-treated | 3 |
| 606 | dmi-treated | 3 |
| 607 | early-detected | 3 |
| 608 | elective-pci | 3 |
| 609 | esa-naïve | 3 |
| 610 | escitalopram-alone | 3 |
| 611 | exemestane-treated | 3 |
| 612 | fesoterodine-treated | 3 |
| 613 | flurbiprofen-treated | 3 |
| 614 | fpns-treated | 3 |
| 615 | glucocorticoid-naïve | 3 |
| 616 | griseofulvin-treated | 3 |
| 617 | hcv-mono-infected | 3 |
| 618 | hd-ckd | 3 |
| 619 | hematopathy | 3 |
| 620 | high-triglyceride | 3 |
| 621 | hiv-2-infected | 3 |
| 622 | hiv-treated | 3 |
| 623 | hiv/haart | 3 |
| 624 | hypercholesteremic | 3 |
| 625 | hypnotics/anxiolytics-abusing | 3 |
| 626 | icd-treated | 3 |
| 627 | immunotherapy-treated | 3 |
| 628 | integrase-inhibitor-naive | 3 |
| 629 | ivabradine-treated | 3 |
| 630 | leflunomide-treated | 3 |
| 631 | lmwh-treated | 3 |
| 632 | lpi-treated | 3 |
| 633 | macrolide-treated | 3 |
| 634 | mdi-treated | 3 |
| 635 | methamphetamine-abusing | 3 |
| 636 | n-acetylcysteine-treated | 3 |
| 637 | naïve-to-treatment | 3 |
| 638 | netilmicin-treated | 3 |
| 639 | nic-treated | 3 |
| 640 | no-diuretic | 3 |
| 641 | non-ald | 3 |
| 642 | non-anuric | 3 |
| 643 | non-ard | 3 |
| 644 | non-ba | 3 |
| 645 | non-dan | 3 |
| 646 | non-dge | 3 |
| 647 | non-dialysed | 3 |
| 648 | non-esrd | 3 |
| 649 | non-hemophiliac | 3 |
| 650 | non-inhibitor | 3 |
| 651 | non-qatari | 3 |
| 652 | non-resected | 3 |
| 653 | non-rheumatoid-arthritis | 3 |
| 654 | non-viremic | 3 |
| 655 | nonautistic | 3 |
| 656 | nonduloxetine-treated | 3 |
| 657 | nonexpanded | 3 |
| 658 | nonhemophiliac | 3 |
| 659 | nonhypoxic | 3 |
| 660 | nonyoung | 3 |
| 661 | norepinephrine-treated | 3 |
| 662 | not-weak | 3 |
| 663 | off-range | 3 |
| 664 | olanzapine-group | 3 |
| 665 | older/unfit | 3 |
| 666 | opcab-converted | 3 |
| 667 | p2ry8-crlf2+ | 3 |
| 668 | panitumumab-treated | 3 |
| 669 | pharmaceutical-care | 3 |
| 670 | plerixafor-mobilised | 3 |
| 671 | polypectomized | 3 |
| 672 | poor-responder | 3 |
| 673 | post-coarctectomy | 3 |
| 674 | rolofylline-treated | 3 |
| 675 | ropinirole-treated | 3 |
| 676 | saxagliptin-treated | 3 |
| 677 | ser49 | 3 |
| 678 | span-100-positive | 3 |
| 679 | tavr-treated | 3 |
| 680 | thalidomide-treated | 3 |
| 681 | thiazide-treated | 3 |
| 682 | tid-positive | 3 |
| 683 | tips-treated | 3 |
| 684 | tnbs-colitis | 3 |
| 685 | torcetrapib-treated | 3 |
| 686 | tp-treated | 3 |
| 687 | transfusion-independent | 3 |
| 688 | transfusion-naive | 3 |
| 689 | trimetazidine-treated | 3 |
| 690 | urban-living | 3 |
| 691 | vismodegib-treated | 3 |
| 692 | vka-treated | 3 |
| 693 | younger/fit | 3 |
| 694 | zimelidine-treated | 3 |
| 695 | 1-to-5-year-old | 2 |
| 696 | 104.408 | 2 |
| 697 | 11,324 | 2 |
| 698 | 11,506 | 2 |
| 699 | 13,875 | 2 |
| 700 | 13,990 | 2 |
| 701 | 14,611 | 2 |
| 702 | 14/36 | 2 |
| 703 | 19,102 | 2 |
| 704 | 19/156 | 2 |
| 705 | 2,251 | 2 |
| 706 | 2,257 | 2 |
| 707 | 2,905 | 2 |
| 708 | 24,500 | 2 |
| 709 | 29,423 | 2 |
| 710 | 29/234 | 2 |
| 711 | 3,343 | 2 |
| 712 | 3,558 | 2 |
| 713 | 3,746 | 2 |
| 714 | 35,970 | 2 |
| 715 | 3717 | 2 |
| 716 | 3813 | 2 |
| 717 | 3969 | 2 |
| 718 | 4,082 | 2 |
| 719 | 4,665 | 2 |
| 720 | 44/75 | 2 |
| 721 | 4464 | 2 |
| 722 | 5,044 | 2 |
| 723 | 5,172 | 2 |
| 724 | 5,233 | 2 |
| 725 | 5,678 | 2 |
| 726 | 51,321 | 2 |
| 727 | 5395 | 2 |
| 728 | 5731 | 2 |
| 729 | 6,066 | 2 |
| 730 | 63/158 | 2 |
| 731 | 7,150 | 2 |
| 732 | 7,489 | 2 |
| 733 | 7,665 | 2 |
| 734 | 7,954 | 2 |
| 735 | 7448 | 2 |
| 736 | 75/77 | 2 |
| 737 | 8,101 | 2 |
| 738 | 8507 | 2 |
| 739 | 8831 | 2 |
| 740 | 9,193 | 2 |
| 741 | 9,978 | 2 |
| 742 | ac-treated | 2 |
| 743 | acei-intolerant | 2 |
| 744 | acute-stroke | 2 |
| 745 | adalimumab-randomized | 2 |
| 746 | adt-treated | 2 |
| 747 | ambulance-enrolled | 2 |
| 748 | amphetamine-allocated | 2 |
| 749 | amx-cl-treated | 2 |
| 750 | anti-tnfalpha-treated | 2 |
| 751 | anti-vegf-refractory | 2 |
| 752 | ap-cml | 2 |
| 753 | apixaban-treated | 2 |
| 754 | apla-positive | 2 |
| 755 | arteriopathic | 2 |
| 756 | aspirin-free | 2 |
| 757 | astemizole-treated | 2 |
| 758 | azacitidine-treated | 2 |
| 759 | azd9773-treated | 2 |
| 760 | bcg-refractory | 2 |
| 761 | bes-implanted | 2 |
| 762 | beta-blocker-naïve | 2 |
| 763 | beta-blocker-treated | 2 |
| 764 | binge-eating/vomiting | 2 |
| 765 | bortezomib-naive | 2 |
| 766 | bronchiectatic | 2 |
| 767 | brv-treated | 2 |
| 768 | carboplatin-treated | 2 |
| 769 | cardiopathic | 2 |
| 770 | cdp-treated | 2 |
| 771 | cea-treated | 2 |
| 772 | chinese-canadian | 2 |
| 773 | cil+ | 2 |
| 774 | cilengitide-treated | 2 |
| 775 | citicoline-treated | 2 |
| 776 | cladribine-treated | 2 |
| 777 | clonidine-treated | 2 |
| 778 | colchicine-unresponsive | 2 |
| 779 | cpib-resistant | 2 |
| 780 | cs-866-treated | 2 |
| 781 | ctni-negative | 2 |
| 782 | cyc-treated | 2 |
| 783 | denture-wearing | 2 |
| 784 | desferrioxamine-treated | 2 |
| 785 | desloratadine-treated | 2 |
| 786 | diabetic-hypertensive | 2 |
| 787 | djiboutian | 2 |
| 788 | double-ventricle | 2 |
| 789 | dutch-antillean | 2 |
| 790 | endoscopy-positive | 2 |
| 791 | epirubicin-exposed | 2 |
| 792 | eqw-treated | 2 |
| 793 | ethanol-dependent | 2 |
| 794 | etomidate-exposed | 2 |
| 795 | eve-treated | 2 |
| 796 | fga-treated | 2 |
| 797 | fgas-treated | 2 |
| 798 | fibrate-treated | 2 |
| 799 | fluticasone-treated | 2 |
| 800 | flx-treated | 2 |
| 801 | folate-treated | 2 |
| 802 | gad-alum-treated | 2 |
| 803 | gepirone-er-treated | 2 |
| 804 | gerd-negative | 2 |
| 805 | glucagon-treated | 2 |
| 806 | gs-positive | 2 |
| 807 | haemodialyzed | 2 |
| 808 | hamster-allergic | 2 |
| 809 | hbsag-seropositive | 2 |
| 810 | hbv/hcv-coinfected | 2 |
| 811 | hiv+/tb | 2 |
| 812 | hiv-hcv-coinfected | 2 |
| 813 | hl-deficient | 2 |
| 814 | hypo-albuminemic | 2 |
| 815 | ibo-induced | 2 |
| 816 | icu-admitted | 2 |
| 817 | ifnβ-treatment-naïve | 2 |
| 818 | il-2-treated | 2 |
| 819 | immunocomprised | 2 |
| 820 | insulin-taking | 2 |
| 821 | intensive-pathway | 2 |
| 822 | ipilimumab-treated | 2 |
| 823 | is-treated | 2 |
| 824 | josamycin-treated | 2 |
| 825 | kc-naive | 2 |
| 826 | korean/taiwanese | 2 |
| 827 | kt-treated | 2 |
| 828 | lacosamide-treated | 2 |
| 829 | laquinimod-treated | 2 |
| 830 | ldaa-treated | 2 |
| 831 | lenalidomide-treated | 2 |
| 832 | lixisenatide-treated | 2 |
| 833 | loop-treated | 2 |
| 834 | low-ts | 2 |
| 835 | low-upa/pai-1 | 2 |
| 836 | lr-treated | 2 |
| 837 | mbl-deficient | 2 |
| 838 | mdx-1100-treated | 2 |
| 839 | mec-treated | 2 |
| 840 | medi-528-treated | 2 |
| 841 | metformin-tolerant | 2 |
| 842 | metformin/sulfonylurea-treated | 2 |
| 843 | methadone-intoxicated | 2 |
| 844 | methane-positive | 2 |
| 845 | methylnaltrexone-treated | 2 |
| 846 | mild-hypercholesterolemic | 2 |
| 847 | miltefosine-treated | 2 |
| 848 | mp4ox-treated | 2 |
| 849 | multi-transfused | 2 |
| 850 | multi-treated | 2 |
| 851 | natalizumab-treated | 2 |
| 852 | neocart-treated | 2 |
| 853 | neuroleptic-naive | 2 |
| 854 | ni-group | 2 |
| 855 | nicotinamide-treated | 2 |
| 856 | non-abmi | 2 |
| 857 | non-abuser | 2 |
| 858 | non-bmt | 2 |
| 859 | non-breakthrough | 2 |
| 860 | non-cardiological | 2 |
| 861 | non-evented | 2 |
| 862 | non-fluctuating | 2 |
| 863 | non-gout | 2 |
| 864 | non-hemodialysis | 2 |
| 865 | non-hemodialysis-dependent | 2 |
| 866 | non-hyperuricemia | 2 |
| 867 | non-immobilised | 2 |
| 868 | non-is | 2 |
| 869 | non-paced | 2 |
| 870 | non-pacemaker-dependent | 2 |
| 871 | non-ps | 2 |
| 872 | non-relax-ahf-type | 2 |
| 873 | non-se | 2 |
| 874 | non-selegiline-treated | 2 |
| 875 | non-uri | 2 |
| 876 | nondelirious | 2 |
| 877 | nonimmobilized | 2 |
| 878 | nonpolydipsic | 2 |
| 879 | normal-magnesium | 2 |
| 880 | normoglyceridemic | 2 |
| 881 | normolipoproteinaemic | 2 |
| 882 | olanzapine-naïve | 2 |
| 883 | oligoanuric | 2 |
| 884 | outclinic | 2 |
| 885 | pa32540-treated | 2 |
| 886 | palifermin-exposed | 2 |
| 887 | palonosetron-treated | 2 |
| 888 | panicking | 2 |
| 889 | pdrn-treated | 2 |
| 890 | peg-ifn-treated | 2 |
| 891 | pi-assigned | 2 |
| 892 | pla-treated | 2 |
| 893 | post-revascularized | 2 |
| 894 | postclimacteric | 2 |
| 895 | posthaemorrhoidectomy | 2 |
| 896 | prostacyclin-treated | 2 |
| 897 | psvf-hf | 2 |
| 898 | q-treated | 2 |
| 899 | rhc1inh-treated | 2 |
| 900 | rizatriptan-treated | 2 |
| 901 | rpv-treated | 2 |
| 902 | safety-evaluable | 2 |
| 903 | safranal-treated | 2 |
| 904 | scp-monitored | 2 |
| 905 | scs-treated | 2 |
| 906 | sdg-treated | 2 |
| 907 | se-negative | 2 |
| 908 | ses-implanted | 2 |
| 909 | sifalimumab-treated | 2 |
| 910 | sirt3-/- | 2 |
| 911 | smart-treated | 2 |
| 912 | somatically-ill | 2 |
| 913 | span-100-negative | 2 |
| 914 | spanish-only-speaking | 2 |
| 915 | stable-cad | 2 |
| 916 | stent/dep | 2 |
| 917 | study-naïve | 2 |
| 918 | su-treated | 2 |
| 919 | sulfasalazine-intolerant | 2 |
| 920 | sulfonylurea-treated | 2 |
| 921 | tabalumab-treated | 2 |
| 922 | tam-responsive | 2 |
| 923 | tazarotene-treated | 2 |
| 924 | tce- | 2 |
| 925 | td2m | 2 |
| 926 | thrombolytic-treated | 2 |
| 927 | tm-treated | 2 |
| 928 | tmp/smx-treated | 2 |
| 929 | tpmt*1/*3c | 2 |
| 930 | traditionally-treated | 2 |
| 931 | transfusion-naïve | 2 |
| 932 | treatment-nonresponsive | 2 |
| 933 | trovafloxacin-treated | 2 |
| 934 | uk-born | 2 |
| 935 | varicocelectomised | 2 |
| 936 | vasoreactive | 2 |
| 937 | vigabatrin-treated | 2 |
| 938 | vtd-treated | 2 |
| 939 | xr-ntx-treated | 2 |
| 940 | βiii-tubulin-positive | 2 |
| 941 | 'frda | 1 |
| 942 | -non-naïve | 1 |
| 943 | 1,063/3,423 | 1 |
| 944 | 1,370/1,905 | 1 |
| 945 | 1,497,254 | 1 |
| 946 | 10,448 | 1 |
| 947 | 10,523 | 1 |
| 948 | 10,599 | 1 |
| 949 | 10,634 | 1 |
| 950 | 10,640 | 1 |
| 951 | 10/205 | 1 |
| 952 | 100-out | 1 |
| 953 | 100/130 | 1 |
| 954 | 107/1,045 | 1 |
| 955 | 107/111 | 1 |
| 956 | 108,212 | 1 |
| 957 | 11,037 | 1 |
| 958 | 11,132 | 1 |
| 959 | 11,228 | 1 |
| 960 | 11,592 | 1 |
| 961 | 11,883 | 1 |
| 962 | 11/537 | 1 |
| 963 | 11035 | 1 |
| 964 | 11140 | 1 |
| 965 | 11471 | 1 |
| 966 | 12,428 | 1 |
| 967 | 12,562 | 1 |
| 968 | 12.218 | 1 |
| 969 | 12/209 | 1 |
| 970 | 12/256 | 1 |
| 971 | 12/512 | 1 |
| 972 | 12092 | 1 |
| 973 | 124-130 | 1 |
| 974 | 127/130 | 1 |
| 975 | 127/324 | 1 |
| 976 | 12782 | 1 |
| 977 | 13,593 | 1 |
| 978 | 131/157 | 1 |
| 979 | 131/160 | 1 |
| 980 | 13104 | 1 |
| 981 | 133/124 | 1 |
| 982 | 135/189 | 1 |
| 983 | 13517 | 1 |
| 984 | 137,574 | 1 |
| 985 | 138/589 | 1 |
| 986 | 14,923 | 1 |
| 987 | 14/133 | 1 |
| 988 | 14/152 | 1 |
| 989 | 144,605 | 1 |
| 990 | 145/1,080 | 1 |
| 991 | 15,362 | 1 |
| 992 | 15,601 | 1 |
| 993 | 15,761 | 1 |
| 994 | 15/270 | 1 |
| 995 | 153/1725 | 1 |
| 996 | 157/184 | 1 |
| 997 | 16,323 | 1 |
| 998 | 16,485 | 1 |
| 999 | 16,519 | 1 |
| 1000 | 16,728 | 1 |
| 1001 | 16,742 | 1 |
| 1002 | 16/146 | 1 |
| 1003 | 16/66 | 1 |
| 1004 | 17,219 | 1 |
| 1005 | 17,236 | 1 |
| 1006 | 17/210 | 1 |
| 1007 | 176,505 | 1 |
| 1008 | 18,207 | 1 |
| 1009 | 18,270 | 1 |
| 1010 | 18,662 | 1 |
| 1011 | 18-35-month-old | 1 |
| 1012 | 187,056 | 1 |
| 1013 | 19/68 | 1 |
| 1014 | 192,036 | 1 |
| 1015 | 192ir-treated | 1 |
| 1016 | 197/300 | 1 |
| 1017 | 2,388 | 1 |
| 1018 | 20,410 | 1 |
| 1019 | 20,503 | 1 |
| 1020 | 20,990 | 1 |
| 1021 | 20/157 | 1 |
| 1022 | 208/2121 | 1 |
| 1023 | 21,105 | 1 |
| 1024 | 21,340 | 1 |
| 1025 | 211,920 | 1 |
| 1026 | 218/294 | 1 |
| 1027 | 22,092 | 1 |
| 1028 | 22,530 | 1 |
| 1029 | 22,590 | 1 |
| 1030 | 22,602 | 1 |
| 1031 | 23,110 | 1 |
| 1032 | 23,480 | 1 |
| 1033 | 23,721 | 1 |
| 1034 | 23,962 | 1 |
| 1035 | 23/169 | 1 |
| 1036 | 23/98 | 1 |
| 1037 | 236/242 | 1 |
| 1038 | 24,076 | 1 |
| 1039 | 24,753 | 1 |
| 1040 | 24,779 | 1 |
| 1041 | 24/115 | 1 |
| 1042 | 244/3,423 | 1 |
| 1043 | 2485/7432 | 1 |
| 1044 | 25,661 | 1 |
| 1045 | 25/47 | 1 |
| 1046 | 25/97 | 1 |
| 1047 | 2504/7250 | 1 |
| 1048 | 26/152 | 1 |
| 1049 | 26/195 | 1 |
| 1050 | 27/139 | 1 |
| 1051 | 28,091 | 1 |
| 1052 | 28,636 | 1 |
| 1053 | 28/188 | 1 |
| 1054 | 28/38 | 1 |
| 1055 | 280,081 | 1 |
| 1056 | 2865-3611 | 1 |
| 1057 | 287/4395 | 1 |
| 1058 | 29,677 | 1 |
| 1059 | 29/98 | 1 |
| 1060 | 3,479 | 1 |
| 1061 | 3,512 | 1 |
| 1062 | 3,648 | 1 |
| 1063 | 3,767 | 1 |
| 1064 | 3,777 | 1 |
| 1065 | 3,865 | 1 |
| 1066 | 3,931 | 1 |
| 1067 | 3,987 | 1 |
| 1068 | 3/184 | 1 |
| 1069 | 3/753 | 1 |
| 1070 | 30/146 | 1 |
| 1071 | 30/232 | 1 |
| 1072 | 30/71 | 1 |
| 1073 | 313/344 | 1 |
| 1074 | 32,085 | 1 |
| 1075 | 32,431 | 1 |
| 1076 | 32,689 | 1 |
| 1077 | 32/120 | 1 |
| 1078 | 321/808 | 1 |
| 1079 | 33,244 | 1 |
| 1080 | 33,611 | 1 |
| 1081 | 33/1168 | 1 |
| 1082 | 336/347 | 1 |
| 1083 | 34,677 | 1 |
| 1084 | 356/506 | 1 |
| 1085 | 36,312 | 1 |
| 1086 | 36,406 | 1 |
| 1087 | 36,567 | 1 |
| 1088 | 36/178 | 1 |
| 1089 | 36/468 | 1 |
| 1090 | 364/418 | 1 |
| 1091 | 37/9/0 | 1 |
| 1092 | 38,489 | 1 |
| 1093 | 38,803 | 1 |
| 1094 | 3diabetic | 1 |
| 1095 | 4,076 | 1 |
| 1096 | 4,205 | 1 |
| 1097 | 4,291 | 1 |
| 1098 | 4,308 | 1 |
| 1099 | 4,432 | 1 |
| 1100 | 4,548 | 1 |
| 1101 | 4,592 | 1 |
| 1102 | 4,677 | 1 |
| 1103 | 4,681 | 1 |
| 1104 | 4,833 | 1 |
| 1105 | 4,934 | 1 |
| 1106 | 404/409 | 1 |
| 1107 | 41,256 | 1 |
| 1108 | 41/275 | 1 |
| 1109 | 42/113 | 1 |
| 1110 | 43/85 | 1 |
| 1111 | 430/943 | 1 |
| 1112 | 44,346 | 1 |
| 1113 | 45/132 | 1 |
| 1114 | 461/508 | 1 |
| 1115 | 47/75 | 1 |
| 1116 | 4746/7250 | 1 |
| 1117 | 48/2/0/0 | 1 |
| 1118 | 5,064 | 1 |
| 1119 | 5,179 | 1 |
| 1120 | 5,348 | 1 |
| 1121 | 5,559 | 1 |
| 1122 | 5,820 | 1 |
| 1123 | 5,871 | 1 |
| 1124 | 5,952 | 1 |
| 1125 | 50,397 | 1 |
| 1126 | 51,640 | 1 |
| 1127 | 51/74 | 1 |
| 1128 | 517/591 | 1 |
| 1129 | 52/58 | 1 |
| 1130 | 5293 | 1 |
| 1131 | 53/124 | 1 |
| 1132 | 53/433 | 1 |
| 1133 | 55/210 | 1 |
| 1134 | 55/610 | 1 |
| 1135 | 5577 | 1 |
| 1136 | 5588 | 1 |
| 1137 | 57,205 | 1 |
| 1138 | 5702 | 1 |
| 1139 | 5847 | 1 |
| 1140 | 599/1076 | 1 |
| 1141 | 6,187 | 1 |
| 1142 | 6,355 | 1 |
| 1143 | 6,446 | 1 |
| 1144 | 6,591 | 1 |
| 1145 | 6,746 | 1 |
| 1146 | 6,953 | 1 |
| 1147 | 6.forty-one | 1 |
| 1148 | 60,705 | 1 |
| 1149 | 60,719 | 1 |
| 1150 | 60/286 | 1 |
| 1151 | 6001 | 1 |
| 1152 | 607/1,084 | 1 |
| 1153 | 61,774 | 1 |
| 1154 | 6121 | 1 |
| 1155 | 6160 | 1 |
| 1156 | 6191 | 1 |
| 1157 | 627/666 | 1 |
| 1158 | 628/657 | 1 |
| 1159 | 64/208 | 1 |
| 1160 | 6492 | 1 |
| 1161 | 65/2121 | 1 |
| 1162 | 65/404 | 1 |
| 1163 | 65/602 | 1 |
| 1164 | 6503 | 1 |
| 1165 | 6510 | 1 |
| 1166 | 6518 | 1 |
| 1167 | 6675 | 1 |
| 1168 | 6769 | 1 |
| 1169 | 6848 | 1 |
| 1170 | 69/124 | 1 |
| 1171 | 69/69 | 1 |
| 1172 | 69/89 | 1 |
| 1173 | 6956 | 1 |
| 1174 | 7,016 | 1 |
| 1175 | 7,110 | 1 |
| 1176 | 7,427 | 1 |
| 1177 | 7,484 | 1 |
| 1178 | 7,683 | 1 |
| 1179 | 7,863 | 1 |
| 1180 | 7/3/3 | 1 |
| 1181 | 70/151 | 1 |
| 1182 | 700young | 1 |
| 1183 | 7034 | 1 |
| 1184 | 7162 | 1 |
| 1185 | 72/139 | 1 |
| 1186 | 72/184 | 1 |
| 1187 | 730,664 | 1 |
| 1188 | 734,269 | 1 |
| 1189 | 7364 | 1 |
| 1190 | 7370 | 1 |
| 1191 | 74,256 | 1 |
| 1192 | 74/128 | 1 |
| 1193 | 7476 | 1 |
| 1194 | 7748 | 1 |
| 1195 | 7855 | 1 |
| 1196 | 7888 | 1 |
| 1197 | 79/2,358 | 1 |
| 1198 | 7928 | 1 |
| 1199 | 7967 | 1 |
| 1200 | 8,301 | 1 |
| 1201 | 8,557 | 1 |
| 1202 | 8,966 | 1 |
| 1203 | 8167 | 1 |
| 1204 | 82/98 | 1 |
| 1205 | 8399 | 1 |
| 1206 | 84,429 | 1 |
| 1207 | 84,865 | 1 |
| 1208 | 847/1,518 | 1 |
| 1209 | 8522 | 1 |
| 1210 | 8586 | 1 |
| 1211 | 86/105 | 1 |
| 1212 | 87/104 | 1 |
| 1213 | 870/1955 | 1 |
| 1214 | 8757 | 1 |
| 1215 | 8810 | 1 |
| 1216 | 8838 | 1 |
| 1217 | 8845 | 1 |
| 1218 | 89/641 | 1 |
| 1219 | 89/92 | 1 |
| 1220 | 8991 | 1 |
| 1221 | 9,175 | 1 |
| 1222 | 9,481 | 1 |
| 1223 | 9,544 | 1 |
| 1224 | 9,709 | 1 |
| 1225 | 9,989 | 1 |
| 1226 | 9/2011,57 | 1 |
| 1227 | 90/104 | 1 |
| 1228 | 91/616 | 1 |
| 1229 | 9185 | 1 |
| 1230 | 9189 | 1 |
| 1231 | 9247 | 1 |
| 1232 | 93/98 | 1 |
| 1233 | 9464 | 1 |
| 1234 | 95/186 | 1 |
| 1235 | 95/351 | 1 |
| 1236 | 96/107 | 1 |
| 1237 | 9770 | 1 |
| 1238 | 98/151 | 1 |
| 1239 | 9853 | 1 |
| 1240 | 9858 | 1 |
| 1241 | 99,935 | 1 |
| 1242 | 99/290 | 1 |
| 1243 | 996,364 | 1 |
| 1244 | 9987 | 1 |
| 1245 | abatacept+mtx-treated | 1 |
| 1246 | acadesine-treated | 1 |
| 1247 | ada+mtx-treated | 1 |
| 1248 | adenovirus-treated | 1 |
| 1249 | aggressive-treatment | 1 |
| 1250 | ai-treated | 1 |
| 1251 | aki-free | 1 |
| 1252 | alefacept-treated | 1 |
| 1253 | altri | 1 |
| 1254 | amenorrhea-in | 1 |
| 1255 | amphetamine-treated | 1 |
| 1256 | analgesic-naïve | 1 |
| 1257 | anosognosic | 1 |
| 1258 | anthracyline-treated | 1 |
| 1259 | anti-gad-positive | 1 |
| 1260 | antibiotic-administered | 1 |
| 1261 | antipsychotic-naive/early-phase | 1 |
| 1262 | apl- | 1 |
| 1263 | arrhythmiaprone | 1 |
| 1264 | asian/black | 1 |
| 1265 | aspirin-anticoagulant-treated | 1 |
| 1266 | atd-treated | 1 |
| 1267 | avosentan-treated | 1 |
| 1268 | bacteriologically-positive | 1 |
| 1269 | balicatib-treated | 1 |
| 1270 | balloon-trained | 1 |
| 1271 | benzodiazepine-tolerant | 1 |
| 1272 | besifloxacin-treated | 1 |
| 1273 | bioha-treated | 1 |
| 1274 | bisphosphonate-exposed | 1 |
| 1275 | biv-treated | 1 |
| 1276 | bleeding-prone | 1 |
| 1277 | bon-bos | 1 |
| 1278 | bortezomib-naïve | 1 |
| 1279 | bpv-evaluable | 1 |
| 1280 | bronchopathic | 1 |
| 1281 | bt-naive | 1 |
| 1282 | by-preference | 1 |
| 1283 | camg-treated | 1 |
| 1284 | cangrelor-treated | 1 |
| 1285 | capecitabine-treated | 1 |
| 1286 | cardio-surgical | 1 |
| 1287 | cardioswrgical | 1 |
| 1288 | cefoxitin-treated | 1 |
| 1289 | cetuximab-naïve | 1 |
| 1290 | chd/dm2 | 1 |
| 1291 | chemoradiated | 1 |
| 1292 | chemotherapy-untreated | 1 |
| 1293 | cic-treated | 1 |
| 1294 | cirrhostic | 1 |
| 1295 | cisplatin-naοve | 1 |
| 1296 | ckd-nafld | 1 |
| 1297 | clopidogrel-loaded | 1 |
| 1298 | clozapine-naive | 1 |
| 1299 | cocaine/methamphetamine-dependent | 1 |
| 1300 | com-treated | 1 |
| 1301 | coronaropathic | 1 |
| 1302 | corticosteroid-naïve | 1 |
| 1303 | csa-immunosupressed | 1 |
| 1304 | csr.sixty | 1 |
| 1305 | cyc/aza-treated | 1 |
| 1306 | cyclosporine-a-treated | 1 |
| 1307 | cyp2d6/cyp2c19 | 1 |
| 1308 | czp-exposed | 1 |
| 1309 | d4t-naive | 1 |
| 1310 | dabigatran-assigned | 1 |
| 1311 | danazol-treated | 1 |
| 1312 | deep-burnt | 1 |
| 1313 | deficit-state | 1 |
| 1314 | degarelix-treated | 1 |
| 1315 | dexmedetomidine-added | 1 |
| 1316 | dgf-risk | 1 |
| 1317 | dibenzo-fused | 1 |
| 1318 | diet-failed | 1 |
| 1319 | difficult-access | 1 |
| 1320 | digitalis-treated | 1 |
| 1321 | disqualifies | 1 |
| 1322 | divalproex-resistant | 1 |
| 1323 | divalproextreated | 1 |
| 1324 | dmr-treated | 1 |
| 1325 | dolasetron-treated | 1 |
| 1326 | drb1*13 | 1 |
| 1327 | drisapersen-treated | 1 |
| 1328 | dsa+non-dsa | 1 |
| 1329 | dscg-treated | 1 |
| 1330 | dtth-ish | 1 |
| 1331 | duloxetine-resistant | 1 |
| 1332 | dz1-treated | 1 |
| 1333 | early-mild | 1 |
| 1334 | early-stage-disease | 1 |
| 1335 | ebv-seropositive | 1 |
| 1336 | efficacy.sixty | 1 |
| 1337 | elderly/unfit | 1 |
| 1338 | empagliflozin-treated | 1 |
| 1339 | ems-transported | 1 |
| 1340 | en-treated | 1 |
| 1341 | eosin-positive | 1 |
| 1342 | epi-treated | 1 |
| 1343 | epoetin-treated | 1 |
| 1344 | erythroid-responding | 1 |
| 1345 | etomidate-treated | 1 |
| 1346 | eu-treated | 1 |
| 1347 | eugenol-sensitized | 1 |
| 1348 | eugonadal/hypogonadal | 1 |
| 1349 | extrahospitalized | 1 |
| 1350 | famotidine-treated | 1 |
| 1351 | faod | 1 |
| 1352 | fec-treated | 1 |
| 1353 | fh-dose | 1 |
| 1354 | fibrinogen-treated | 1 |
| 1355 | fludarabine-resistant | 1 |
| 1356 | fludarabine-sensitive | 1 |
| 1357 | fluid-optimized | 1 |
| 1358 | fmh-treated | 1 |
| 1359 | fnc-treated | 1 |
| 1360 | folfox-4-treated | 1 |
| 1361 | folfox/placebo | 1 |
| 1362 | fontan-palliated | 1 |
| 1363 | g-400-administered | 1 |
| 1364 | g1-infected | 1 |
| 1365 | g1/4/6 | 1 |
| 1366 | ga2-positive | 1 |
| 1367 | ganciclovir-treated | 1 |
| 1368 | gastroparietic | 1 |
| 1369 | gbv-c+ | 1 |
| 1370 | gepirone-treated | 1 |
| 1371 | glucagon-infused | 1 |
| 1372 | gm-csf-treated | 1 |
| 1373 | gonadotropin-deficiency | 1 |
| 1374 | good-performance-status | 1 |
| 1375 | grepafloxacin-treated | 1 |
| 1376 | group-d | 1 |
| 1377 | growth-hormone-deficient | 1 |
| 1378 | gs9450-treated | 1 |
| 1379 | harder-to-treat | 1 |
| 1380 | hbv-treated | 1 |
| 1381 | hc2+/hsil- | 1 |
| 1382 | hcv-1/4 | 1 |
| 1383 | hcv-1b-infected | 1 |
| 1384 | hcv-naive | 1 |
| 1385 | hdle-treated | 1 |
| 1386 | healon-treated | 1 |
| 1387 | healthy/osteopenic/osteoporotic | 1 |
| 1388 | heliox-treated | 1 |
| 1389 | high/very-high-risk | 1 |
| 1390 | higher-acuity | 1 |
| 1391 | higher-aged | 1 |
| 1392 | hipertensive | 1 |
| 1393 | hiv-untreated | 1 |
| 1394 | hivinfected | 1 |
| 1395 | hla-mica- | 1 |
| 1396 | hp-infected | 1 |
| 1397 | hpm-treated | 1 |
| 1398 | hs-diabetic | 1 |
| 1399 | ht-responsive | 1 |
| 1400 | hydroxyflutamide-resistant | 1 |
| 1401 | hyperchoelsterolemic | 1 |
| 1402 | hypercholesterolamic | 1 |
| 1403 | hypertriglycemic | 1 |
| 1404 | hypocortisolemic | 1 |
| 1405 | hypofiltering | 1 |
| 1406 | hypothyroidian | 1 |
| 1407 | i1307k-positive | 1 |
| 1408 | iaa-positive | 1 |
| 1409 | id/autistic | 1 |
| 1410 | ifn-alpha-treated | 1 |
| 1411 | ifnbeta-treated | 1 |
| 1412 | ifnβ1a-treated | 1 |
| 1413 | iiiic | 1 |
| 1414 | ileoresected | 1 |
| 1415 | imatinib-resistant/intolerant | 1 |
| 1416 | immune-depressed | 1 |
| 1417 | immunecompetent | 1 |
| 1418 | immuno-compromized | 1 |
| 1419 | incretin-naive | 1 |
| 1420 | infliximab-exposed | 1 |
| 1421 | infliximab-naive | 1 |
| 1422 | integrase-naive | 1 |
| 1423 | interferon-alpha-refractory | 1 |
| 1424 | interferon-experienced | 1 |
| 1425 | invasive-cooled | 1 |
| 1426 | iodide-treated | 1 |
| 1427 | ipragliflozin-treated | 1 |
| 1428 | irs-i | 1 |
| 1429 | is-dependent | 1 |
| 1430 | iv-tpa-eligible | 1 |
| 1431 | iv-tpa-ineligible | 1 |
| 1432 | jak2v617f-positive | 1 |
| 1433 | khalesseh | 1 |
| 1434 | kidney-recipient | 1 |
| 1435 | knee-surgery | 1 |
| 1436 | lb03002-treated | 1 |
| 1437 | lcz696-treated | 1 |
| 1438 | lecithin-treated | 1 |
| 1439 | less-sick | 1 |
| 1440 | levo-treated | 1 |
| 1441 | lipedematous | 1 |
| 1442 | lipid-treatment-naive | 1 |
| 1443 | long-hd | 1 |
| 1444 | long-responding | 1 |
| 1445 | low-dose-treated | 1 |
| 1446 | low-pra | 1 |
| 1447 | low-qor | 1 |
| 1448 | low-tolerance | 1 |
| 1449 | lower-triglyceride | 1 |
| 1450 | lvd-refractory | 1 |
| 1451 | lvh-negative | 1 |
| 1452 | lvh-positive | 1 |
| 1453 | lysozyme-sensitive | 1 |
| 1454 | madit-ii-like | 1 |
| 1455 | madrid.the | 1 |
| 1456 | malignant-neoplasm | 1 |
| 1457 | mastectomised | 1 |
| 1458 | medical-ward | 1 |
| 1459 | mesalamine-treated | 1 |
| 1460 | metformin-cotreated | 1 |
| 1461 | metformin-resistant | 1 |
| 1462 | methylergonovine-treated | 1 |
| 1463 | mezlocillin-treated | 1 |
| 1464 | mgn-3-treated | 1 |
| 1465 | midazolam-sedated | 1 |
| 1466 | migraine/rls | 1 |
| 1467 | mild-group | 1 |
| 1468 | misleads | 1 |
| 1469 | mismatch-selected | 1 |
| 1470 | mite-monosensitized | 1 |
| 1471 | mixed-ancestry | 1 |
| 1472 | mln-treated | 1 |
| 1473 | mood-disordered | 1 |
| 1474 | msc-infused | 1 |
| 1475 | mtx+iast-treated | 1 |
| 1476 | muscle-wasted | 1 |
| 1477 | mycophenolate/dexamethasone-responsive | 1 |
| 1478 | near-lepromatous | 1 |
| 1479 | neck-immobilized | 1 |
| 1480 | neck-irradiated | 1 |
| 1481 | nephropatic | 1 |
| 1482 | neurology/neurosurgical | 1 |
| 1483 | neutropenia-free | 1 |
| 1484 | ng-eligible | 1 |
| 1485 | niv-treated | 1 |
| 1486 | no-fixation | 1 |
| 1487 | no-prior-cabg | 1 |
| 1488 | non-amyloidosis | 1 |
| 1489 | non-arb-exposed | 1 |
| 1490 | non-asiatic | 1 |
| 1491 | non-bevacizumab-treated | 1 |
| 1492 | non-cannabis-using | 1 |
| 1493 | non-cepacia | 1 |
| 1494 | non-ces | 1 |
| 1495 | non-ci-aki | 1 |
| 1496 | non-co-enrolled | 1 |
| 1497 | non-estrogen-treated | 1 |
| 1498 | non-hbv-infected | 1 |
| 1499 | non-hdl-deficient | 1 |
| 1500 | non-hyponatremic | 1 |
| 1501 | non-immunodepressed | 1 |
| 1502 | non-isr | 1 |
| 1503 | non-korsakoff | 1 |
| 1504 | non-ldlr/non-apob | 1 |
| 1505 | non-lvd | 1 |
| 1506 | non-mg | 1 |
| 1507 | non-readmitted | 1 |
| 1508 | non-resectable.the | 1 |
| 1509 | non-t-all | 1 |
| 1510 | non-tegaserod-using | 1 |
| 1511 | nonalexithymic | 1 |
| 1512 | nonconverted | 1 |
| 1513 | nondehydrated | 1 |
| 1514 | nondeleted | 1 |
| 1515 | nonduloxetine | 1 |
| 1516 | nonextractions | 1 |
| 1517 | nonsurgery | 1 |
| 1518 | nor-treated | 1 |
| 1519 | normal-responding | 1 |
| 1520 | normo-triglyceridemic | 1 |
| 1521 | normoalbuminemic | 1 |
| 1522 | normonatraemic | 1 |
| 1523 | normouricaemic | 1 |
| 1524 | novasospasm | 1 |
| 1525 | nsaid-sensitive | 1 |
| 1526 | ntz-treated | 1 |
| 1527 | numberless | 1 |
| 1528 | oligo-amenorrhoeic | 1 |
| 1529 | olmesartan-using | 1 |
| 1530 | om-89-treated | 1 |
| 1531 | onartuzumab-treated | 1 |
| 1532 | oncourologic | 1 |
| 1533 | opiate-naïve | 1 |
| 1534 | orbofiban-treated | 1 |
| 1535 | organ-transplant | 1 |
| 1536 | ot-treated | 1 |
| 1537 | otelixizumab-treated | 1 |
| 1538 | p/evl-treated | 1 |
| 1539 | pa-with | 1 |
| 1540 | pacing-indicated | 1 |
| 1541 | paclitaxel-refractory | 1 |
| 1542 | parecoxib/valdecoxib-treated | 1 |
| 1543 | pazo-panib-treated | 1 |
| 1544 | pci-assigned | 1 |
| 1545 | pcp-diagnosed | 1 |
| 1546 | peep-ventilated | 1 |
| 1547 | pen-naive | 1 |
| 1548 | penicillin-tolerant | 1 |
| 1549 | periostin-high | 1 |
| 1550 | pft-treated | 1 |
| 1551 | pge2-treated | 1 |
| 1552 | phvhf-treated | 1 |
| 1553 | pi-naïve | 1 |
| 1554 | pi-treatment-naïve | 1 |
| 1555 | pin/asap | 1 |
| 1556 | piracetam-treated | 1 |
| 1557 | placebo-given | 1 |
| 1558 | plasma-exchanged | 1 |
| 1559 | platinum-eligible | 1 |
| 1560 | platinum-sensitive/intermediate | 1 |
| 1561 | plato-usa | 1 |
| 1562 | pmmd | 1 |
| 1563 | politraumatized | 1 |
| 1564 | poor-responding | 1 |
| 1565 | post-bltx | 1 |
| 1566 | post-cardiac-surgery | 1 |
| 1567 | post-kc | 1 |
| 1568 | post-oa | 1 |
| 1569 | post-pkp | 1 |
| 1570 | postcoarctectomy | 1 |
| 1571 | predialysis-ckd | 1 |
| 1572 | ptbii-positive | 1 |
| 1573 | pulse-treated | 1 |
| 1574 | ra-refractory | 1 |
| 1575 | radiotherapy-naive | 1 |
| 1576 | radiotherapy-naïve | 1 |
| 1577 | raltegravir-treated | 1 |
| 1578 | recently-symptomatic | 1 |
| 1579 | refractory-relapsed | 1 |
| 1580 | resected/resectable | 1 |
| 1581 | rhythm-controlled | 1 |
| 1582 | ris-st-treated | 1 |
| 1583 | rituximab-retreated | 1 |
| 1584 | rotigotine-treated | 1 |
| 1585 | saxagliptin-naive | 1 |
| 1586 | schizophrenia—the | 1 |
| 1587 | scorpion-stung | 1 |
| 1588 | screening-derived | 1 |
| 1589 | screening-only | 1 |
| 1590 | sensory-disabled | 1 |
| 1591 | septic-shock | 1 |
| 1592 | severely-disabled | 1 |
| 1593 | severity.thirty-nine | 1 |
| 1594 | sibutraminetreated | 1 |
| 1595 | sifalimumab-dosed | 1 |
| 1596 | signature-negative | 1 |
| 1597 | simvastatintreated | 1 |
| 1598 | single-stented | 1 |
| 1599 | sk-treated | 1 |
| 1600 | skilled-nursing | 1 |
| 1601 | sm-injured | 1 |
| 1602 | snakebitten | 1 |
| 1603 | somatostatin-treated | 1 |
| 1604 | sotalol-treated | 1 |
| 1605 | sp100-negative | 1 |
| 1606 | sparfloxacin-treated | 1 |
| 1607 | spinally-injured | 1 |
| 1608 | spondylarthroses | 1 |
| 1609 | srl-converted | 1 |
| 1610 | ssa/ssb-negative | 1 |
| 1611 | ssv-treated | 1 |
| 1612 | staple-treated | 1 |
| 1613 | statin/ezetimibe-treated | 1 |
| 1614 | subgroup-2 | 1 |
| 1615 | sunitinib-intolerant | 1 |
| 1616 | super-morbid-obese | 1 |
| 1617 | surface-cooled | 1 |
| 1618 | surgery-treated | 1 |
| 1619 | t12pr24-treated | 1 |
| 1620 | t2dm.fourty-four | 1 |
| 1621 | t4-substituted | 1 |
| 1622 | tachosil®-treated | 1 |
| 1623 | tacrolimus-cotreated | 1 |
| 1624 | tbi/sah | 1 |
| 1625 | tdf/ftc-treated | 1 |
| 1626 | tension-headache | 1 |
| 1627 | terbutaline-treated | 1 |
| 1628 | teriparatide-receiving | 1 |
| 1629 | tesamorelin-treated | 1 |
| 1630 | tezosentan-treated | 1 |
| 1631 | tg-matched | 1 |
| 1632 | tg-mmc-treated | 1 |
| 1633 | tilt-negative | 1 |
| 1634 | timothy-treated | 1 |
| 1635 | tip-treated | 1 |
| 1636 | tlv-treated | 1 |
| 1637 | tnfi-experienced | 1 |
| 1638 | tnfα-antagonist-naïve | 1 |
| 1639 | total,116 | 1 |
| 1640 | traumatic-hemorrhagic | 1 |
| 1641 | treatment-exposed | 1 |
| 1642 | trial.cirrhotic | 1 |
| 1643 | triflusal-treated | 1 |
| 1644 | trimethoprim/sulfamethoxazole-treated | 1 |
| 1645 | ttv-positive | 1 |
| 1646 | tuberculosis-coinfected | 1 |
| 1647 | u.s.-treated | 1 |
| 1648 | uf-intolerant | 1 |
| 1649 | un-transfused | 1 |
| 1650 | under-dosaged | 1 |
| 1651 | usl255-treated | 1 |
| 1652 | vaniprevir-treated | 1 |
| 1653 | vareniclinetreated | 1 |
| 1654 | varicocele-affected | 1 |
| 1655 | vasoplegic | 1 |
| 1656 | ventilaled | 1 |
| 1657 | ventilated-group | 1 |
| 1658 | vka-naïve | 1 |
| 1659 | vlx-treated | 1 |
| 1660 | volume-responsive | 1 |
| 1661 | vv1 | 1 |
| 1662 | well-suppressed | 1 |
| 1663 | wheelchair-mobilised | 1 |
| 1664 | working/in-school | 1 |
| 1665 | xenon-treated | 1 |
| 1666 | zdv/3tc/nvp-treated | 1 |
| 1667 | zeep-ventilated | 1 |
| 1668 | α-blocker-naïve | 1 |
| 1669 | ≤50-year-old | 1 |
| 1 | 'frda | 1 |
| 2 | 'non-trial | 3 |
| 3 | -ineligible | 3 |
| 4 | -non-naïve | 1 |
| 5 | -seronegative | 5 |
| 6 | 1,063/3,423 | 1 |
| 7 | 1,370/1,905 | 1 |
| 8 | 1,476 | 4 |
| 9 | 1,497,254 | 1 |
| 10 | 1,591 | 7 |
| 11 | 1,628 | 4 |
| 12 | 1,653 | 4 |
| 13 | 1,664 | 4 |
| 14 | 1,792 | 5 |
| 15 | 1-to-5-year-old | 2 |
| 16 | 10,001 | 12 |
| 17 | 10,448 | 1 |
| 18 | 10,523 | 1 |
| 19 | 10,599 | 1 |
| 20 | 10,634 | 1 |
| 21 | 10,640 | 1 |
| 22 | 10/205 | 1 |
| 23 | 100-out | 1 |
| 24 | 100/130 | 1 |
| 25 | 104.408 | 2 |
| 26 | 107/1,045 | 1 |
| 27 | 107/111 | 1 |
| 28 | 108,212 | 1 |
| 29 | 11,037 | 1 |
| 30 | 11,132 | 1 |
| 31 | 11,228 | 1 |
| 32 | 11,324 | 2 |
| 33 | 11,506 | 2 |
| 34 | 11,592 | 1 |
| 35 | 11,883 | 1 |
| 36 | 11/537 | 1 |
| 37 | 11035 | 1 |
| 38 | 11140 | 1 |
| 39 | 11471 | 1 |
| 40 | 12,428 | 1 |
| 41 | 12,562 | 1 |
| 42 | 12.218 | 1 |
| 43 | 12/209 | 1 |
| 44 | 12/256 | 1 |
| 45 | 12/512 | 1 |
| 46 | 12092 | 1 |
| 47 | 124-130 | 1 |
| 48 | 127/130 | 1 |
| 49 | 127/324 | 1 |
| 50 | 12782 | 1 |
| 51 | 13,593 | 1 |
| 52 | 13,819 | 7 |
| 53 | 13,875 | 2 |
| 54 | 13,990 | 2 |
| 55 | 131/157 | 1 |
| 56 | 131/160 | 1 |
| 57 | 13104 | 1 |
| 58 | 131i-treated | 3 |
| 59 | 133/124 | 1 |
| 60 | 135/189 | 1 |
| 61 | 13517 | 1 |
| 62 | 137,574 | 1 |
| 63 | 138/589 | 1 |
| 64 | 14,611 | 2 |
| 65 | 14,703 | 6 |
| 66 | 14,923 | 1 |
| 67 | 14/133 | 1 |
| 68 | 14/152 | 1 |
| 69 | 14/36 | 2 |
| 70 | 144,605 | 1 |
| 71 | 145/1,080 | 1 |
| 72 | 15,362 | 1 |
| 73 | 15,601 | 1 |
| 74 | 15,761 | 1 |
| 75 | 15,939 | 4 |
| 76 | 15/270 | 1 |
| 77 | 153/1725 | 1 |
| 78 | 157/184 | 1 |
| 79 | 16,323 | 1 |
| 80 | 16,485 | 1 |
| 81 | 16,519 | 1 |
| 82 | 16,728 | 1 |
| 83 | 16,742 | 1 |
| 84 | 16/146 | 1 |
| 85 | 16/66 | 1 |
| 86 | 17,219 | 1 |
| 87 | 17,236 | 1 |
| 88 | 17/210 | 1 |
| 89 | 176,505 | 1 |
| 90 | 18,201 | 6 |
| 91 | 18,207 | 1 |
| 92 | 18,270 | 1 |
| 93 | 18,662 | 1 |
| 94 | 18-35-month-old | 1 |
| 95 | 187,056 | 1 |
| 96 | 19,102 | 2 |
| 97 | 19,185 | 4 |
| 98 | 19,193 | 3 |
| 99 | 19/156 | 2 |
| 100 | 19/68 | 1 |
| 101 | 192,036 | 1 |
| 102 | 192ir-treated | 1 |
| 103 | 197/300 | 1 |
| 104 | 2,065 | 3 |
| 105 | 2,181 | 3 |
| 106 | 2,231 | 4 |
| 107 | 2,251 | 2 |
| 108 | 2,257 | 2 |
| 109 | 2,331 | 13 |
| 110 | 2,364 | 3 |
| 111 | 2,388 | 1 |
| 112 | 2,466 | 7 |
| 113 | 2,662 | 4 |
| 114 | 2,769 | 3 |
| 115 | 2,905 | 2 |
| 116 | 20,410 | 1 |
| 117 | 20,503 | 1 |
| 118 | 20,990 | 1 |
| 119 | 20/157 | 1 |
| 120 | 208/2121 | 1 |
| 121 | 21,105 | 1 |
| 122 | 21,340 | 1 |
| 123 | 211,920 | 1 |
| 124 | 218/294 | 1 |
| 125 | 22,092 | 1 |
| 126 | 22,530 | 1 |
| 127 | 22,590 | 1 |
| 128 | 22,602 | 1 |
| 129 | 23,110 | 1 |
| 130 | 23,480 | 1 |
| 131 | 23,721 | 1 |
| 132 | 23,962 | 1 |
| 133 | 23/169 | 1 |
| 134 | 23/98 | 1 |
| 135 | 236/242 | 1 |
| 136 | 24,076 | 1 |
| 137 | 24,500 | 2 |
| 138 | 24,753 | 1 |
| 139 | 24,779 | 1 |
| 140 | 24/115 | 1 |
| 141 | 2439 | 6 |
| 142 | 244/3,423 | 1 |
| 143 | 2485/7432 | 1 |
| 144 | 25,661 | 1 |
| 145 | 25/47 | 1 |
| 146 | 25/97 | 1 |
| 147 | 2504/7250 | 1 |
| 148 | 26,449 | 4 |
| 149 | 26/152 | 1 |
| 150 | 26/195 | 1 |
| 151 | 27,492 | 3 |
| 152 | 27/139 | 1 |
| 153 | 28,091 | 1 |
| 154 | 28,636 | 1 |
| 155 | 28/188 | 1 |
| 156 | 28/38 | 1 |
| 157 | 280,081 | 1 |
| 158 | 2865-3611 | 1 |
| 159 | 287/4395 | 1 |
| 160 | 29,423 | 2 |
| 161 | 29,677 | 1 |
| 162 | 29/234 | 2 |
| 163 | 29/98 | 1 |
| 164 | 3,202 | 3 |
| 165 | 3,340 | 4 |
| 166 | 3,343 | 2 |
| 167 | 3,479 | 1 |
| 168 | 3,512 | 1 |
| 169 | 3,544 | 6 |
| 170 | 3,558 | 2 |
| 171 | 3,648 | 1 |
| 172 | 3,687 | 6 |
| 173 | 3,746 | 2 |
| 174 | 3,767 | 1 |
| 175 | 3,777 | 1 |
| 176 | 3,865 | 1 |
| 177 | 3,931 | 1 |
| 178 | 3,987 | 1 |
| 179 | 3/184 | 1 |
| 180 | 3/753 | 1 |
| 181 | 30/146 | 1 |
| 182 | 30/232 | 1 |
| 183 | 30/71 | 1 |
| 184 | 313/344 | 1 |
| 185 | 32,085 | 1 |
| 186 | 32,431 | 1 |
| 187 | 32,689 | 1 |
| 188 | 32/120 | 1 |
| 189 | 321/808 | 1 |
| 190 | 33,244 | 1 |
| 191 | 33,611 | 1 |
| 192 | 33/1168 | 1 |
| 193 | 336/347 | 1 |
| 194 | 34,677 | 1 |
| 195 | 35,970 | 2 |
| 196 | 356/506 | 1 |
| 197 | 36,312 | 1 |
| 198 | 36,406 | 1 |
| 199 | 36,567 | 1 |
| 200 | 36/178 | 1 |
| 201 | 36/468 | 1 |
| 202 | 364/418 | 1 |
| 203 | 37/9/0 | 1 |
| 204 | 3717 | 2 |
| 205 | 3779 | 5 |
| 206 | 38,489 | 1 |
| 207 | 38,803 | 1 |
| 208 | 3813 | 2 |
| 209 | 3838 | 6 |
| 210 | 3969 | 2 |
| 211 | 3diabetic | 1 |
| 212 | 4,016 | 3 |
| 213 | 4,076 | 1 |
| 214 | 4,081 | 3 |
| 215 | 4,082 | 2 |
| 216 | 4,205 | 1 |
| 217 | 4,291 | 1 |
| 218 | 4,308 | 1 |
| 219 | 4,432 | 1 |
| 220 | 4,548 | 1 |
| 221 | 4,592 | 1 |
| 222 | 4,665 | 2 |
| 223 | 4,677 | 1 |
| 224 | 4,681 | 1 |
| 225 | 4,833 | 1 |
| 226 | 4,934 | 1 |
| 227 | 404/409 | 1 |
| 228 | 4043 | 3 |
| 229 | 41,021 | 3 |
| 230 | 41,256 | 1 |
| 231 | 41/275 | 1 |
| 232 | 42/113 | 1 |
| 233 | 43/85 | 1 |
| 234 | 430/943 | 1 |
| 235 | 44,346 | 1 |
| 236 | 44/75 | 2 |
| 237 | 4464 | 2 |
| 238 | 4468 | 3 |
| 239 | 45/132 | 1 |
| 240 | 4503 | 3 |
| 241 | 461/508 | 1 |
| 242 | 47/75 | 1 |
| 243 | 4732 | 7 |
| 244 | 4746/7250 | 1 |
| 245 | 48/2/0/0 | 1 |
| 246 | 4892 | 3 |
| 247 | 5,044 | 2 |
| 248 | 5,064 | 1 |
| 249 | 5,172 | 2 |
| 250 | 5,179 | 1 |
| 251 | 5,233 | 2 |
| 252 | 5,348 | 1 |
| 253 | 5,552 | 3 |
| 254 | 5,559 | 1 |
| 255 | 5,678 | 2 |
| 256 | 5,820 | 1 |
| 257 | 5,871 | 1 |
| 258 | 5,952 | 1 |
| 259 | 50,397 | 1 |
| 260 | 51,321 | 2 |
| 261 | 51,640 | 1 |
| 262 | 51/74 | 1 |
| 263 | 517/591 | 1 |
| 264 | 52/58 | 1 |
| 265 | 5293 | 1 |
| 266 | 53/124 | 1 |
| 267 | 53/433 | 1 |
| 268 | 5380 | 3 |
| 269 | 5395 | 2 |
| 270 | 54,696 | 3 |
| 271 | 55/210 | 1 |
| 272 | 55/610 | 1 |
| 273 | 5577 | 1 |
| 274 | 5588 | 1 |
| 275 | 57,205 | 1 |
| 276 | 5702 | 1 |
| 277 | 5731 | 2 |
| 278 | 5747 | 3 |
| 279 | 5847 | 1 |
| 280 | 599/1076 | 1 |
| 281 | 6,066 | 2 |
| 282 | 6,187 | 1 |
| 283 | 6,355 | 1 |
| 284 | 6,446 | 1 |
| 285 | 6,591 | 1 |
| 286 | 6,746 | 1 |
| 287 | 6,797 | 3 |
| 288 | 6,953 | 1 |
| 289 | 6.forty-one | 1 |
| 290 | 60,705 | 1 |
| 291 | 60,719 | 1 |
| 292 | 60/286 | 1 |
| 293 | 6001 | 1 |
| 294 | 607/1,084 | 1 |
| 295 | 61,774 | 1 |
| 296 | 6121 | 1 |
| 297 | 6160 | 1 |
| 298 | 6191 | 1 |
| 299 | 6216 | 3 |
| 300 | 627/666 | 1 |
| 301 | 628/657 | 1 |
| 302 | 63/158 | 2 |
| 303 | 6323 | 3 |
| 304 | 64/208 | 1 |
| 305 | 6492 | 1 |
| 306 | 65/2121 | 1 |
| 307 | 65/404 | 1 |
| 308 | 65/602 | 1 |
| 309 | 6503 | 1 |
| 310 | 6510 | 1 |
| 311 | 6518 | 1 |
| 312 | 6675 | 1 |
| 313 | 6769 | 1 |
| 314 | 6780 | 4 |
| 315 | 6848 | 1 |
| 316 | 69/124 | 1 |
| 317 | 69/69 | 1 |
| 318 | 69/89 | 1 |
| 319 | 6906 | 3 |
| 320 | 6956 | 1 |
| 321 | 7,016 | 1 |
| 322 | 7,110 | 1 |
| 323 | 7,150 | 2 |
| 324 | 7,427 | 1 |
| 325 | 7,484 | 1 |
| 326 | 7,489 | 2 |
| 327 | 7,599 | 3 |
| 328 | 7,665 | 2 |
| 329 | 7,683 | 1 |
| 330 | 7,754 | 3 |
| 331 | 7,863 | 1 |
| 332 | 7,954 | 2 |
| 333 | 7/3/3 | 1 |
| 334 | 70/151 | 1 |
| 335 | 700young | 1 |
| 336 | 7034 | 1 |
| 337 | 7162 | 1 |
| 338 | 72/139 | 1 |
| 339 | 72/184 | 1 |
| 340 | 730,664 | 1 |
| 341 | 734,269 | 1 |
| 342 | 7364 | 1 |
| 343 | 7370 | 1 |
| 344 | 74,256 | 1 |
| 345 | 74/128 | 1 |
| 346 | 7448 | 2 |
| 347 | 7476 | 1 |
| 348 | 75/77 | 2 |
| 349 | 7748 | 1 |
| 350 | 7855 | 1 |
| 351 | 7888 | 1 |
| 352 | 79/2,358 | 1 |
| 353 | 7928 | 1 |
| 354 | 7950 | 3 |
| 355 | 7967 | 1 |
| 356 | 8,101 | 2 |
| 357 | 8,301 | 1 |
| 358 | 8,557 | 1 |
| 359 | 8,966 | 1 |
| 360 | 8164 | 5 |
| 361 | 8167 | 1 |
| 362 | 82/98 | 1 |
| 363 | 8399 | 1 |
| 364 | 84,429 | 1 |
| 365 | 84,865 | 1 |
| 366 | 847/1,518 | 1 |
| 367 | 8507 | 2 |
| 368 | 8522 | 1 |
| 369 | 8586 | 1 |
| 370 | 86/105 | 1 |
| 371 | 87/104 | 1 |
| 372 | 870/1955 | 1 |
| 373 | 8757 | 1 |
| 374 | 8810 | 1 |
| 375 | 8831 | 2 |
| 376 | 8838 | 1 |
| 377 | 8845 | 1 |
| 378 | 89/641 | 1 |
| 379 | 89/92 | 1 |
| 380 | 8991 | 1 |
| 381 | 9,175 | 1 |
| 382 | 9,193 | 2 |
| 383 | 9,481 | 1 |
| 384 | 9,544 | 1 |
| 385 | 9,709 | 1 |
| 386 | 9,978 | 2 |
| 387 | 9,989 | 1 |
| 388 | 9/2011,57 | 1 |
| 389 | 90/104 | 1 |
| 390 | 9014 | 9 |
| 391 | 91/616 | 1 |
| 392 | 9185 | 1 |
| 393 | 9189 | 1 |
| 394 | 9247 | 1 |
| 395 | 93/98 | 1 |
| 396 | 9461 | 4 |
| 397 | 9464 | 1 |
| 398 | 95/186 | 1 |
| 399 | 95/351 | 1 |
| 400 | 96/107 | 1 |
| 401 | 9770 | 1 |
| 402 | 9779 | 3 |
| 403 | 98/151 | 1 |
| 404 | 9853 | 1 |
| 405 | 9858 | 1 |
| 406 | 99,935 | 1 |
| 407 | 99/290 | 1 |
| 408 | 996,364 | 1 |
| 409 | 9987 | 1 |
| 410 | aat-deficient | 6 |
| 411 | abatacept+mtx-treated | 1 |
| 412 | abatacept-treated | 21 |
| 413 | abciximab-treated | 9 |
| 414 | ac-treated | 2 |
| 415 | acadesine-treated | 1 |
| 416 | acas-eligible | 4 |
| 417 | ace-intolerant | 7 |
| 418 | acei-intolerant | 2 |
| 419 | acei/arb-treated | 3 |
| 420 | acl-injured | 11 |
| 421 | acpa-negative | 13 |
| 422 | acpa-positive | 22 |
| 423 | acromegalic | 99 |
| 424 | acute-stroke | 2 |
| 425 | ada+mtx-treated | 1 |
| 426 | ada-treated | 3 |
| 427 | adalimumab-randomized | 2 |
| 428 | adalimumab-treated | 38 |
| 429 | adenovirus-treated | 1 |
| 430 | adrc-treated | 5 |
| 431 | adt-treated | 2 |
| 432 | adv-treated | 7 |
| 433 | aggressive-treatment | 1 |
| 434 | ai-treated | 1 |
| 435 | aki-free | 1 |
| 436 | albuminuric | 12 |
| 437 | alcohol-treated | 25 |
| 438 | alefacept-treated | 1 |
| 439 | alemtuzumab-treated | 3 |
| 440 | alitretinoin-treated | 3 |
| 441 | allicor-treated | 4 |
| 442 | alloxan-diabetic | 4 |
| 443 | altri | 1 |
| 444 | am/amp-treated | 3 |
| 445 | ambrisentan-treated | 4 |
| 446 | ambulance-enrolled | 2 |
| 447 | amenorrhea-in | 1 |
| 448 | amio-off | 4 |
| 449 | amio-on | 5 |
| 450 | amiodarone-treated | 14 |
| 451 | amoxicillin-treated | 26 |
| 452 | amoxicillin/clavulanate-treated | 8 |
| 453 | amphetamine-allocated | 2 |
| 454 | amphetamine-treated | 1 |
| 455 | ampicillin-treated | 7 |
| 456 | ams-susceptible | 4 |
| 457 | amx-cl-treated | 2 |
| 458 | an-fep | 5 |
| 459 | anakinra-treated | 3 |
| 460 | analgesic-naïve | 1 |
| 461 | anosognosic | 1 |
| 462 | anthracyline-treated | 1 |
| 463 | anti-gad-positive | 1 |
| 464 | anti-tnfalpha-treated | 2 |
| 465 | anti-vegf-refractory | 2 |
| 466 | antibiotic-administered | 1 |
| 467 | antipsychotic-naive | 24 |
| 468 | antipsychotic-naive/early-phase | 1 |
| 469 | antipsychotic-naïve | 33 |
| 470 | antipsychotic-stabilized | 3 |
| 471 | antipsychotic-treated | 9 |
| 472 | antiretroviral-naive | 77 |
| 473 | antiretroviral-naïve | 48 |
| 474 | antiretroviral-treated | 9 |
| 475 | anuric | 49 |
| 476 | ap-cml | 2 |
| 477 | apixaban-treated | 2 |
| 478 | apl- | 1 |
| 479 | apla-positive | 2 |
| 480 | appendectomised | 4 |
| 481 | aprotinin-treated | 9 |
| 482 | arb-treated | 18 |
| 483 | argatroban-treated | 3 |
| 484 | arrhythmiaprone | 1 |
| 485 | arteriopathic | 2 |
| 486 | arv-experienced | 3 |
| 487 | arv-treated | 7 |
| 488 | as-tga | 4 |
| 489 | asian-region | 5 |
| 490 | asian/black | 1 |
| 491 | aspirin-anticoagulant-treated | 1 |
| 492 | aspirin-free | 2 |
| 493 | aspirin-resistant | 17 |
| 494 | aspirin-treated | 49 |
| 495 | astemizole-treated | 2 |
| 496 | asthmatic | 1,502 |
| 497 | atd-treated | 1 |
| 498 | atenolol-treated | 15 |
| 499 | atomoxetine-treated | 14 |
| 500 | atorvastatin-treated | 62 |
| 501 | autoantibody-positive | 23 |
| 502 | aviremic | 9 |
| 503 | avosentan-treated | 1 |
| 504 | axitinib-treated | 3 |
| 505 | aza-treated | 10 |
| 506 | azacitidine-treated | 2 |
| 507 | azathioprine-treated | 8 |
| 508 | azd9773-treated | 2 |
| 509 | azt-naive | 3 |
| 510 | b-thalassemic | 3 |
| 511 | bacteriologically-positive | 1 |
| 512 | balicatib-treated | 1 |
| 513 | balloon-trained | 1 |
| 514 | bcg-refractory | 2 |
| 515 | bcg-treated | 8 |
| 516 | bed-bound | 8 |
| 517 | belatacept-treated | 18 |
| 518 | benzodiazepine-tolerant | 1 |
| 519 | bes-implanted | 2 |
| 520 | besifloxacin-treated | 1 |
| 521 | beta-blocker-naïve | 2 |
| 522 | beta-blocker-treated | 2 |
| 523 | bevacizumab-treated | 34 |
| 524 | binge-eating/vomiting | 2 |
| 525 | bioha-treated | 1 |
| 526 | biologic-naïve | 5 |
| 527 | biologics-naive | 11 |
| 528 | bisphosphonate-exposed | 1 |
| 529 | bisphosphonate-treated | 9 |
| 530 | biv-treated | 1 |
| 531 | bivalirudin-treated | 4 |
| 532 | bleeding-prone | 1 |
| 533 | bon-bos | 1 |
| 534 | bortezomib-naive | 2 |
| 535 | bortezomib-naïve | 1 |
| 536 | bpv-evaluable | 1 |
| 537 | brain-damaged | 16 |
| 538 | brain-injured | 38 |
| 539 | brcaness | 4 |
| 540 | bromocriptine-treated | 5 |
| 541 | bronchiectatic | 2 |
| 542 | bronchitic | 47 |
| 543 | bronchopathic | 1 |
| 544 | brv-treated | 2 |
| 545 | bt-naive | 1 |
| 546 | budesonide-treated | 7 |
| 547 | busulfan-treated | 6 |
| 548 | by-preference | 1 |
| 549 | c-peptide-negative | 4 |
| 550 | c-peptide-positive | 4 |
| 551 | cabg-treated | 10 |
| 552 | cachectic | 23 |
| 553 | calcitriol-resistant | 4 |
| 554 | camg-treated | 1 |
| 555 | candiduric | 3 |
| 556 | cangrelor-treated | 1 |
| 557 | capecitabine-treated | 1 |
| 558 | carboplatin-treated | 2 |
| 559 | cardio-surgical | 1 |
| 560 | cardiomyopathic | 40 |
| 561 | cardiopathic | 2 |
| 562 | cardioswrgical | 1 |
| 563 | carumonam-treated | 4 |
| 564 | carvedilol-treated | 7 |
| 565 | cdc-treated | 3 |
| 566 | cdp-treated | 2 |
| 567 | cea-treated | 2 |
| 568 | cediranib-treated | 7 |
| 569 | cefaclor-treated | 18 |
| 570 | cefdinir-treated | 4 |
| 571 | cefepime-treated | 4 |
| 572 | cefonicid-treated | 7 |
| 573 | cefoxitin-treated | 1 |
| 574 | ceftibuten-treated | 4 |
| 575 | ceftriaxone-treated | 9 |
| 576 | celecoxib-treated | 12 |
| 577 | cell-treated | 22 |
| 578 | cerivastatin-treated | 3 |
| 579 | cetirizine-treated | 3 |
| 580 | cetuximab-naïve | 1 |
| 581 | cetuximab-treated | 5 |
| 582 | cfs/fm | 9 |
| 583 | chd/dm2 | 1 |
| 584 | chemo-naive | 11 |
| 585 | chemo-naïve | 10 |
| 586 | chemonaive | 27 |
| 587 | chemonaïve | 11 |
| 588 | chemoradiated | 1 |
| 589 | chemotherapy-naive | 108 |
| 590 | chemotherapy-naïve | 62 |
| 591 | chemotherapy-untreated | 1 |
| 592 | chinese-canadian | 2 |
| 593 | cic-treated | 1 |
| 594 | cidb | 7 |
| 595 | cil+ | 2 |
| 596 | cilengitide-treated | 2 |
| 597 | cilostazol-treated | 11 |
| 598 | cinacalcet-treated | 8 |
| 599 | cip-treated | 7 |
| 600 | cirrhostic | 1 |
| 601 | cisplatin-ineligible | 3 |
| 602 | cisplatin-naοve | 1 |
| 603 | citicoline-treated | 2 |
| 604 | ckd-nafld | 1 |
| 605 | cladribine-treated | 2 |
| 606 | clarithromycin-treated | 25 |
| 607 | clazosentan-treated | 3 |
| 608 | clindamycin-treated | 6 |
| 609 | clonidine-treated | 2 |
| 610 | clopidogrel-loaded | 1 |
| 611 | clopidogrel-naive | 3 |
| 612 | clopidogrel-treated | 26 |
| 613 | clotrimazole-treated | 3 |
| 614 | clozapine-naive | 1 |
| 615 | clozapine-treated | 26 |
| 616 | clr-treated | 4 |
| 617 | co-amoxiclav-treated | 3 |
| 618 | co-poisoned | 4 |
| 619 | cocaine/methamphetamine-dependent | 1 |
| 620 | colchicine-unresponsive | 2 |
| 621 | com-treated | 1 |
| 622 | comparator-treated | 16 |
| 623 | controlled-hypertensive | 3 |
| 624 | coronaropathic | 1 |
| 625 | corticosteroid-naïve | 1 |
| 626 | cpib-resistant | 2 |
| 627 | critically-ill | 40 |
| 628 | cryoglobulinaemic | 4 |
| 629 | cryptozoospermic | 3 |
| 630 | cs-866-treated | 2 |
| 631 | cs-treated | 7 |
| 632 | csa-immunosupressed | 1 |
| 633 | csa-treated | 41 |
| 634 | csc-treated | 3 |
| 635 | csf-treated | 5 |
| 636 | csr.sixty | 1 |
| 637 | ctni-negative | 2 |
| 638 | cya-treated | 5 |
| 639 | cyc-treated | 2 |
| 640 | cyc/aza-treated | 1 |
| 641 | cyclophosphamide-treated | 5 |
| 642 | cyclosporine-a-treated | 1 |
| 643 | cyclosporine-treated | 53 |
| 644 | cyp2d6/cyp2c19 | 1 |
| 645 | czp-exposed | 1 |
| 646 | czp-treated | 8 |
| 647 | d4t-naive | 1 |
| 648 | dabigatran-assigned | 1 |
| 649 | danazol-treated | 1 |
| 650 | dapagliflozin-treated | 4 |
| 651 | ddavp-treated | 7 |
| 652 | deep-burnt | 1 |
| 653 | deficit-state | 1 |
| 654 | degarelix-treated | 1 |
| 655 | degludec-treated | 3 |
| 656 | denture-wearing | 2 |
| 657 | desferrioxamine-treated | 2 |
| 658 | designer-drug-abusing | 6 |
| 659 | desloratadine-treated | 2 |
| 660 | dexmedetomidine-added | 1 |
| 661 | dfo-treated | 3 |
| 662 | dgf-risk | 1 |
| 663 | diabetic-hypertensive | 2 |
| 664 | dibenzo-fused | 1 |
| 665 | diet-failed | 1 |
| 666 | difficult-access | 1 |
| 667 | difficult-to-wean | 11 |
| 668 | digitalis-treated | 1 |
| 669 | digoxin-treated | 3 |
| 670 | direct-admit | 4 |
| 671 | dirithromycin-treated | 7 |
| 672 | disqualifies | 1 |
| 673 | disulfiram-treated | 4 |
| 674 | divalproex-resistant | 1 |
| 675 | divalproex-treated | 9 |
| 676 | divalproextreated | 1 |
| 677 | djiboutian | 2 |
| 678 | dmard-naïve | 15 |
| 679 | dmi-treated | 3 |
| 680 | dmr-treated | 1 |
| 681 | dolasetron-treated | 1 |
| 682 | donepezil-treated | 15 |
| 683 | dothiepin-treated | 4 |
| 684 | double-ventricle | 2 |
| 685 | doxorubicin-treated | 10 |
| 686 | drb1*13 | 1 |
| 687 | drisapersen-treated | 1 |
| 688 | drug-naive | 104 |
| 689 | drug-naïve | 157 |
| 690 | dsa+non-dsa | 1 |
| 691 | dscg-treated | 1 |
| 692 | dtth-ish | 1 |
| 693 | duloxetine-resistant | 1 |
| 694 | duloxetine-treated | 91 |
| 695 | dutch-antillean | 2 |
| 696 | dyslipemic | 4 |
| 697 | dyslipidaemic | 61 |
| 698 | dyslipidemic | 315 |
| 699 | dyslipoproteinemic | 5 |
| 700 | dysphagic | 34 |
| 701 | dyspneic | 26 |
| 702 | dz1-treated | 1 |
| 703 | early-detected | 3 |
| 704 | early-mild | 1 |
| 705 | early-stage-disease | 1 |
| 706 | early-treated | 6 |
| 707 | ebv-seropositive | 1 |
| 708 | ecmo-referred | 5 |
| 709 | efalizumab-treated | 7 |
| 710 | efavirenz-treated | 5 |
| 711 | efficacy.sixty | 1 |
| 712 | egg-allergic | 10 |
| 713 | elca-treated | 5 |
| 714 | elderly/unfit | 1 |
| 715 | elective-pci | 3 |
| 716 | eltrombopag-treated | 6 |
| 717 | empagliflozin-treated | 1 |
| 718 | ems-transported | 1 |
| 719 | en-treated | 1 |
| 720 | endoscopy-positive | 2 |
| 721 | enprofylline-treated | 4 |
| 722 | entecavir-switch | 6 |
| 723 | eosin-positive | 1 |
| 724 | epi-treated | 1 |
| 725 | epirubicin-exposed | 2 |
| 726 | epoetin-treated | 1 |
| 727 | eqw-treated | 2 |
| 728 | erlotinib-treated | 7 |
| 729 | erythroid-responding | 1 |
| 730 | erythromycin-treated | 14 |
| 731 | erythropoietin-treated | 6 |
| 732 | esa-naïve | 3 |
| 733 | esa-treated | 6 |
| 734 | escitalopram-alone | 3 |
| 735 | escitalopram-treated | 20 |
| 736 | etanercept-treated | 18 |
| 737 | ethanol-dependent | 2 |
| 738 | etomidate-exposed | 2 |
| 739 | etomidate-treated | 1 |
| 740 | etravirine-treated | 5 |
| 741 | etv-treated | 7 |
| 742 | eu-treated | 1 |
| 743 | eugenol-sensitized | 1 |
| 744 | eugonadal/hypogonadal | 1 |
| 745 | eve-treated | 2 |
| 746 | everolimus-treated | 15 |
| 747 | evolocumab-treated | 4 |
| 748 | exemestane-treated | 3 |
| 749 | exenatide-treated | 12 |
| 750 | extrahospitalized | 1 |
| 751 | ezetimibe-treated | 5 |
| 752 | famotidine-treated | 1 |
| 753 | faod | 1 |
| 754 | fcm-treated | 5 |
| 755 | fec-treated | 1 |
| 756 | fesoterodine-treated | 3 |
| 757 | fga-treated | 2 |
| 758 | fgas-treated | 2 |
| 759 | fh-dose | 1 |
| 760 | fhl3 | 4 |
| 761 | fibrate-treated | 2 |
| 762 | fibrinogen-treated | 1 |
| 763 | fingolimod-treated | 6 |
| 764 | first-biopsy | 4 |
| 765 | first-episodic | 4 |
| 766 | fleroxacin-treated | 5 |
| 767 | flt3-itd-negative | 7 |
| 768 | flt3-itd-positive | 4 |
| 769 | fludarabine-resistant | 1 |
| 770 | fludarabine-sensitive | 1 |
| 771 | fluid-optimized | 1 |
| 772 | fluoxetine-treated | 62 |
| 773 | flurbiprofen-treated | 3 |
| 774 | fluticasone-treated | 2 |
| 775 | fluvastatin-treated | 15 |
| 776 | flx-treated | 2 |
| 777 | fmh-treated | 1 |
| 778 | fnc-treated | 1 |
| 779 | folate-treated | 2 |
| 780 | folfox-4-treated | 1 |
| 781 | folfox/placebo | 1 |
| 782 | fontan-palliated | 1 |
| 783 | formoterol-randomised | 4 |
| 784 | fpns-treated | 3 |
| 785 | front-door | 4 |
| 786 | furosemide-treated | 8 |
| 787 | g-400-administered | 1 |
| 788 | g-csf-treated | 5 |
| 789 | g1-infected | 1 |
| 790 | g1/4/6 | 1 |
| 791 | ga2-positive | 1 |
| 792 | gabapentin-treated | 9 |
| 793 | gad-alum-treated | 2 |
| 794 | galantamine-treated | 4 |
| 795 | ganciclovir-treated | 1 |
| 796 | gastrectomized | 19 |
| 797 | gastroparetic | 5 |
| 798 | gastroparietic | 1 |
| 799 | gbv-c+ | 1 |
| 800 | gemfibrozil-treated | 5 |
| 801 | genotype-positive | 4 |
| 802 | gepirone-er-treated | 2 |
| 803 | gepirone-treated | 1 |
| 804 | gerd-negative | 2 |
| 805 | glargine-treated | 7 |
| 806 | glucagon-infused | 1 |
| 807 | glucagon-treated | 2 |
| 808 | glucocorticoid-naïve | 3 |
| 809 | glucocorticoid-treated | 8 |
| 810 | gly/gly | 33 |
| 811 | gm-csf-treated | 1 |
| 812 | golimumab-treated | 13 |
| 813 | gonadotropin-deficiency | 1 |
| 814 | good-performance-status | 1 |
| 815 | goserelin-treated | 5 |
| 816 | granulocytopenic | 39 |
| 817 | grepafloxacin-treated | 1 |
| 818 | griseofulvin-treated | 3 |
| 819 | group-d | 1 |
| 820 | growth-hormone-deficient | 1 |
| 821 | gs-positive | 2 |
| 822 | gs9450-treated | 1 |
| 823 | guanfacine-treated | 4 |
| 824 | guselkumab-treated | 5 |
| 825 | haemodialysed | 23 |
| 826 | haemodialyzed | 2 |
| 827 | haemophilic | 30 |
| 828 | hahd | 10 |
| 829 | hamster-allergic | 2 |
| 830 | harder-to-treat | 1 |
| 831 | hbeag-negative | 86 |
| 832 | hbeag-positive | 142 |
| 833 | hbo-treated | 7 |
| 834 | hbsag-seropositive | 2 |
| 835 | hbv-infected | 25 |
| 836 | hbv-monoinfected | 5 |
| 837 | hbv-treated | 1 |
| 838 | hbv/hcv-coinfected | 2 |
| 839 | hc2+/hsil- | 1 |
| 840 | hctz-treated | 5 |
| 841 | hcv-1/4 | 1 |
| 842 | hcv-1b-infected | 1 |
| 843 | hcv-infected | 140 |
| 844 | hcv-mono-infected | 3 |
| 845 | hcv-monoinfected | 8 |
| 846 | hcv-naive | 1 |
| 847 | hd- | 4 |
| 848 | hd-ckd | 3 |
| 849 | hdle-treated | 1 |
| 850 | hdv-infected | 4 |
| 851 | head-injured | 18 |
| 852 | healon-treated | 1 |
| 853 | healthy/osteopenic/osteoporotic | 1 |
| 854 | heliox-treated | 1 |
| 855 | hematopathy | 3 |
| 856 | hemodialysed | 4 |
| 857 | hemodialyzed | 51 |
| 858 | heparin-treated | 13 |
| 859 | hepatectomized | 6 |
| 860 | high-anxiety | 7 |
| 861 | high-cardiovascular-risk | 4 |
| 862 | high-triglyceride | 3 |
| 863 | high/very-high-risk | 1 |
| 864 | higher-acuity | 1 |
| 865 | higher-aged | 1 |
| 866 | hip-fractured | 7 |
| 867 | hipertensive | 1 |
| 868 | hiv+/tb | 2 |
| 869 | hiv-2-infected | 3 |
| 870 | hiv-coinfected | 9 |
| 871 | hiv-hcv-coinfected | 2 |
| 872 | hiv-monoinfected | 5 |
| 873 | hiv-treated | 3 |
| 874 | hiv-untreated | 1 |
| 875 | hiv/haart | 3 |
| 876 | hiv/hcv-coinfected | 18 |
| 877 | hivinfected | 1 |
| 878 | hl-deficient | 2 |
| 879 | hla-mica- | 1 |
| 880 | hmpv-infected | 10 |
| 881 | hp-infected | 1 |
| 882 | hp-negative | 4 |
| 883 | hp-positive | 11 |
| 884 | hpm-treated | 1 |
| 885 | hqd | 5 |
| 886 | hs-diabetic | 1 |
| 887 | ht-responsive | 1 |
| 888 | hydrocephalic | 5 |
| 889 | hydroxyflutamide-resistant | 1 |
| 890 | hyperandrogenic | 14 |
| 891 | hyperchoelsterolemic | 1 |
| 892 | hypercholesteremic | 3 |
| 893 | hypercholesterolaemic | 351 |
| 894 | hypercholesterolamic | 1 |
| 895 | hypercholesterolemic | 1,701 |
| 896 | hyperglycaemic | 83 |
| 897 | hyperglycemic | 303 |
| 898 | hyperlipemic | 29 |
| 899 | hyperlipidaemic | 81 |
| 900 | hyperlipidemic | 518 |
| 901 | hyperlipoproteinaemic | 10 |
| 902 | hyperlipoproteinemic | 12 |
| 903 | hyperoh | 6 |
| 904 | hyperphosphatemic | 9 |
| 905 | hyperprolactinemic | 13 |
| 906 | hypersecretive | 5 |
| 907 | hypertense | 6 |
| 908 | hypertensive | 8,415 |
| 909 | hypertensive-diabetic | 15 |
| 910 | hyperthyroid | 193 |
| 911 | hypertriglycemic | 1 |
| 912 | hypertriglyceridaemic | 22 |
| 913 | hypertriglyceridemic | 192 |
| 914 | hyperuricemic | 56 |
| 915 | hypnotics/anxiolytics-abusing | 3 |
| 916 | hypo-albuminemic | 2 |
| 917 | hypoalbuminemic | 34 |
| 918 | hypocortisolemic | 1 |
| 919 | hypofiltering | 1 |
| 920 | hypomagnesemic | 125 |
| 921 | hyponatremic | 39 |
| 922 | hypoparathyroid | 4 |
| 923 | hypotension-prone | 7 |
| 924 | hypothyroid | 333 |
| 925 | hypothyroidian | 1 |
| 926 | hypozincemic | 4 |
| 927 | i1307k-positive | 1 |
| 928 | iaa-positive | 1 |
| 929 | ibo-induced | 2 |
| 930 | icd-treated | 3 |
| 931 | icu-admitted | 2 |
| 932 | id/autistic | 1 |
| 933 | ifn-alpha-treated | 1 |
| 934 | ifn-treated | 8 |
| 935 | ifnbeta-treated | 1 |
| 936 | ifnβ-treatment-naïve | 2 |
| 937 | ifnβ1a-treated | 1 |
| 938 | igad | 15 |
| 939 | iiiic | 1 |
| 940 | il-2-treated | 2 |
| 941 | ileoresected | 1 |
| 942 | imatinib-resistant/intolerant | 1 |
| 943 | imatinib-treated | 9 |
| 944 | immune-depressed | 1 |
| 945 | immunecompetent | 1 |
| 946 | immuno-compromised | 9 |
| 947 | immuno-compromized | 1 |
| 948 | immuno-suppressed | 4 |
| 949 | immunocomprised | 2 |
| 950 | immunocompromized | 5 |
| 951 | immunodiscordant | 4 |
| 952 | immunotherapy-treated | 3 |
| 953 | incretin-naive | 1 |
| 954 | infliximab-exposed | 1 |
| 955 | infliximab-naive | 1 |
| 956 | infliximab-treated | 33 |
| 957 | inh-susceptible | 4 |
| 958 | inotrope-dependent | 6 |
| 959 | insomniac | 15 |
| 960 | insulin-deficient | 9 |
| 961 | insulin-naive | 37 |
| 962 | insulin-naïve | 39 |
| 963 | insulin-resistant | 211 |
| 964 | insulin-taking | 2 |
| 965 | insulin-treated | 148 |
| 966 | insulin-using | 5 |
| 967 | integrase-inhibitor-naive | 3 |
| 968 | integrase-naive | 1 |
| 969 | intensive-pathway | 2 |
| 970 | interferon-alpha-refractory | 1 |
| 971 | interferon-experienced | 1 |
| 972 | interferon-treated | 8 |
| 973 | invasive-cooled | 1 |
| 974 | iodide-treated | 1 |
| 975 | ip-treated | 5 |
| 976 | ipilimumab-treated | 2 |
| 977 | ipragliflozin-treated | 1 |
| 978 | iron-overloaded | 12 |
| 979 | irs-i | 1 |
| 980 | is-dependent | 1 |
| 981 | is-treated | 2 |
| 982 | iv-tpa-eligible | 1 |
| 983 | iv-tpa-ineligible | 1 |
| 984 | iv-treated | 6 |
| 985 | ivabradine-treated | 3 |
| 986 | jak2v617f-positive | 1 |
| 987 | josamycin-treated | 2 |
| 988 | kc-naive | 2 |
| 989 | ketorolac-treated | 6 |
| 990 | khalesseh | 1 |
| 991 | kidney-recipient | 1 |
| 992 | kidney-transplanted | 4 |
| 993 | kikyo | 5 |
| 994 | knee-surgery | 1 |
| 995 | korean/taiwanese | 2 |
| 996 | kt-treated | 2 |
| 997 | l-dopa-treated | 6 |
| 998 | lacosamide-treated | 2 |
| 999 | lam-resistant | 10 |
| 1000 | lamivudine-maintained | 4 |
| 1001 | lamivudine-refractory | 7 |
| 1002 | lapatinib-treated | 7 |
| 1003 | laquinimod-treated | 2 |
| 1004 | laryngectomised | 8 |
| 1005 | laryngectomized | 19 |
| 1006 | lb03002-treated | 1 |
| 1007 | lcz696-treated | 1 |
| 1008 | ldaa-treated | 2 |
| 1009 | lecithin-treated | 1 |
| 1010 | leflunomide-treated | 3 |
| 1011 | lenalidomide-treated | 2 |
| 1012 | less-sick | 1 |
| 1013 | levo-treated | 1 |
| 1014 | levodopa-treated | 19 |
| 1015 | linaclotide-treated | 5 |
| 1016 | linezolid-treated | 9 |
| 1017 | lipedematous | 1 |
| 1018 | lipid-treatment-naive | 1 |
| 1019 | lipoatrophic | 9 |
| 1020 | lipodystrophic | 10 |
| 1021 | lipodystrophy-positive | 4 |
| 1022 | lisinopril-treated | 4 |
| 1023 | lithium-treated | 22 |
| 1024 | liver-transplanted | 13 |
| 1025 | lixisenatide-treated | 2 |
| 1026 | lmwh-treated | 3 |
| 1027 | lomefloxacin-treated | 12 |
| 1028 | long-hd | 1 |
| 1029 | long-responding | 1 |
| 1030 | loop-treated | 2 |
| 1031 | lorcaserin-treated | 4 |
| 1032 | low-dose-treated | 1 |
| 1033 | low-functioning | 11 |
| 1034 | low-potassium | 9 |
| 1035 | low-pra | 1 |
| 1036 | low-qor | 1 |
| 1037 | low-tolerance | 1 |
| 1038 | low-ts | 2 |
| 1039 | low-upa/pai-1 | 2 |
| 1040 | lower-triglyceride | 1 |
| 1041 | lpi-treated | 3 |
| 1042 | lqt1 | 8 |
| 1043 | lr-treated | 2 |
| 1044 | lvd-refractory | 1 |
| 1045 | lvh-negative | 1 |
| 1046 | lvh-positive | 1 |
| 1047 | ly2605541-treated | 4 |
| 1048 | lysozyme-sensitive | 1 |
| 1049 | macroalbuminuric | 24 |
| 1050 | macrolide-treated | 3 |
| 1051 | madit-ii-like | 1 |
| 1052 | madrid.the | 1 |
| 1053 | malignant-neoplasm | 1 |
| 1054 | maraviroc-treated | 7 |
| 1055 | mastectomised | 1 |
| 1056 | mbl-deficient | 2 |
| 1057 | mdi-treated | 3 |
| 1058 | mdx-1100-treated | 2 |
| 1059 | mec-treated | 2 |
| 1060 | medi-528-treated | 2 |
| 1061 | medical-ward | 1 |
| 1062 | medication-experienced | 4 |
| 1063 | medication-naive | 32 |
| 1064 | medication-naïve | 45 |
| 1065 | memantine-treated | 11 |
| 1066 | mesalamine-treated | 1 |
| 1067 | mesalazine-treated | 5 |
| 1068 | met-comt | 4 |
| 1069 | met-negative | 4 |
| 1070 | met-treated | 6 |
| 1071 | metformin-cotreated | 1 |
| 1072 | metformin-resistant | 1 |
| 1073 | metformin-tolerant | 2 |
| 1074 | metformin-treated | 55 |
| 1075 | metformin/sulfonylurea-treated | 2 |
| 1076 | methadone-intoxicated | 2 |
| 1077 | methamphetamine-abusing | 3 |
| 1078 | methane-positive | 2 |
| 1079 | methotrexate-treated | 13 |
| 1080 | methylergonovine-treated | 1 |
| 1081 | methylnaltrexone-treated | 2 |
| 1082 | methylprednisolone-treated | 6 |
| 1083 | metoclopramide-treated | 4 |
| 1084 | mezlocillin-treated | 1 |
| 1085 | mgn-3-treated | 1 |
| 1086 | microalbuminuric | 85 |
| 1087 | midazolam-sedated | 1 |
| 1088 | migraine/rls | 1 |
| 1089 | mild-group | 1 |
| 1090 | mild-hypercholesterolemic | 2 |
| 1091 | miltefosine-treated | 2 |
| 1092 | mirtazapine-treated | 14 |
| 1093 | misleads | 1 |
| 1094 | mismatch-selected | 1 |
| 1095 | mite-monosensitized | 1 |
| 1096 | mixed-ancestry | 1 |
| 1097 | mln-treated | 1 |
| 1098 | mmf-treated | 10 |
| 1099 | modafinil-treated | 5 |
| 1100 | mood-disordered | 1 |
| 1101 | moxifloxacin-treated | 8 |
| 1102 | mp4ox-treated | 2 |
| 1103 | mpa-treated | 4 |
| 1104 | msc-infused | 1 |
| 1105 | mtx+iast-treated | 1 |
| 1106 | mtx-naive | 7 |
| 1107 | mtx-naïve | 12 |
| 1108 | multi-transfused | 2 |
| 1109 | multi-treated | 2 |
| 1110 | multiple-trauma | 5 |
| 1111 | muscle-wasted | 1 |
| 1112 | mycophenolate/dexamethasone-responsive | 1 |
| 1113 | myelosuppressed | 4 |
| 1114 | n-acetylcysteine-treated | 3 |
| 1115 | naftifine-treated | 4 |
| 1116 | naltrexone-treated | 8 |
| 1117 | narcoleptic | 6 |
| 1118 | natalizumab-treated | 2 |
| 1119 | naïve-to-treatment | 3 |
| 1120 | near-lepromatous | 1 |
| 1121 | neck-immobilized | 1 |
| 1122 | neck-irradiated | 1 |
| 1123 | nefazodone-treated | 5 |
| 1124 | neocart-treated | 2 |
| 1125 | nephropathic | 14 |
| 1126 | nephropatic | 1 |
| 1127 | nesb | 8 |
| 1128 | nesiritide-treated | 5 |
| 1129 | netilmicin-treated | 3 |
| 1130 | neuroleptic-naive | 2 |
| 1131 | neurology/neurosurgical | 1 |
| 1132 | neutropaenic | 13 |
| 1133 | neutropenia-free | 1 |
| 1134 | neutropenic | 458 |
| 1135 | nevirapine-treated | 6 |
| 1136 | ng-eligible | 1 |
| 1137 | ni-group | 2 |
| 1138 | nic-treated | 3 |
| 1139 | nicardipine-treated | 4 |
| 1140 | nicotinamide-treated | 2 |
| 1141 | niv-treated | 1 |
| 1142 | no-diuretic | 3 |
| 1143 | no-fixation | 1 |
| 1144 | no-prior-cabg | 1 |
| 1145 | non-abmi | 2 |
| 1146 | non-abuser | 2 |
| 1147 | non-ald | 3 |
| 1148 | non-ambulatory | 16 |
| 1149 | non-ami | 6 |
| 1150 | non-amyloidosis | 1 |
| 1151 | non-anuric | 3 |
| 1152 | non-arb-exposed | 1 |
| 1153 | non-ard | 3 |
| 1154 | non-asiatic | 1 |
| 1155 | non-azotemic | 6 |
| 1156 | non-ba | 3 |
| 1157 | non-bevacizumab-treated | 1 |
| 1158 | non-bmt | 2 |
| 1159 | non-breakthrough | 2 |
| 1160 | non-cachectic | 5 |
| 1161 | non-cannabis-using | 1 |
| 1162 | non-cardiological | 2 |
| 1163 | non-cepacia | 1 |
| 1164 | non-ces | 1 |
| 1165 | non-ci-aki | 1 |
| 1166 | non-cirrhotic | 46 |
| 1167 | non-co-enrolled | 1 |
| 1168 | non-constipated | 8 |
| 1169 | non-crai | 5 |
| 1170 | non-dan | 3 |
| 1171 | non-dge | 3 |
| 1172 | non-diabetic | 999 |
| 1173 | non-dialysed | 3 |
| 1174 | non-dialysis | 46 |
| 1175 | non-dialyzed | 5 |
| 1176 | non-ecmo-referred | 5 |
| 1177 | non-edda | 5 |
| 1178 | non-esrd | 3 |
| 1179 | non-estrogen-treated | 1 |
| 1180 | non-evented | 2 |
| 1181 | non-fluctuating | 2 |
| 1182 | non-gout | 2 |
| 1183 | non-hbv-infected | 1 |
| 1184 | non-hct | 4 |
| 1185 | non-hd | 19 |
| 1186 | non-hdl-deficient | 1 |
| 1187 | non-hemodialysis | 2 |
| 1188 | non-hemodialysis-dependent | 2 |
| 1189 | non-hemodialyzed | 4 |
| 1190 | non-hemophiliac | 3 |
| 1191 | non-hyperuricemia | 2 |
| 1192 | non-hyponatremic | 1 |
| 1193 | non-immobilised | 2 |
| 1194 | non-immunodepressed | 1 |
| 1195 | non-inhibitor | 3 |
| 1196 | non-insulin-treated | 27 |
| 1197 | non-is | 2 |
| 1198 | non-isr | 1 |
| 1199 | non-japanese | 44 |
| 1200 | non-korsakoff | 1 |
| 1201 | non-laba-treated | 4 |
| 1202 | non-ldlr/non-apob | 1 |
| 1203 | non-lvd | 1 |
| 1204 | non-malnourished | 6 |
| 1205 | non-mg | 1 |
| 1206 | non-nephrotic | 10 |
| 1207 | non-neutropenic | 32 |
| 1208 | non-paced | 2 |
| 1209 | non-pacemaker-dependent | 2 |
| 1210 | non-progressing | 5 |
| 1211 | non-ps | 2 |
| 1212 | non-qatari | 3 |
| 1213 | non-rd | 5 |
| 1214 | non-readmitted | 1 |
| 1215 | non-regenerative | 8 |
| 1216 | non-relapsing | 6 |
| 1217 | non-relax-ahf-type | 2 |
| 1218 | non-resectable.the | 1 |
| 1219 | non-resected | 3 |
| 1220 | non-rheumatoid-arthritis | 3 |
| 1221 | non-rvr | 9 |
| 1222 | non-sdldl | 5 |
| 1223 | non-se | 2 |
| 1224 | non-selegiline-treated | 2 |
| 1225 | non-shock | 10 |
| 1226 | non-splenectomized | 11 |
| 1227 | non-statin-treated | 5 |
| 1228 | non-t-all | 1 |
| 1229 | non-tegaserod-using | 1 |
| 1230 | non-transfer | 5 |
| 1231 | non-transplanted | 17 |
| 1232 | non-uri | 2 |
| 1233 | non-vap | 7 |
| 1234 | non-viremic | 3 |
| 1235 | nonalexithymic | 1 |
| 1236 | nonanticoagulated | 8 |
| 1237 | nonautistic | 3 |
| 1238 | noncirrhotic | 28 |
| 1239 | nonconverted | 1 |
| 1240 | nondehydrated | 1 |
| 1241 | nondeleted | 1 |
| 1242 | nondelirious | 2 |
| 1243 | nondiabetic | 1,061 |
| 1244 | nondialysis | 44 |
| 1245 | nondialysis-dependent | 7 |
| 1246 | nondialyzed | 11 |
| 1247 | nonduloxetine | 1 |
| 1248 | nonduloxetine-treated | 3 |
| 1249 | nonexpanded | 3 |
| 1250 | nonextractions | 1 |
| 1251 | nonhemophiliac | 3 |
| 1252 | nonhypercholesterolemic | 8 |
| 1253 | nonhypoxic | 3 |
| 1254 | nonimmobilized | 2 |
| 1255 | noninducible | 5 |
| 1256 | nonmalnourished | 7 |
| 1257 | nonneutropenic | 15 |
| 1258 | nonpolydipsic | 2 |
| 1259 | nonsurgery | 1 |
| 1260 | nontraumatized | 5 |
| 1261 | nonyoung | 3 |
| 1262 | nor-treated | 1 |
| 1263 | norepinephrine-treated | 3 |
| 1264 | norfloxacin-treated | 5 |
| 1265 | normal-magnesium | 2 |
| 1266 | normal-responding | 1 |
| 1267 | normo-triglyceridemic | 1 |
| 1268 | normoalbuminemic | 1 |
| 1269 | normoalbuminuric | 126 |
| 1270 | normocholesterolaemic | 27 |
| 1271 | normoglyceridemic | 2 |
| 1272 | normolipoproteinaemic | 2 |
| 1273 | normonatraemic | 1 |
| 1274 | normonatremic | 7 |
| 1275 | normophosphatemic | 4 |
| 1276 | normotriglyceridaemic | 4 |
| 1277 | normotriglyceridemic | 20 |
| 1278 | normouricaemic | 1 |
| 1279 | not-weak | 3 |
| 1280 | novasospasm | 1 |
| 1281 | nsaid-sensitive | 1 |
| 1282 | ntz-treated | 1 |
| 1283 | nucleoside-naive | 17 |
| 1284 | nucleoside-naïve | 5 |
| 1285 | numberless | 1 |
| 1286 | oac-treated | 4 |
| 1287 | ocd-bipolar | 4 |
| 1288 | octreotide-treated | 5 |
| 1289 | ofc-treated | 8 |
| 1290 | off-range | 3 |
| 1291 | olanzapine-group | 3 |
| 1292 | olanzapine-naïve | 2 |
| 1293 | olanzapine-treated | 82 |
| 1294 | older/unfit | 3 |
| 1295 | oligo-amenorrhoeic | 1 |
| 1296 | oligoanuric | 2 |
| 1297 | oligozoospermic | 12 |
| 1298 | olmesartan-treated | 9 |
| 1299 | olmesartan-using | 1 |
| 1300 | olz-treated | 4 |
| 1301 | om-89-treated | 1 |
| 1302 | omalizumab-treated | 14 |
| 1303 | omeprazole-treated | 12 |
| 1304 | onabotulinumtoxina-treated | 12 |
| 1305 | onartuzumab-treated | 1 |
| 1306 | onco-hematological | 9 |
| 1307 | oncourologic | 1 |
| 1308 | ondansetron-treated | 4 |
| 1309 | opcab-converted | 3 |
| 1310 | opiate-naïve | 1 |
| 1311 | opioid-experienced | 14 |
| 1312 | opioid-naive | 16 |
| 1313 | opioid-naïve | 15 |
| 1314 | opioid-tolerant | 17 |
| 1315 | opioid-treated | 9 |
| 1316 | orbofiban-treated | 1 |
| 1317 | organ-transplant | 1 |
| 1318 | orlistat-treated | 15 |
| 1319 | ot-treated | 1 |
| 1320 | otelixizumab-treated | 1 |
| 1321 | outclinic | 2 |
| 1322 | overweight+obese | 4 |
| 1323 | p/evl-treated | 1 |
| 1324 | p2ry8-crlf2+ | 3 |
| 1325 | pa-with | 1 |
| 1326 | pa32540-treated | 2 |
| 1327 | pacemaker-dependent | 17 |
| 1328 | pacing-indicated | 1 |
| 1329 | paclitaxel-refractory | 1 |
| 1330 | palifermin-exposed | 2 |
| 1331 | palonosetron-treated | 2 |
| 1332 | pamidronate-treated | 6 |
| 1333 | panicking | 2 |
| 1334 | panitumumab-treated | 3 |
| 1335 | parecoxib/valdecoxib-treated | 1 |
| 1336 | paroxetine-treated | 18 |
| 1337 | pazo-panib-treated | 1 |
| 1338 | pazopanib-treated | 8 |
| 1339 | pbo-treated | 7 |
| 1340 | pci-assigned | 1 |
| 1341 | pcp-diagnosed | 1 |
| 1342 | pdrn-treated | 2 |
| 1343 | peach-allergic | 4 |
| 1344 | peep-ventilated | 1 |
| 1345 | peg-ifn-treated | 2 |
| 1346 | pen-naive | 1 |
| 1347 | pen-naïve | 5 |
| 1348 | penicillin-allergic | 7 |
| 1349 | penicillin-tolerant | 1 |
| 1350 | pentoxifylline-treated | 7 |
| 1351 | periostin-high | 1 |
| 1352 | pft-treated | 1 |
| 1353 | pge2-treated | 1 |
| 1354 | pharmaceutical-care | 3 |
| 1355 | phenylketonuric | 5 |
| 1356 | phvhf-treated | 1 |
| 1357 | pi-assigned | 2 |
| 1358 | pi-naïve | 1 |
| 1359 | pi-treatment-naïve | 1 |
| 1360 | pin/asap | 1 |
| 1361 | pioglitazone-treated | 22 |
| 1362 | piracetam-treated | 1 |
| 1363 | pitavastatin-treated | 6 |
| 1364 | pla-treated | 2 |
| 1365 | placebo-given | 1 |
| 1366 | plasma-exchanged | 1 |
| 1367 | platinum-eligible | 1 |
| 1368 | platinum-sensitive/intermediate | 1 |
| 1369 | plato-usa | 1 |
| 1370 | plerixafor-mobilised | 3 |
| 1371 | pmmd | 1 |
| 1372 | politraumatized | 1 |
| 1373 | polymedicated | 10 |
| 1374 | polypathological | 7 |
| 1375 | polypectomized | 3 |
| 1376 | polytransfused | 7 |
| 1377 | poor-responder | 3 |
| 1378 | poor-responding | 1 |
| 1379 | post-bltx | 1 |
| 1380 | post-cardiac-surgery | 1 |
| 1381 | post-coarctectomy | 3 |
| 1382 | post-gastrectomy | 6 |
| 1383 | post-kc | 1 |
| 1384 | post-oa | 1 |
| 1385 | post-pkp | 1 |
| 1386 | post-revascularized | 2 |
| 1387 | postclimacteric | 2 |
| 1388 | postcoarctectomy | 1 |
| 1389 | posthaemorrhoidectomy | 2 |
| 1390 | pramlintide-treated | 4 |
| 1391 | prasugrel-treated | 8 |
| 1392 | pravastatin-treated | 38 |
| 1393 | pre-diabetic | 52 |
| 1394 | pre-hypertensive | 21 |
| 1395 | prediabetic | 114 |
| 1396 | predialysis-ckd | 1 |
| 1397 | pregabalin-treated | 18 |
| 1398 | premanifest | 6 |
| 1399 | presbyopic | 19 |
| 1400 | propofol-treated | 5 |
| 1401 | propranolol-treated | 15 |
| 1402 | prostacyclin-treated | 2 |
| 1403 | proteinuric | 146 |
| 1404 | psvf-hf | 2 |
| 1405 | ptbii-positive | 1 |
| 1406 | pulse-treated | 1 |
| 1407 | pump-treated | 7 |
| 1408 | q-treated | 2 |
| 1409 | r-tof | 5 |
| 1410 | ra-refractory | 1 |
| 1411 | radiotherapy-naive | 1 |
| 1412 | radiotherapy-naïve | 1 |
| 1413 | raltegravir-treated | 1 |
| 1414 | ramipril-treated | 7 |
| 1415 | recently-symptomatic | 1 |
| 1416 | refractory-relapsed | 1 |
| 1417 | resected/resectable | 1 |
| 1418 | rhc1inh-treated | 2 |
| 1419 | rhinitic | 7 |
| 1420 | rhythm-controlled | 1 |
| 1421 | ribavirin-treated | 5 |
| 1422 | riluzole-treated | 4 |
| 1423 | rimonabant-treated | 5 |
| 1424 | ris-st-treated | 1 |
| 1425 | risperidone-treated | 30 |
| 1426 | rituximab-retreated | 1 |
| 1427 | rituximab-treated | 27 |
| 1428 | rivaroxaban-treated | 10 |
| 1429 | rivastigmine-treated | 9 |
| 1430 | rizatriptan-treated | 2 |
| 1431 | rlai-treated | 4 |
| 1432 | rolofylline-treated | 3 |
| 1433 | ropinirole-treated | 3 |
| 1434 | rosiglitazone-treated | 10 |
| 1435 | rotigotine-treated | 1 |
| 1436 | rpv-treated | 2 |
| 1437 | rt-pa-treated | 9 |
| 1438 | rtx-treated | 8 |
| 1439 | ruxolitinib-treated | 7 |
| 1440 | rv-paced | 7 |
| 1441 | rygb-1 | 5 |
| 1442 | rygb-2 | 5 |
| 1443 | s-ipf | 4 |
| 1444 | safety-evaluable | 2 |
| 1445 | safranal-treated | 2 |
| 1446 | saxagliptin-naive | 1 |
| 1447 | saxagliptin-treated | 3 |
| 1448 | scd-heft-like | 4 |
| 1449 | schizophrenia—the | 1 |
| 1450 | schizophrenic | 404 |
| 1451 | scorpion-stung | 1 |
| 1452 | scp-monitored | 2 |
| 1453 | screening-derived | 1 |
| 1454 | screening-only | 1 |
| 1455 | scs-treated | 2 |
| 1456 | sdg-treated | 2 |
| 1457 | se-negative | 2 |
| 1458 | sensory-disabled | 1 |
| 1459 | septic-shock | 1 |
| 1460 | ser49 | 3 |
| 1461 | sertraline-treated | 36 |
| 1462 | ses-implanted | 2 |
| 1463 | ses-treated | 7 |
| 1464 | sevelamer-treated | 14 |
| 1465 | severely-disabled | 1 |
| 1466 | severity.thirty-nine | 1 |
| 1467 | sibutraminetreated | 1 |
| 1468 | sifalimumab-dosed | 1 |
| 1469 | sifalimumab-treated | 2 |
| 1470 | signature-negative | 1 |
| 1471 | sildenafil-treated | 10 |
| 1472 | simeprevir-treated | 4 |
| 1473 | simvastatin-treated | 62 |
| 1474 | simvastatintreated | 1 |
| 1475 | single-stented | 1 |
| 1476 | sirolimus-treated | 10 |
| 1477 | sirt3-/- | 2 |
| 1478 | sitagliptin-treated | 8 |
| 1479 | sjögren׳s | 9 |
| 1480 | sk-treated | 1 |
| 1481 | skilled-nursing | 1 |
| 1482 | slit-treated | 6 |
| 1483 | sln-positive | 4 |
| 1484 | sm-injured | 1 |
| 1485 | smart-treated | 2 |
| 1486 | snakebitten | 1 |
| 1487 | somatically-ill | 2 |
| 1488 | somatostatin-treated | 1 |
| 1489 | sorafenib-treated | 7 |
| 1490 | sotalol-treated | 1 |
| 1491 | sp100-negative | 1 |
| 1492 | span-100-negative | 2 |
| 1493 | span-100-positive | 3 |
| 1494 | spanish-only-speaking | 2 |
| 1495 | sparfloxacin-treated | 1 |
| 1496 | spinally-injured | 1 |
| 1497 | splenectomized | 34 |
| 1498 | spondylarthroses | 1 |
| 1499 | sputum-positive | 4 |
| 1500 | srl-converted | 1 |
| 1501 | ssa/ssb-negative | 1 |
| 1502 | ssri-treated | 11 |
| 1503 | ssv-treated | 1 |
| 1504 | stable-cad | 2 |
| 1505 | staple-treated | 1 |
| 1506 | statin-intolerant | 33 |
| 1507 | statin-naive | 38 |
| 1508 | statin-naïve | 24 |
| 1509 | statin-treated | 204 |
| 1510 | statin/ezetimibe-treated | 1 |
| 1511 | stent/dep | 2 |
| 1512 | steroid-naive | 30 |
| 1513 | stimulant-naïve | 7 |
| 1514 | study-naïve | 2 |
| 1515 | su-treated | 2 |
| 1516 | subgroup-2 | 1 |
| 1517 | sulfasalazine-intolerant | 2 |
| 1518 | sulfasalazine-treated | 4 |
| 1519 | sulfonylurea-treated | 2 |
| 1520 | sunitinib-intolerant | 1 |
| 1521 | sunitinib-treated | 18 |
| 1522 | super-morbid-obese | 1 |
| 1523 | super-obese | 47 |
| 1524 | surface-cooled | 1 |
| 1525 | surgery-treated | 1 |
| 1526 | t12pr24-treated | 1 |
| 1527 | t2dm.fourty-four | 1 |
| 1528 | t4-substituted | 1 |
| 1529 | tabalumab-treated | 2 |
| 1530 | tac-treated | 7 |
| 1531 | tachosil®-treated | 1 |
| 1532 | tacrolimus-cotreated | 1 |
| 1533 | tacrolimus-treated | 28 |
| 1534 | tadalafil-treated | 12 |
| 1535 | tam-responsive | 2 |
| 1536 | tamsulosin-treated | 4 |
| 1537 | tavr-treated | 3 |
| 1538 | tazarotene-treated | 2 |
| 1539 | tb-hiv-coinfected | 5 |
| 1540 | tbi/sah | 1 |
| 1541 | tca-treated | 6 |
| 1542 | tce- | 2 |
| 1543 | tcm-treated | 4 |
| 1544 | td2m | 2 |
| 1545 | tdf/ftc-treated | 1 |
| 1546 | tegaserod-treated | 10 |
| 1547 | telaprevir-treated | 7 |
| 1548 | telmisartan-treated | 25 |
| 1549 | tension-headache | 1 |
| 1550 | terbutaline-treated | 1 |
| 1551 | teriparatide-receiving | 1 |
| 1552 | teriparatide-treated | 8 |
| 1553 | tesamorelin-treated | 1 |
| 1554 | tezosentan-treated | 1 |
| 1555 | tg-matched | 1 |
| 1556 | tg-mmc-treated | 1 |
| 1557 | thalassaemic | 12 |
| 1558 | thalassemic | 37 |
| 1559 | thalidomide-exposed | 4 |
| 1560 | thalidomide-naive | 4 |
| 1561 | thalidomide-treated | 3 |
| 1562 | therapy-experienced | 4 |
| 1563 | therapy-naive | 30 |
| 1564 | therapy-naïve | 12 |
| 1565 | thiazide-treated | 3 |
| 1566 | thrombolysis-treated | 5 |
| 1567 | thrombolytic-treated | 2 |
| 1568 | thyrotoxic | 41 |
| 1569 | ticagrelor-treated | 14 |
| 1570 | tid-positive | 3 |
| 1571 | tigecycline-treated | 4 |
| 1572 | tilt-negative | 1 |
| 1573 | timothy-treated | 1 |
| 1574 | tip-treated | 1 |
| 1575 | tips-treated | 3 |
| 1576 | tlv-treated | 1 |
| 1577 | tm-treated | 2 |
| 1578 | tmp/smx-treated | 2 |
| 1579 | tmz-treated | 4 |
| 1580 | tnbs-colitis | 3 |
| 1581 | tnfi-experienced | 1 |
| 1582 | tnfα-antagonist-naïve | 1 |
| 1583 | tocilizumab-treated | 5 |
| 1584 | torcetrapib-treated | 3 |
| 1585 | total,116 | 1 |
| 1586 | tp-treated | 3 |
| 1587 | tpa-treated | 5 |
| 1588 | tpmt*1/*3c | 2 |
| 1589 | tracheotomized | 6 |
| 1590 | traditionally-treated | 2 |
| 1591 | transfusion-independent | 3 |
| 1592 | transfusion-naive | 3 |
| 1593 | transfusion-naïve | 2 |
| 1594 | transplant-eligible | 7 |
| 1595 | trastuzumab-treated | 13 |
| 1596 | traumatic-hemorrhagic | 1 |
| 1597 | treatment-experienced | 224 |
| 1598 | treatment-exposed | 1 |
| 1599 | treatment-naive | 499 |
| 1600 | treatment-naïve | 343 |
| 1601 | treatment-nonresponsive | 2 |
| 1602 | treatment-option | 4 |
| 1603 | trial-eligible | 12 |
| 1604 | trial.cirrhotic | 1 |
| 1605 | triflusal-treated | 1 |
| 1606 | trimetazidine-treated | 3 |
| 1607 | trimethoprim/sulfamethoxazole-treated | 1 |
| 1608 | troponin-negative | 7 |
| 1609 | troponin-positive | 10 |
| 1610 | trovafloxacin-treated | 2 |
| 1611 | ttv-positive | 1 |
| 1612 | tube-fed | 20 |
| 1613 | tuberculosis-coinfected | 1 |
| 1614 | u.s.-treated | 1 |
| 1615 | uf-intolerant | 1 |
| 1616 | uk-born | 2 |
| 1617 | un-transfused | 1 |
| 1618 | under-dosaged | 1 |
| 1619 | uraemic | 78 |
| 1620 | urban-living | 3 |
| 1621 | uremic | 401 |
| 1622 | usl255-treated | 1 |
| 1623 | ustekinumab-treated | 28 |
| 1624 | vagotomised | 10 |
| 1625 | vancomycin-treated | 16 |
| 1626 | vaniprevir-treated | 1 |
| 1627 | varenicline-treated | 11 |
| 1628 | vareniclinetreated | 1 |
| 1629 | varicocele-affected | 1 |
| 1630 | varicocelectomised | 2 |
| 1631 | vasoplegic | 1 |
| 1632 | vasoreactive | 2 |
| 1633 | venlafaxine-treated | 14 |
| 1634 | ventilaled | 1 |
| 1635 | ventilated-group | 1 |
| 1636 | verapamil-treated | 5 |
| 1637 | vigabatrin-treated | 2 |
| 1638 | vildagliptin-treated | 5 |
| 1639 | virologically-suppressed | 6 |
| 1640 | vismodegib-treated | 3 |
| 1641 | vka-experienced | 14 |
| 1642 | vka-naïve | 1 |
| 1643 | vka-treated | 3 |
| 1644 | vlx-treated | 1 |
| 1645 | volume-responsive | 1 |
| 1646 | vtd-treated | 2 |
| 1647 | vv1 | 1 |
| 1648 | vvir-randomized | 4 |
| 1649 | warfarin-treated | 28 |
| 1650 | weight-losing | 10 |
| 1651 | well-hydrated | 8 |
| 1652 | well-suppressed | 1 |
| 1653 | wheelchair-mobilised | 1 |
| 1654 | working/in-school | 1 |
| 1655 | xenon-treated | 1 |
| 1656 | xerostomic | 12 |
| 1657 | xr-ntx-treated | 2 |
| 1658 | young-to-middle-age | 4 |
| 1659 | younger/fit | 3 |
| 1660 | zanamivir-treated | 4 |
| 1661 | zdv/3tc/nvp-treated | 1 |
| 1662 | zeep-ventilated | 1 |
| 1663 | zibotentan-treated | 5 |
| 1664 | zimelidine-treated | 3 |
| 1665 | ziprasidone-treated | 6 |
| 1666 | zofenopril-treated | 5 |
| 1667 | α-blocker-naïve | 1 |
| 1668 | βiii-tubulin-positive | 2 |
| 1669 | ≤50-year-old | 1 |
| 1 | p2ry8-crlf2+ | 3 |
| 2 | gbv-c+ | 1 |
| 3 | cil+ | 2 |
| 4 | sirt3-/- | 2 |
| 5 | hla-mica- | 1 |
| 6 | hd- | 4 |
| 7 | tce- | 2 |
| 8 | hc2+/hsil- | 1 |
| 9 | apl- | 1 |
| 10 | 48/2/0/0 | 1 |
| 11 | 37/9/0 | 1 |
| 12 | 197/300 | 1 |
| 13 | 24,500 | 2 |
| 14 | 23,110 | 1 |
| 15 | 7,110 | 1 |
| 16 | 55/210 | 1 |
| 17 | 17/210 | 1 |
| 18 | 20,410 | 1 |
| 19 | 6510 | 1 |
| 20 | 55/610 | 1 |
| 21 | 8810 | 1 |
| 22 | 32/120 | 1 |
| 23 | 5,820 | 1 |
| 24 | 211,920 | 1 |
| 25 | 124-130 | 1 |
| 26 | 100/130 | 1 |
| 27 | 127/130 | 1 |
| 28 | 22,530 | 1 |
| 29 | 11140 | 1 |
| 30 | 21,340 | 1 |
| 31 | 3,340 | 4 |
| 32 | 10,640 | 1 |
| 33 | 51,640 | 1 |
| 34 | 7,150 | 2 |
| 35 | 2504/7250 | 1 |
| 36 | 4746/7250 | 1 |
| 37 | 7950 | 3 |
| 38 | 131/160 | 1 |
| 39 | 6160 | 1 |
| 40 | 18,270 | 1 |
| 41 | 15/270 | 1 |
| 42 | 7370 | 1 |
| 43 | 9770 | 1 |
| 44 | 35,970 | 2 |
| 45 | 145/1,080 | 1 |
| 46 | 5380 | 3 |
| 47 | 23,480 | 1 |
| 48 | 6780 | 4 |
| 49 | 99/290 | 1 |
| 50 | 22,590 | 1 |
| 51 | 20,990 | 1 |
| 52 | 13,990 | 2 |
| 53 | rygb-1 | 5 |
| 54 | low-upa/pai-1 | 2 |
| 55 | 10,001 | 12 |
| 56 | 6001 | 1 |
| 57 | 8,101 | 2 |
| 58 | 18,201 | 6 |
| 59 | 8,301 | 1 |
| 60 | 15,601 | 1 |
| 61 | 107/111 | 1 |
| 62 | 33,611 | 1 |
| 63 | 14,611 | 2 |
| 64 | 2865-3611 | 1 |
| 65 | 41,021 | 3 |
| 66 | 65/2121 | 1 |
| 67 | 208/2121 | 1 |
| 68 | 6121 | 1 |
| 69 | 51,321 | 2 |
| 70 | 23,721 | 1 |
| 71 | 2,231 | 4 |
| 72 | 2,331 | 13 |
| 73 | 32,431 | 1 |
| 74 | 5731 | 2 |
| 75 | 8831 | 2 |
| 76 | 3,931 | 1 |
| 77 | 89/641 | 1 |
| 78 | 70/151 | 1 |
| 79 | 98/151 | 1 |
| 80 | 2,251 | 2 |
| 81 | 95/351 | 1 |
| 82 | 9461 | 4 |
| 83 | 25,661 | 1 |
| 84 | 15,761 | 1 |
| 85 | 30/71 | 1 |
| 86 | 11471 | 1 |
| 87 | 5,871 | 1 |
| 88 | 280,081 | 1 |
| 89 | 4,081 | 3 |
| 90 | 2,181 | 3 |
| 91 | 9,481 | 1 |
| 92 | 4,681 | 1 |
| 93 | 28,091 | 1 |
| 94 | 6191 | 1 |
| 95 | 4,291 | 1 |
| 96 | 1,591 | 7 |
| 97 | 6,591 | 1 |
| 98 | 517/591 | 1 |
| 99 | 8991 | 1 |
| 100 | lqt1 | 8 |
| 101 | vv1 | 1 |
| 102 | rygb-2 | 5 |
| 103 | subgroup-2 | 1 |
| 104 | 19,102 | 2 |
| 105 | 3,202 | 3 |
| 106 | 22,602 | 1 |
| 107 | 65/602 | 1 |
| 108 | 5702 | 1 |
| 109 | 108,212 | 1 |
| 110 | 36,312 | 1 |
| 111 | 3,512 | 1 |
| 112 | 12/512 | 1 |
| 113 | 8522 | 1 |
| 114 | 11,132 | 1 |
| 115 | 45/132 | 1 |
| 116 | 30/232 | 1 |
| 117 | 4,432 | 1 |
| 118 | 2485/7432 | 1 |
| 119 | 4732 | 7 |
| 120 | 236/242 | 1 |
| 121 | 16,742 | 1 |
| 122 | 14/152 | 1 |
| 123 | 26/152 | 1 |
| 124 | 5,552 | 3 |
| 125 | 5,952 | 1 |
| 126 | 7162 | 1 |
| 127 | 15,362 | 1 |
| 128 | 12,562 | 1 |
| 129 | 2,662 | 4 |
| 130 | 18,662 | 1 |
| 131 | 23,962 | 1 |
| 132 | 5,172 | 2 |
| 133 | 4,082 | 2 |
| 134 | 12782 | 1 |
| 135 | 89/92 | 1 |
| 136 | 22,092 | 1 |
| 137 | 12092 | 1 |
| 138 | 27,492 | 3 |
| 139 | 6492 | 1 |
| 140 | 11,592 | 1 |
| 141 | 4,592 | 1 |
| 142 | 1,792 | 5 |
| 143 | 4892 | 3 |
| 144 | chd/dm2 | 1 |
| 145 | 7/3/3 | 1 |
| 146 | 20,503 | 1 |
| 147 | 4503 | 3 |
| 148 | 6503 | 1 |
| 149 | 14,703 | 6 |
| 150 | 38,803 | 1 |
| 151 | drb1*13 | 1 |
| 152 | 42/113 | 1 |
| 153 | 3813 | 2 |
| 154 | 16,323 | 1 |
| 155 | 6323 | 3 |
| 156 | 1,063/3,423 | 1 |
| 157 | 244/3,423 | 1 |
| 158 | 29,423 | 2 |
| 159 | 10,523 | 1 |
| 160 | 14,923 | 1 |
| 161 | 14/133 | 1 |
| 162 | 5,233 | 2 |
| 163 | 53/433 | 1 |
| 164 | 4,833 | 1 |
| 165 | 4043 | 3 |
| 166 | 3,343 | 2 |
| 167 | 430/943 | 1 |
| 168 | 1,653 | 4 |
| 169 | 24,753 | 1 |
| 170 | 3/753 | 1 |
| 171 | 9853 | 1 |
| 172 | 6,953 | 1 |
| 173 | 7,863 | 1 |
| 174 | 7,683 | 1 |
| 175 | 11,883 | 1 |
| 176 | 9,193 | 2 |
| 177 | 19,193 | 3 |
| 178 | 5293 | 1 |
| 179 | 13,593 | 1 |
| 180 | fhl3 | 4 |
| 181 | hcv-1/4 | 1 |
| 182 | 90/104 | 1 |
| 183 | 87/104 | 1 |
| 184 | 13104 | 1 |
| 185 | 65/404 | 1 |
| 186 | 9014 | 9 |
| 187 | 133/124 | 1 |
| 188 | 53/124 | 1 |
| 189 | 69/124 | 1 |
| 190 | 11,324 | 2 |
| 191 | 127/324 | 1 |
| 192 | 7034 | 1 |
| 193 | 29/234 | 2 |
| 194 | 10,634 | 1 |
| 195 | 4,934 | 1 |
| 196 | 5,044 | 2 |
| 197 | 33,244 | 1 |
| 198 | 313/344 | 1 |
| 199 | 3,544 | 6 |
| 200 | 9,544 | 1 |
| 201 | 1,497,254 | 1 |
| 202 | 7,754 | 3 |
| 203 | 7,954 | 2 |
| 204 | 5,064 | 1 |
| 205 | 8164 | 5 |
| 206 | 2,364 | 3 |
| 207 | 996,364 | 1 |
| 208 | 7364 | 1 |
| 209 | 4464 | 2 |
| 210 | 9464 | 1 |
| 211 | 730,664 | 1 |
| 212 | 1,664 | 4 |
| 213 | 51/74 | 1 |
| 214 | 137,574 | 1 |
| 215 | 61,774 | 1 |
| 216 | 607/1,084 | 1 |
| 217 | 72/184 | 1 |
| 218 | 3/184 | 1 |
| 219 | 157/184 | 1 |
| 220 | 7,484 | 1 |
| 221 | 218/294 | 1 |
| 222 | 21,105 | 1 |
| 223 | 86/105 | 1 |
| 224 | 4,205 | 1 |
| 225 | 57,205 | 1 |
| 226 | 10/205 | 1 |
| 227 | 176,505 | 1 |
| 228 | 144,605 | 1 |
| 229 | 60,705 | 1 |
| 230 | 1,370/1,905 | 1 |
| 231 | 2,905 | 2 |
| 232 | 24/115 | 1 |
| 233 | 153/1725 | 1 |
| 234 | 11035 | 1 |
| 235 | 99,935 | 1 |
| 236 | 107/1,045 | 1 |
| 237 | 8845 | 1 |
| 238 | 6,355 | 1 |
| 239 | 7855 | 1 |
| 240 | 870/1955 | 1 |
| 241 | 2,065 | 3 |
| 242 | 4,665 | 2 |
| 243 | 7,665 | 2 |
| 244 | 3,865 | 1 |
| 245 | 84,865 | 1 |
| 246 | 44/75 | 2 |
| 247 | 47/75 | 1 |
| 248 | 9,175 | 1 |
| 249 | 41/275 | 1 |
| 250 | 6675 | 1 |
| 251 | 13,875 | 2 |
| 252 | 43/85 | 1 |
| 253 | 32,085 | 1 |
| 254 | 19,185 | 4 |
| 255 | 9185 | 1 |
| 256 | 16,485 | 1 |
| 257 | 26/195 | 1 |
| 258 | 287/4395 | 1 |
| 259 | 5395 | 2 |
| 260 | g1/4/6 | 1 |
| 261 | 36,406 | 1 |
| 262 | 11,506 | 2 |
| 263 | 356/506 | 1 |
| 264 | 6906 | 3 |
| 265 | 4,016 | 3 |
| 266 | 7,016 | 1 |
| 267 | total,116 | 1 |
| 268 | 6216 | 3 |
| 269 | 91/616 | 1 |
| 270 | 14/36 | 2 |
| 271 | 192,036 | 1 |
| 272 | 17,236 | 1 |
| 273 | 28,636 | 1 |
| 274 | 30/146 | 1 |
| 275 | 16/146 | 1 |
| 276 | 44,346 | 1 |
| 277 | 6,446 | 1 |
| 278 | 3,746 | 2 |
| 279 | 6,746 | 1 |
| 280 | 187,056 | 1 |
| 281 | 19/156 | 2 |
| 282 | 41,256 | 1 |
| 283 | 74,256 | 1 |
| 284 | 12/256 | 1 |
| 285 | 6956 | 1 |
| 286 | 16/66 | 1 |
| 287 | 6,066 | 2 |
| 288 | 2,466 | 7 |
| 289 | 627/666 | 1 |
| 290 | 8,966 | 1 |
| 291 | 4,076 | 1 |
| 292 | 24,076 | 1 |
| 293 | 599/1076 | 1 |
| 294 | 1,476 | 4 |
| 295 | 7476 | 1 |
| 296 | 95/186 | 1 |
| 297 | 60/286 | 1 |
| 298 | 8586 | 1 |
| 299 | 54,696 | 3 |
| 300 | 96/107 | 1 |
| 301 | 18,207 | 1 |
| 302 | 8507 | 2 |
| 303 | 13517 | 1 |
| 304 | 3717 | 2 |
| 305 | 7,427 | 1 |
| 306 | 11,037 | 1 |
| 307 | 11/537 | 1 |
| 308 | 25/47 | 1 |
| 309 | 9247 | 1 |
| 310 | 336/347 | 1 |
| 311 | 5747 | 3 |
| 312 | 5847 | 1 |
| 313 | 9/2011,57 | 1 |
| 314 | 20/157 | 1 |
| 315 | 131/157 | 1 |
| 316 | 2,257 | 2 |
| 317 | 8,557 | 1 |
| 318 | 628/657 | 1 |
| 319 | 8757 | 1 |
| 320 | 8167 | 1 |
| 321 | 36,567 | 1 |
| 322 | 3,767 | 1 |
| 323 | 7967 | 1 |
| 324 | 75/77 | 2 |
| 325 | 5577 | 1 |
| 326 | 4,677 | 1 |
| 327 | 34,677 | 1 |
| 328 | 29,677 | 1 |
| 329 | 3,777 | 1 |
| 330 | 6,187 | 1 |
| 331 | 3,687 | 6 |
| 332 | 3,987 | 1 |
| 333 | 9987 | 1 |
| 334 | 25/97 | 1 |
| 335 | 50,397 | 1 |
| 336 | 6,797 | 3 |
| 337 | 64/208 | 1 |
| 338 | 4,308 | 1 |
| 339 | 104.408 | 2 |
| 340 | 461/508 | 1 |
| 341 | 321/808 | 1 |
| 342 | 12.218 | 1 |
| 343 | 364/418 | 1 |
| 344 | 847/1,518 | 1 |
| 345 | 6518 | 1 |
| 346 | 74/128 | 1 |
| 347 | 11,228 | 1 |
| 348 | 12,428 | 1 |
| 349 | 1,628 | 4 |
| 350 | 16,728 | 1 |
| 351 | 7928 | 1 |
| 352 | 28/38 | 1 |
| 353 | 3838 | 6 |
| 354 | 8838 | 1 |
| 355 | 5,348 | 1 |
| 356 | 10,448 | 1 |
| 357 | 7448 | 2 |
| 358 | 4,548 | 1 |
| 359 | 3,648 | 1 |
| 360 | 7748 | 1 |
| 361 | 6848 | 1 |
| 362 | 52/58 | 1 |
| 363 | 63/158 | 2 |
| 364 | 79/2,358 | 1 |
| 365 | 3,558 | 2 |
| 366 | 9858 | 1 |
| 367 | 19/68 | 1 |
| 368 | 33/1168 | 1 |
| 369 | 36/468 | 1 |
| 370 | 4468 | 3 |
| 371 | 36/178 | 1 |
| 372 | 5,678 | 2 |
| 373 | 9,978 | 2 |
| 374 | 28/188 | 1 |
| 375 | 2,388 | 1 |
| 376 | 5588 | 1 |
| 377 | 7888 | 1 |
| 378 | 82/98 | 1 |
| 379 | 23/98 | 1 |
| 380 | 93/98 | 1 |
| 381 | 29/98 | 1 |
| 382 | 12/209 | 1 |
| 383 | 404/409 | 1 |
| 384 | 9,709 | 1 |
| 385 | 17,219 | 1 |
| 386 | 16,519 | 1 |
| 387 | 60,719 | 1 |
| 388 | 13,819 | 7 |
| 389 | cyp2d6/cyp2c19 | 1 |
| 390 | 84,429 | 1 |
| 391 | 72/139 | 1 |
| 392 | 27/139 | 1 |
| 393 | 2439 | 6 |
| 394 | 15,939 | 4 |
| 395 | 26,449 | 4 |
| 396 | ser49 | 3 |
| 397 | 5,559 | 1 |
| 398 | 69/69 | 1 |
| 399 | 23/169 | 1 |
| 400 | 734,269 | 1 |
| 401 | 2,769 | 3 |
| 402 | 6769 | 1 |
| 403 | 3969 | 2 |
| 404 | 5,179 | 1 |
| 405 | 3,479 | 1 |
| 406 | 24,779 | 1 |
| 407 | 3779 | 5 |
| 408 | 9779 | 3 |
| 409 | 69/89 | 1 |
| 410 | 135/189 | 1 |
| 411 | 9189 | 1 |
| 412 | 7,489 | 2 |
| 413 | 38,489 | 1 |
| 414 | 138/589 | 1 |
| 415 | 32,689 | 1 |
| 416 | 9,989 | 1 |
| 417 | 8399 | 1 |
| 418 | 10,599 | 1 |
| 419 | 7,599 | 3 |
| 420 | non-ba | 3 |
| 421 | non-edda | 5 |
| 422 | 'frda | 1 |
| 423 | as-tga | 4 |
| 424 | non-cepacia | 1 |
| 425 | non-hyperuricemia | 2 |
| 426 | multiple-trauma | 5 |
| 427 | post-oa | 1 |
| 428 | low-pra | 1 |
| 429 | dsa+non-dsa | 1 |
| 430 | plato-usa | 1 |
| 431 | cidb | 7 |
| 432 | non-ldlr/non-apob | 1 |
| 433 | nesb | 8 |
| 434 | hiv+/tb | 2 |
| 435 | tpmt*1/*3c | 2 |
| 436 | non-hemophiliac | 3 |
| 437 | nonhemophiliac | 3 |
| 438 | insomniac | 15 |
| 439 | first-episodic | 4 |
| 440 | dyspneic | 26 |
| 441 | oligo-amenorrhoeic | 1 |
| 442 | dysphagic | 34 |
| 443 | traumatic-hemorrhagic | 1 |
| 444 | vasoplegic | 1 |
| 445 | oncourologic | 1 |
| 446 | egg-allergic | 10 |
| 447 | peach-allergic | 4 |
| 448 | penicillin-allergic | 7 |
| 449 | hamster-allergic | 2 |
| 450 | lipoatrophic | 9 |
| 451 | lipodystrophic | 10 |
| 452 | bronchopathic | 1 |
| 453 | cardiopathic | 2 |
| 454 | arteriopathic | 2 |
| 455 | coronaropathic | 1 |
| 456 | nephropathic | 14 |
| 457 | cardiomyopathic | 40 |
| 458 | iiiic | 1 |
| 459 | acromegalic | 99 |
| 460 | hydrocephalic | 5 |
| 461 | haemophilic | 30 |
| 462 | hypercholesterolamic | 1 |
| 463 | normouricaemic | 1 |
| 464 | hyperglycaemic | 83 |
| 465 | hyperlipidaemic | 81 |
| 466 | dyslipidaemic | 61 |
| 467 | normotriglyceridaemic | 4 |
| 468 | hypertriglyceridaemic | 22 |
| 469 | normocholesterolaemic | 27 |
| 470 | hypercholesterolaemic | 351 |
| 471 | normolipoproteinaemic | 2 |
| 472 | hyperlipoproteinaemic | 10 |
| 473 | cryoglobulinaemic | 4 |
| 474 | normonatraemic | 1 |
| 475 | uraemic | 78 |
| 476 | thalassaemic | 12 |
| 477 | hyperuricemic | 56 |
| 478 | hypozincemic | 4 |
| 479 | hypertriglycemic | 1 |
| 480 | hyperglycemic | 303 |
| 481 | hyperlipidemic | 518 |
| 482 | dyslipidemic | 315 |
| 483 | normo-triglyceridemic | 1 |
| 484 | normotriglyceridemic | 20 |
| 485 | hypertriglyceridemic | 192 |
| 486 | normoglyceridemic | 2 |
| 487 | hypercholesterolemic | 1,701 |
| 488 | mild-hypercholesterolemic | 2 |
| 489 | nonhypercholesterolemic | 8 |
| 490 | hyperchoelsterolemic | 1 |
| 491 | hypocortisolemic | 1 |
| 492 | hyperlipoproteinemic | 12 |
| 493 | dyslipoproteinemic | 5 |
| 494 | hypo-albuminemic | 2 |
| 495 | normoalbuminemic | 1 |
| 496 | hypoalbuminemic | 34 |
| 497 | hyperprolactinemic | 13 |
| 498 | hyperlipemic | 29 |
| 499 | dyslipemic | 4 |
| 500 | hypercholesteremic | 3 |
| 501 | non-viremic | 3 |
| 502 | aviremic | 9 |
| 503 | normonatremic | 7 |
| 504 | hyponatremic | 39 |
| 505 | non-hyponatremic | 1 |
| 506 | uremic | 401 |
| 507 | hypomagnesemic | 125 |
| 508 | thalassemic | 37 |
| 509 | b-thalassemic | 3 |
| 510 | normophosphatemic | 4 |
| 511 | hyperphosphatemic | 9 |
| 512 | non-azotemic | 6 |
| 513 | xerostomic | 12 |
| 514 | oligozoospermic | 12 |
| 515 | cryptozoospermic | 3 |
| 516 | nonalexithymic | 1 |
| 517 | neutropaenic | 13 |
| 518 | hyperandrogenic | 14 |
| 519 | neutropenic | 458 |
| 520 | non-neutropenic | 32 |
| 521 | nonneutropenic | 15 |
| 522 | granulocytopenic | 39 |
| 523 | schizophrenic | 404 |
| 524 | outclinic | 2 |
| 525 | presbyopic | 19 |
| 526 | postclimacteric | 2 |
| 527 | candiduric | 3 |
| 528 | anuric | 49 |
| 529 | non-anuric | 3 |
| 530 | oligoanuric | 2 |
| 531 | proteinuric | 146 |
| 532 | albuminuric | 12 |
| 533 | normoalbuminuric | 126 |
| 534 | macroalbuminuric | 24 |
| 535 | microalbuminuric | 85 |
| 536 | phenylketonuric | 5 |
| 537 | anosognosic | 1 |
| 538 | nonpolydipsic | 2 |
| 539 | non-asiatic | 1 |
| 540 | asthmatic | 1,502 |
| 541 | recently-symptomatic | 1 |
| 542 | nephropatic | 1 |
| 543 | bronchiectatic | 2 |
| 544 | cachectic | 23 |
| 545 | non-cachectic | 5 |
| 546 | pre-diabetic | 52 |
| 547 | hypertensive-diabetic | 15 |
| 548 | alloxan-diabetic | 4 |
| 549 | non-diabetic | 999 |
| 550 | hs-diabetic | 1 |
| 551 | 3diabetic | 1 |
| 552 | prediabetic | 114 |
| 553 | nondiabetic | 1,061 |
| 554 | gastroparietic | 1 |
| 555 | gastroparetic | 5 |
| 556 | no-diuretic | 3 |
| 557 | bronchitic | 47 |
| 558 | rhinitic | 7 |
| 559 | non-cirrhotic | 46 |
| 560 | trial.cirrhotic | 1 |
| 561 | noncirrhotic | 28 |
| 562 | non-nephrotic | 10 |
| 563 | healthy/osteopenic/osteoporotic | 1 |
| 564 | narcoleptic | 6 |
| 565 | id/autistic | 1 |
| 566 | nonautistic | 3 |
| 567 | cirrhostic | 1 |
| 568 | nonhypoxic | 3 |
| 569 | thyrotoxic | 41 |
| 570 | post-kc | 1 |
| 571 | group-d | 1 |
| 572 | stable-cad | 2 |
| 573 | igad | 15 |
| 574 | non-paced | 2 |
| 575 | rv-paced | 7 |
| 576 | vka-experienced | 14 |
| 577 | opioid-experienced | 14 |
| 578 | tnfi-experienced | 1 |
| 579 | medication-experienced | 4 |
| 580 | interferon-experienced | 1 |
| 581 | treatment-experienced | 224 |
| 582 | arv-experienced | 3 |
| 583 | therapy-experienced | 4 |
| 584 | ibo-induced | 2 |
| 585 | clopidogrel-loaded | 1 |
| 586 | iron-overloaded | 12 |
| 587 | dexmedetomidine-added | 1 |
| 588 | nonexpanded | 3 |
| 589 | tube-fed | 20 |
| 590 | higher-aged | 1 |
| 591 | brain-damaged | 16 |
| 592 | under-dosaged | 1 |
| 593 | plasma-exchanged | 1 |
| 594 | tg-matched | 1 |
| 595 | non-malnourished | 6 |
| 596 | nonmalnourished | 7 |
| 597 | ventilaled | 1 |
| 598 | severely-disabled | 1 |
| 599 | sensory-disabled | 1 |
| 600 | diet-failed | 1 |
| 601 | ambulance-enrolled | 2 |
| 602 | non-co-enrolled | 1 |
| 603 | rhythm-controlled | 1 |
| 604 | surface-cooled | 1 |
| 605 | invasive-cooled | 1 |
| 606 | pci-assigned | 1 |
| 607 | pi-assigned | 2 |
| 608 | dabigatran-assigned | 1 |
| 609 | balloon-trained | 1 |
| 610 | lamivudine-maintained | 4 |
| 611 | co-poisoned | 4 |
| 612 | mood-disordered | 1 |
| 613 | g-400-administered | 1 |
| 614 | antibiotic-administered | 1 |
| 615 | scp-monitored | 2 |
| 616 | ecmo-referred | 5 |
| 617 | non-ecmo-referred | 5 |
| 618 | head-injured | 18 |
| 619 | acl-injured | 11 |
| 620 | sm-injured | 1 |
| 621 | brain-injured | 38 |
| 622 | spinally-injured | 1 |
| 623 | hip-fractured | 7 |
| 624 | wheelchair-mobilised | 1 |
| 625 | plerixafor-mobilised | 3 |
| 626 | non-immobilised | 2 |
| 627 | formoterol-randomised | 4 |
| 628 | immuno-compromised | 9 |
| 629 | appendectomised | 4 |
| 630 | laryngectomised | 8 |
| 631 | varicocelectomised | 2 |
| 632 | mastectomised | 1 |
| 633 | vagotomised | 10 |
| 634 | immunocomprised | 2 |
| 635 | sifalimumab-dosed | 1 |
| 636 | pcp-diagnosed | 1 |
| 637 | infliximab-exposed | 1 |
| 638 | non-arb-exposed | 1 |
| 639 | thalidomide-exposed | 4 |
| 640 | etomidate-exposed | 2 |
| 641 | bisphosphonate-exposed | 1 |
| 642 | epirubicin-exposed | 2 |
| 643 | palifermin-exposed | 2 |
| 644 | czp-exposed | 1 |
| 645 | treatment-exposed | 1 |
| 646 | refractory-relapsed | 1 |
| 647 | immune-depressed | 1 |
| 648 | non-immunodepressed | 1 |
| 649 | well-suppressed | 1 |
| 650 | immuno-suppressed | 4 |
| 651 | virologically-suppressed | 6 |
| 652 | myelosuppressed | 4 |
| 653 | csa-immunosupressed | 1 |
| 654 | dibenzo-fused | 1 |
| 655 | msc-infused | 1 |
| 656 | glucagon-infused | 1 |
| 657 | multi-transfused | 2 |
| 658 | un-transfused | 1 |
| 659 | polytransfused | 7 |
| 660 | non-dialysed | 3 |
| 661 | haemodialysed | 23 |
| 662 | hemodialysed | 4 |
| 663 | polymedicated | 10 |
| 664 | pacing-indicated | 1 |
| 665 | methadone-intoxicated | 2 |
| 666 | amphetamine-allocated | 2 |
| 667 | midazolam-sedated | 1 |
| 668 | u.s.-treated | 1 |
| 669 | mdx-1100-treated | 2 |
| 670 | pa32540-treated | 2 |
| 671 | gs9450-treated | 1 |
| 672 | ly2605541-treated | 4 |
| 673 | dz1-treated | 1 |
| 674 | il-2-treated | 2 |
| 675 | lb03002-treated | 1 |
| 676 | pge2-treated | 1 |
| 677 | mgn-3-treated | 1 |
| 678 | azd9773-treated | 2 |
| 679 | folfox-4-treated | 1 |
| 680 | t12pr24-treated | 1 |
| 681 | usl255-treated | 1 |
| 682 | cs-866-treated | 2 |
| 683 | lcz696-treated | 1 |
| 684 | medi-528-treated | 2 |
| 685 | om-89-treated | 1 |
| 686 | cyclosporine-a-treated | 1 |
| 687 | ifnβ1a-treated | 1 |
| 688 | ldaa-treated | 2 |
| 689 | non-laba-treated | 4 |
| 690 | elca-treated | 5 |
| 691 | tca-treated | 6 |
| 692 | ada-treated | 3 |
| 693 | cea-treated | 2 |
| 694 | sulfonylurea-treated | 2 |
| 695 | metformin/sulfonylurea-treated | 2 |
| 696 | fga-treated | 2 |
| 697 | bioha-treated | 1 |
| 698 | ifn-alpha-treated | 1 |
| 699 | anti-tnfalpha-treated | 2 |
| 700 | vka-treated | 3 |
| 701 | pla-treated | 2 |
| 702 | onabotulinumtoxina-treated | 12 |
| 703 | rt-pa-treated | 9 |
| 704 | mpa-treated | 4 |
| 705 | l-dopa-treated | 6 |
| 706 | levodopa-treated | 19 |
| 707 | tpa-treated | 5 |
| 708 | anakinra-treated | 3 |
| 709 | csa-treated | 41 |
| 710 | esa-treated | 6 |
| 711 | ifnbeta-treated | 1 |
| 712 | cya-treated | 5 |
| 713 | aza-treated | 10 |
| 714 | cyc/aza-treated | 1 |
| 715 | abciximab-treated | 9 |
| 716 | infliximab-treated | 33 |
| 717 | cetuximab-treated | 5 |
| 718 | rituximab-treated | 27 |
| 719 | evolocumab-treated | 4 |
| 720 | guselkumab-treated | 5 |
| 721 | tabalumab-treated | 2 |
| 722 | adalimumab-treated | 38 |
| 723 | sifalimumab-treated | 2 |
| 724 | ipilimumab-treated | 2 |
| 725 | golimumab-treated | 13 |
| 726 | panitumumab-treated | 3 |
| 727 | ustekinumab-treated | 28 |
| 728 | bevacizumab-treated | 34 |
| 729 | non-bevacizumab-treated | 1 |
| 730 | efalizumab-treated | 7 |
| 731 | omalizumab-treated | 14 |
| 732 | natalizumab-treated | 2 |
| 733 | tocilizumab-treated | 5 |
| 734 | otelixizumab-treated | 1 |
| 735 | alemtuzumab-treated | 3 |
| 736 | onartuzumab-treated | 1 |
| 737 | trastuzumab-treated | 13 |
| 738 | vismodegib-treated | 3 |
| 739 | pazo-panib-treated | 1 |
| 740 | pazopanib-treated | 8 |
| 741 | cediranib-treated | 7 |
| 742 | sorafenib-treated | 7 |
| 743 | imatinib-treated | 9 |
| 744 | lapatinib-treated | 7 |
| 745 | ruxolitinib-treated | 7 |
| 746 | sunitinib-treated | 18 |
| 747 | axitinib-treated | 3 |
| 748 | erlotinib-treated | 7 |
| 749 | torcetrapib-treated | 3 |
| 750 | balicatib-treated | 1 |
| 751 | parecoxib/valdecoxib-treated | 1 |
| 752 | celecoxib-treated | 12 |
| 753 | arb-treated | 18 |
| 754 | acei/arb-treated | 3 |
| 755 | ac-treated | 2 |
| 756 | ketorolac-treated | 6 |
| 757 | oac-treated | 4 |
| 758 | tac-treated | 7 |
| 759 | cdc-treated | 3 |
| 760 | degludec-treated | 3 |
| 761 | fec-treated | 1 |
| 762 | mec-treated | 2 |
| 763 | ofc-treated | 8 |
| 764 | cic-treated | 1 |
| 765 | nic-treated | 3 |
| 766 | antipsychotic-treated | 9 |
| 767 | thrombolytic-treated | 2 |
| 768 | tg-mmc-treated | 1 |
| 769 | fnc-treated | 1 |
| 770 | maraviroc-treated | 7 |
| 771 | adrc-treated | 5 |
| 772 | csc-treated | 3 |
| 773 | tdf/ftc-treated | 1 |
| 774 | cyc-treated | 2 |
| 775 | icd-treated | 3 |
| 776 | cefonicid-treated | 7 |
| 777 | linezolid-treated | 9 |
| 778 | glucocorticoid-treated | 8 |
| 779 | opioid-treated | 9 |
| 780 | fingolimod-treated | 6 |
| 781 | laquinimod-treated | 2 |
| 782 | tegaserod-treated | 10 |
| 783 | atd-treated | 1 |
| 784 | vtd-treated | 2 |
| 785 | ezetimibe-treated | 5 |
| 786 | statin/ezetimibe-treated | 1 |
| 787 | iodide-treated | 1 |
| 788 | macrolide-treated | 3 |
| 789 | cyclophosphamide-treated | 5 |
| 790 | nicotinamide-treated | 2 |
| 791 | metoclopramide-treated | 4 |
| 792 | lacosamide-treated | 2 |
| 793 | furosemide-treated | 8 |
| 794 | thalidomide-treated | 3 |
| 795 | lenalidomide-treated | 2 |
| 796 | leflunomide-treated | 3 |
| 797 | budesonide-treated | 7 |
| 798 | lixisenatide-treated | 2 |
| 799 | exenatide-treated | 12 |
| 800 | teriparatide-treated | 8 |
| 801 | cilengitide-treated | 2 |
| 802 | nesiritide-treated | 5 |
| 803 | pramlintide-treated | 4 |
| 804 | octreotide-treated | 5 |
| 805 | linaclotide-treated | 5 |
| 806 | thiazide-treated | 3 |
| 807 | hdle-treated | 1 |
| 808 | ropinirole-treated | 3 |
| 809 | clotrimazole-treated | 3 |
| 810 | omeprazole-treated | 12 |
| 811 | trimethoprim/sulfamethoxazole-treated | 1 |
| 812 | astemizole-treated | 2 |
| 813 | riluzole-treated | 4 |
| 814 | staple-treated | 1 |
| 815 | cefepime-treated | 4 |
| 816 | exemestane-treated | 3 |
| 817 | tazarotene-treated | 2 |
| 818 | capecitabine-treated | 1 |
| 819 | cladribine-treated | 2 |
| 820 | guanfacine-treated | 4 |
| 821 | ivabradine-treated | 3 |
| 822 | desloratadine-treated | 2 |
| 823 | zimelidine-treated | 3 |
| 824 | clonidine-treated | 2 |
| 825 | azacitidine-treated | 2 |
| 826 | famotidine-treated | 1 |
| 827 | trimetazidine-treated | 3 |
| 828 | fesoterodine-treated | 3 |
| 829 | n-acetylcysteine-treated | 3 |
| 830 | naftifine-treated | 4 |
| 831 | glargine-treated | 7 |
| 832 | sertraline-treated | 36 |
| 833 | terbutaline-treated | 1 |
| 834 | varenicline-treated | 11 |
| 835 | tigecycline-treated | 4 |
| 836 | non-selegiline-treated | 2 |
| 837 | pentoxifylline-treated | 7 |
| 838 | rolofylline-treated | 3 |
| 839 | enprofylline-treated | 4 |
| 840 | citicoline-treated | 2 |
| 841 | anthracyline-treated | 1 |
| 842 | mesalamine-treated | 1 |
| 843 | amphetamine-treated | 1 |
| 844 | galantamine-treated | 4 |
| 845 | desferrioxamine-treated | 2 |
| 846 | rivastigmine-treated | 9 |
| 847 | nevirapine-treated | 6 |
| 848 | mirtazapine-treated | 14 |
| 849 | olanzapine-treated | 82 |
| 850 | clozapine-treated | 26 |
| 851 | nicardipine-treated | 4 |
| 852 | norepinephrine-treated | 3 |
| 853 | etravirine-treated | 5 |
| 854 | cyclosporine-treated | 53 |
| 855 | azathioprine-treated | 8 |
| 856 | acadesine-treated | 1 |
| 857 | miltefosine-treated | 2 |
| 858 | duloxetine-treated | 91 |
| 859 | nonduloxetine-treated | 3 |
| 860 | atomoxetine-treated | 14 |
| 861 | paroxetine-treated | 18 |
| 862 | fluoxetine-treated | 62 |
| 863 | memantine-treated | 11 |
| 864 | rotigotine-treated | 1 |
| 865 | bromocriptine-treated | 5 |
| 866 | methylergonovine-treated | 1 |
| 867 | venlafaxine-treated | 14 |
| 868 | sulfasalazine-treated | 4 |
| 869 | mesalazine-treated | 5 |
| 870 | cetirizine-treated | 3 |
| 871 | risperidone-treated | 30 |
| 872 | ziprasidone-treated | 6 |
| 873 | nefazodone-treated | 5 |
| 874 | methylprednisolone-treated | 6 |
| 875 | amiodarone-treated | 14 |
| 876 | gepirone-treated | 1 |
| 877 | fluticasone-treated | 2 |
| 878 | ceftriaxone-treated | 9 |
| 879 | naltrexone-treated | 8 |
| 880 | methylnaltrexone-treated | 2 |
| 881 | rosiglitazone-treated | 10 |
| 882 | pioglitazone-treated | 22 |
| 883 | pulse-treated | 1 |
| 884 | low-dose-treated | 1 |
| 885 | etomidate-treated | 1 |
| 886 | folate-treated | 2 |
| 887 | amoxicillin/clavulanate-treated | 8 |
| 888 | bisphosphonate-treated | 9 |
| 889 | pamidronate-treated | 6 |
| 890 | fibrate-treated | 2 |
| 891 | methotrexate-treated | 13 |
| 892 | eve-treated | 2 |
| 893 | phvhf-treated | 1 |
| 894 | mmf-treated | 10 |
| 895 | csf-treated | 5 |
| 896 | g-csf-treated | 5 |
| 897 | gm-csf-treated | 1 |
| 898 | eltrombopag-treated | 6 |
| 899 | cabg-treated | 10 |
| 900 | bcg-treated | 8 |
| 901 | dscg-treated | 1 |
| 902 | sdg-treated | 2 |
| 903 | camg-treated | 1 |
| 904 | fmh-treated | 1 |
| 905 | rhc1inh-treated | 2 |
| 906 | lmwh-treated | 3 |
| 907 | 131i-treated | 3 |
| 908 | ai-treated | 1 |
| 909 | rlai-treated | 4 |
| 910 | mdi-treated | 3 |
| 911 | dmi-treated | 3 |
| 912 | epi-treated | 1 |
| 913 | lpi-treated | 3 |
| 914 | ssri-treated | 11 |
| 915 | multi-treated | 2 |
| 916 | sk-treated | 1 |
| 917 | safranal-treated | 2 |
| 918 | antiretroviral-treated | 9 |
| 919 | triflusal-treated | 1 |
| 920 | amx-cl-treated | 2 |
| 921 | clopidogrel-treated | 26 |
| 922 | prasugrel-treated | 8 |
| 923 | tadalafil-treated | 12 |
| 924 | sildenafil-treated | 10 |
| 925 | verapamil-treated | 5 |
| 926 | modafinil-treated | 5 |
| 927 | ramipril-treated | 7 |
| 928 | zofenopril-treated | 5 |
| 929 | lisinopril-treated | 4 |
| 930 | donepezil-treated | 15 |
| 931 | gemfibrozil-treated | 5 |
| 932 | cell-treated | 22 |
| 933 | propofol-treated | 5 |
| 934 | alcohol-treated | 25 |
| 935 | sotalol-treated | 1 |
| 936 | carvedilol-treated | 7 |
| 937 | propranolol-treated | 15 |
| 938 | atenolol-treated | 15 |
| 939 | danazol-treated | 1 |
| 940 | cilostazol-treated | 11 |
| 941 | p/evl-treated | 1 |
| 942 | carumonam-treated | 4 |
| 943 | disulfiram-treated | 4 |
| 944 | escitalopram-treated | 20 |
| 945 | piracetam-treated | 1 |
| 946 | fcm-treated | 5 |
| 947 | tcm-treated | 4 |
| 948 | com-treated | 1 |
| 949 | hpm-treated | 1 |
| 950 | tm-treated | 2 |
| 951 | lithium-treated | 22 |
| 952 | gad-alum-treated | 2 |
| 953 | apixaban-treated | 2 |
| 954 | rivaroxaban-treated | 10 |
| 955 | orbofiban-treated | 1 |
| 956 | argatroban-treated | 3 |
| 957 | busulfan-treated | 6 |
| 958 | ambrisentan-treated | 4 |
| 959 | avosentan-treated | 1 |
| 960 | clazosentan-treated | 3 |
| 961 | tezosentan-treated | 1 |
| 962 | zibotentan-treated | 5 |
| 963 | rizatriptan-treated | 2 |
| 964 | olmesartan-treated | 9 |
| 965 | telmisartan-treated | 25 |
| 966 | en-treated | 1 |
| 967 | flurbiprofen-treated | 3 |
| 968 | fibrinogen-treated | 1 |
| 969 | non-estrogen-treated | 1 |
| 970 | drisapersen-treated | 1 |
| 971 | ceftibuten-treated | 4 |
| 972 | ifn-treated | 8 |
| 973 | peg-ifn-treated | 2 |
| 974 | grepafloxacin-treated | 1 |
| 975 | trovafloxacin-treated | 2 |
| 976 | lomefloxacin-treated | 12 |
| 977 | besifloxacin-treated | 1 |
| 978 | moxifloxacin-treated | 8 |
| 979 | sparfloxacin-treated | 1 |
| 980 | norfloxacin-treated | 5 |
| 981 | fleroxacin-treated | 5 |
| 982 | doxorubicin-treated | 10 |
| 983 | netilmicin-treated | 3 |
| 984 | clindamycin-treated | 6 |
| 985 | josamycin-treated | 2 |
| 986 | vancomycin-treated | 16 |
| 987 | clarithromycin-treated | 25 |
| 988 | dirithromycin-treated | 7 |
| 989 | erythromycin-treated | 14 |
| 990 | bivalirudin-treated | 4 |
| 991 | lecithin-treated | 1 |
| 992 | pregabalin-treated | 18 |
| 993 | prostacyclin-treated | 2 |
| 994 | goserelin-treated | 5 |
| 995 | tesamorelin-treated | 1 |
| 996 | ampicillin-treated | 7 |
| 997 | amoxicillin-treated | 26 |
| 998 | mezlocillin-treated | 1 |
| 999 | insulin-treated | 148 |
| 1000 | non-insulin-treated | 27 |
| 1001 | metformin-treated | 55 |
| 1002 | aprotinin-treated | 9 |
| 1003 | alitretinoin-treated | 3 |
| 1004 | dothiepin-treated | 4 |
| 1005 | warfarin-treated | 28 |
| 1006 | heparin-treated | 13 |
| 1007 | lorcaserin-treated | 4 |
| 1008 | aspirin-treated | 49 |
| 1009 | ribavirin-treated | 5 |
| 1010 | vigabatrin-treated | 2 |
| 1011 | tamsulosin-treated | 4 |
| 1012 | carboplatin-treated | 2 |
| 1013 | statin-treated | 204 |
| 1014 | non-statin-treated | 5 |
| 1015 | pravastatin-treated | 38 |
| 1016 | pitavastatin-treated | 6 |
| 1017 | cerivastatin-treated | 3 |
| 1018 | simvastatin-treated | 62 |
| 1019 | atorvastatin-treated | 62 |
| 1020 | fluvastatin-treated | 15 |
| 1021 | somatostatin-treated | 1 |
| 1022 | erythropoietin-treated | 6 |
| 1023 | epoetin-treated | 1 |
| 1024 | cefoxitin-treated | 1 |
| 1025 | gabapentin-treated | 9 |
| 1026 | vildagliptin-treated | 5 |
| 1027 | sitagliptin-treated | 8 |
| 1028 | saxagliptin-treated | 3 |
| 1029 | griseofulvin-treated | 3 |
| 1030 | digoxin-treated | 3 |
| 1031 | dapagliflozin-treated | 4 |
| 1032 | empagliflozin-treated | 1 |
| 1033 | ipragliflozin-treated | 1 |
| 1034 | mln-treated | 1 |
| 1035 | glucagon-treated | 2 |
| 1036 | healon-treated | 1 |
| 1037 | xenon-treated | 1 |
| 1038 | interferon-treated | 8 |
| 1039 | dolasetron-treated | 1 |
| 1040 | ondansetron-treated | 4 |
| 1041 | palonosetron-treated | 2 |
| 1042 | pdrn-treated | 2 |
| 1043 | hbo-treated | 7 |
| 1044 | pbo-treated | 7 |
| 1045 | dfo-treated | 3 |
| 1046 | levo-treated | 1 |
| 1047 | cdp-treated | 2 |
| 1048 | ip-treated | 5 |
| 1049 | cip-treated | 7 |
| 1050 | tip-treated | 1 |
| 1051 | am/amp-treated | 3 |
| 1052 | pump-treated | 7 |
| 1053 | loop-treated | 2 |
| 1054 | tp-treated | 3 |
| 1055 | ddavp-treated | 7 |
| 1056 | zdv/3tc/nvp-treated | 1 |
| 1057 | czp-treated | 8 |
| 1058 | q-treated | 2 |
| 1059 | gepirone-er-treated | 2 |
| 1060 | beta-blocker-treated | 2 |
| 1061 | sevelamer-treated | 14 |
| 1062 | 192ir-treated | 1 |
| 1063 | cefdinir-treated | 4 |
| 1064 | raltegravir-treated | 1 |
| 1065 | telaprevir-treated | 7 |
| 1066 | simeprevir-treated | 4 |
| 1067 | vaniprevir-treated | 1 |
| 1068 | zanamivir-treated | 4 |
| 1069 | ganciclovir-treated | 1 |
| 1070 | lr-treated | 2 |
| 1071 | clr-treated | 4 |
| 1072 | dmr-treated | 1 |
| 1073 | allicor-treated | 4 |
| 1074 | cefaclor-treated | 18 |
| 1075 | ticagrelor-treated | 14 |
| 1076 | cangrelor-treated | 1 |
| 1077 | nor-treated | 1 |
| 1078 | comparator-treated | 16 |
| 1079 | tavr-treated | 3 |
| 1080 | fgas-treated | 2 |
| 1081 | cs-treated | 7 |
| 1082 | scs-treated | 2 |
| 1083 | ses-treated | 7 |
| 1084 | is-treated | 2 |
| 1085 | digitalis-treated | 1 |
| 1086 | thrombolysis-treated | 5 |
| 1087 | fpns-treated | 3 |
| 1088 | tips-treated | 3 |
| 1089 | tacrolimus-treated | 28 |
| 1090 | everolimus-treated | 15 |
| 1091 | sirolimus-treated | 10 |
| 1092 | adenovirus-treated | 1 |
| 1093 | orlistat-treated | 15 |
| 1094 | adt-treated | 2 |
| 1095 | cinacalcet-treated | 8 |
| 1096 | met-treated | 6 |
| 1097 | pft-treated | 1 |
| 1098 | slit-treated | 6 |
| 1099 | kt-treated | 2 |
| 1100 | rimonabant-treated | 5 |
| 1101 | aspirin-anticoagulant-treated | 1 |
| 1102 | ot-treated | 1 |
| 1103 | alefacept-treated | 1 |
| 1104 | abatacept-treated | 21 |
| 1105 | belatacept-treated | 18 |
| 1106 | etanercept-treated | 18 |
| 1107 | neocart-treated | 2 |
| 1108 | smart-treated | 2 |
| 1109 | ris-st-treated | 1 |
| 1110 | mtx+iast-treated | 1 |
| 1111 | eu-treated | 1 |
| 1112 | su-treated | 2 |
| 1113 | co-amoxiclav-treated | 3 |
| 1114 | hbv-treated | 1 |
| 1115 | adv-treated | 7 |
| 1116 | iv-treated | 6 |
| 1117 | biv-treated | 1 |
| 1118 | hiv-treated | 3 |
| 1119 | niv-treated | 1 |
| 1120 | tlv-treated | 1 |
| 1121 | rpv-treated | 2 |
| 1122 | arv-treated | 7 |
| 1123 | brv-treated | 2 |
| 1124 | ssv-treated | 1 |
| 1125 | etv-treated | 7 |
| 1126 | eqw-treated | 2 |
| 1127 | divalproex-treated | 9 |
| 1128 | degarelix-treated | 1 |
| 1129 | flx-treated | 2 |
| 1130 | vlx-treated | 1 |
| 1131 | tmp/smx-treated | 2 |
| 1132 | mp4ox-treated | 2 |
| 1133 | heliox-treated | 1 |
| 1134 | ada+mtx-treated | 1 |
| 1135 | abatacept+mtx-treated | 1 |
| 1136 | xr-ntx-treated | 2 |
| 1137 | rtx-treated | 8 |
| 1138 | timothy-treated | 1 |
| 1139 | traditionally-treated | 2 |
| 1140 | early-treated | 6 |
| 1141 | immunotherapy-treated | 3 |
| 1142 | surgery-treated | 1 |
| 1143 | olz-treated | 4 |
| 1144 | tmz-treated | 4 |
| 1145 | efavirenz-treated | 5 |
| 1146 | hctz-treated | 5 |
| 1147 | ntz-treated | 1 |
| 1148 | tachosil®-treated | 1 |
| 1149 | vareniclinetreated | 1 |
| 1150 | sibutraminetreated | 1 |
| 1151 | rituximab-retreated | 1 |
| 1152 | simvastatintreated | 1 |
| 1153 | hiv-untreated | 1 |
| 1154 | chemotherapy-untreated | 1 |
| 1155 | metformin-cotreated | 1 |
| 1156 | tacrolimus-cotreated | 1 |
| 1157 | divalproextreated | 1 |
| 1158 | chemoradiated | 1 |
| 1159 | neck-irradiated | 1 |
| 1160 | fontan-palliated | 1 |
| 1161 | peep-ventilated | 1 |
| 1162 | zeep-ventilated | 1 |
| 1163 | nonanticoagulated | 8 |
| 1164 | non-constipated | 8 |
| 1165 | well-hydrated | 8 |
| 1166 | nondehydrated | 1 |
| 1167 | varicocele-affected | 1 |
| 1168 | g1-infected | 1 |
| 1169 | hiv-2-infected | 3 |
| 1170 | hcv-1b-infected | 1 |
| 1171 | hcv-mono-infected | 3 |
| 1172 | hp-infected | 1 |
| 1173 | hbv-infected | 25 |
| 1174 | non-hbv-infected | 1 |
| 1175 | hcv-infected | 140 |
| 1176 | hdv-infected | 4 |
| 1177 | hmpv-infected | 10 |
| 1178 | tuberculosis-coinfected | 1 |
| 1179 | hiv-hcv-coinfected | 2 |
| 1180 | hbv/hcv-coinfected | 2 |
| 1181 | hiv/hcv-coinfected | 18 |
| 1182 | hiv-coinfected | 9 |
| 1183 | tb-hiv-coinfected | 5 |
| 1184 | hbv-monoinfected | 5 |
| 1185 | hcv-monoinfected | 8 |
| 1186 | hiv-monoinfected | 5 |
| 1187 | hivinfected | 1 |
| 1188 | mismatch-selected | 1 |
| 1189 | non-resected | 3 |
| 1190 | ileoresected | 1 |
| 1191 | early-detected | 3 |
| 1192 | nondeleted | 1 |
| 1193 | bes-implanted | 2 |
| 1194 | ses-implanted | 2 |
| 1195 | non-transplanted | 17 |
| 1196 | liver-transplanted | 13 |
| 1197 | kidney-transplanted | 4 |
| 1198 | single-stented | 1 |
| 1199 | non-evented | 2 |
| 1200 | opcab-converted | 3 |
| 1201 | srl-converted | 1 |
| 1202 | nonconverted | 1 |
| 1203 | ems-transported | 1 |
| 1204 | muscle-wasted | 1 |
| 1205 | icu-admitted | 2 |
| 1206 | non-readmitted | 1 |
| 1207 | t4-substituted | 1 |
| 1208 | screening-derived | 1 |
| 1209 | extrahospitalized | 1 |
| 1210 | antipsychotic-stabilized | 3 |
| 1211 | neck-immobilized | 1 |
| 1212 | nonimmobilized | 2 |
| 1213 | fluid-optimized | 1 |
| 1214 | adalimumab-randomized | 2 |
| 1215 | vvir-randomized | 4 |
| 1216 | immuno-compromized | 1 |
| 1217 | immunocompromized | 5 |
| 1218 | laryngectomized | 19 |
| 1219 | splenectomized | 34 |
| 1220 | non-splenectomized | 11 |
| 1221 | polypectomized | 3 |
| 1222 | gastrectomized | 19 |
| 1223 | hepatectomized | 6 |
| 1224 | tracheotomized | 6 |
| 1225 | post-revascularized | 2 |
| 1226 | politraumatized | 1 |
| 1227 | nontraumatized | 5 |
| 1228 | eugenol-sensitized | 1 |
| 1229 | mite-monosensitized | 1 |
| 1230 | non-dialyzed | 5 |
| 1231 | nondialyzed | 11 |
| 1232 | haemodialyzed | 2 |
| 1233 | hemodialyzed | 51 |
| 1234 | non-hemodialyzed | 4 |
| 1235 | long-hd | 1 |
| 1236 | non-hd | 19 |
| 1237 | hahd | 10 |
| 1238 | hypoparathyroid | 4 |
| 1239 | hypothyroid | 333 |
| 1240 | hyperthyroid | 193 |
| 1241 | hd-ckd | 3 |
| 1242 | predialysis-ckd | 1 |
| 1243 | non-ald | 3 |
| 1244 | ckd-nafld | 1 |
| 1245 | early-mild | 1 |
| 1246 | 18-35-month-old | 1 |
| 1247 | ≤50-year-old | 1 |
| 1248 | 1-to-5-year-old | 2 |
| 1249 | pmmd | 1 |
| 1250 | bed-bound | 8 |
| 1251 | faod | 1 |
| 1252 | hqd | 5 |
| 1253 | non-rd | 5 |
| 1254 | non-ard | 3 |
| 1255 | medical-ward | 1 |
| 1256 | non-esrd | 3 |
| 1257 | non-lvd | 1 |
| 1258 | low-tolerance | 1 |
| 1259 | by-preference | 1 |
| 1260 | high-triglyceride | 3 |
| 1261 | lower-triglyceride | 1 |
| 1262 | neutropenia-free | 1 |
| 1263 | aki-free | 1 |
| 1264 | aspirin-free | 2 |
| 1265 | young-to-middle-age | 4 |
| 1266 | non-dge | 3 |
| 1267 | off-range | 3 |
| 1268 | tension-headache | 1 |
| 1269 | madrid.the | 1 |
| 1270 | non-resectable.the | 1 |
| 1271 | schizophrenia—the | 1 |
| 1272 | madit-ii-like | 1 |
| 1273 | scd-heft-like | 4 |
| 1274 | acute-stroke | 2 |
| 1275 | resected/resectable | 1 |
| 1276 | bpv-evaluable | 1 |
| 1277 | safety-evaluable | 2 |
| 1278 | noninducible | 5 |
| 1279 | iv-tpa-eligible | 1 |
| 1280 | ng-eligible | 1 |
| 1281 | trial-eligible | 12 |
| 1282 | platinum-eligible | 1 |
| 1283 | acas-eligible | 4 |
| 1284 | transplant-eligible | 7 |
| 1285 | -ineligible | 3 |
| 1286 | iv-tpa-ineligible | 1 |
| 1287 | cisplatin-ineligible | 3 |
| 1288 | inh-susceptible | 4 |
| 1289 | ams-susceptible | 4 |
| 1290 | double-ventricle | 2 |
| 1291 | severity.thirty-nine | 1 |
| 1292 | nonduloxetine | 1 |
| 1293 | 6.forty-one | 1 |
| 1294 | escitalopram-alone | 3 |
| 1295 | bleeding-prone | 1 |
| 1296 | hypotension-prone | 7 |
| 1297 | arrhythmiaprone | 1 |
| 1298 | non-relax-ahf-type | 2 |
| 1299 | pharmaceutical-care | 3 |
| 1300 | non-se | 2 |
| 1301 | early-stage-disease | 1 |
| 1302 | antipsychotic-naive/early-phase | 1 |
| 1303 | overweight+obese | 4 |
| 1304 | super-morbid-obese | 1 |
| 1305 | super-obese | 47 |
| 1306 | non-japanese | 44 |
| 1307 | korean/taiwanese | 2 |
| 1308 | hypertense | 6 |
| 1309 | fh-dose | 1 |
| 1310 | platinum-sensitive/intermediate | 1 |
| 1311 | deficit-state | 1 |
| 1312 | infliximab-naive | 1 |
| 1313 | bortezomib-naive | 2 |
| 1314 | antipsychotic-naive | 24 |
| 1315 | neuroleptic-naive | 2 |
| 1316 | kc-naive | 2 |
| 1317 | opioid-naive | 16 |
| 1318 | steroid-naive | 30 |
| 1319 | thalidomide-naive | 4 |
| 1320 | nucleoside-naive | 17 |
| 1321 | clozapine-naive | 1 |
| 1322 | integrase-naive | 1 |
| 1323 | drug-naive | 104 |
| 1324 | antiretroviral-naive | 77 |
| 1325 | clopidogrel-naive | 3 |
| 1326 | pen-naive | 1 |
| 1327 | insulin-naive | 37 |
| 1328 | statin-naive | 38 |
| 1329 | incretin-naive | 1 |
| 1330 | saxagliptin-naive | 1 |
| 1331 | transfusion-naive | 3 |
| 1332 | medication-naive | 32 |
| 1333 | chemo-naive | 11 |
| 1334 | integrase-inhibitor-naive | 3 |
| 1335 | biologics-naive | 11 |
| 1336 | d4t-naive | 1 |
| 1337 | bt-naive | 1 |
| 1338 | treatment-naive | 499 |
| 1339 | lipid-treatment-naive | 1 |
| 1340 | azt-naive | 3 |
| 1341 | hcv-naive | 1 |
| 1342 | mtx-naive | 7 |
| 1343 | therapy-naive | 30 |
| 1344 | radiotherapy-naive | 1 |
| 1345 | chemotherapy-naive | 108 |
| 1346 | chemonaive | 27 |
| 1347 | hipertensive | 1 |
| 1348 | hypertensive | 8,415 |
| 1349 | diabetic-hypertensive | 2 |
| 1350 | controlled-hypertensive | 3 |
| 1351 | pre-hypertensive | 21 |
| 1352 | volume-responsive | 1 |
| 1353 | mycophenolate/dexamethasone-responsive | 1 |
| 1354 | tam-responsive | 2 |
| 1355 | ht-responsive | 1 |
| 1356 | treatment-nonresponsive | 2 |
| 1357 | colchicine-unresponsive | 2 |
| 1358 | span-100-negative | 2 |
| 1359 | sp100-negative | 1 |
| 1360 | acpa-negative | 13 |
| 1361 | ssa/ssb-negative | 1 |
| 1362 | gerd-negative | 2 |
| 1363 | flt3-itd-negative | 7 |
| 1364 | c-peptide-negative | 4 |
| 1365 | signature-negative | 1 |
| 1366 | se-negative | 2 |
| 1367 | hbeag-negative | 86 |
| 1368 | lvh-negative | 1 |
| 1369 | ctni-negative | 2 |
| 1370 | troponin-negative | 7 |
| 1371 | hp-negative | 4 |
| 1372 | met-negative | 4 |
| 1373 | tilt-negative | 1 |
| 1374 | -seronegative | 5 |
| 1375 | non-regenerative | 8 |
| 1376 | vasoreactive | 2 |
| 1377 | hypersecretive | 5 |
| 1378 | nsaid-sensitive | 1 |
| 1379 | lysozyme-sensitive | 1 |
| 1380 | fludarabine-sensitive | 1 |
| 1381 | span-100-positive | 3 |
| 1382 | ga2-positive | 1 |
| 1383 | iaa-positive | 1 |
| 1384 | apla-positive | 2 |
| 1385 | acpa-positive | 22 |
| 1386 | anti-gad-positive | 1 |
| 1387 | tid-positive | 3 |
| 1388 | flt3-itd-positive | 4 |
| 1389 | c-peptide-positive | 4 |
| 1390 | methane-positive | 2 |
| 1391 | genotype-positive | 4 |
| 1392 | jak2v617f-positive | 1 |
| 1393 | hbeag-positive | 142 |
| 1394 | lvh-positive | 1 |
| 1395 | ptbii-positive | 1 |
| 1396 | i1307k-positive | 1 |
| 1397 | sputum-positive | 4 |
| 1398 | βiii-tubulin-positive | 2 |
| 1399 | troponin-positive | 10 |
| 1400 | eosin-positive | 1 |
| 1401 | sln-positive | 4 |
| 1402 | hp-positive | 11 |
| 1403 | gs-positive | 2 |
| 1404 | ttv-positive | 1 |
| 1405 | autoantibody-positive | 23 |
| 1406 | lipodystrophy-positive | 4 |
| 1407 | bacteriologically-positive | 1 |
| 1408 | endoscopy-positive | 2 |
| 1409 | hbsag-seropositive | 2 |
| 1410 | ebv-seropositive | 1 |
| 1411 | vka-naïve | 1 |
| 1412 | esa-naïve | 3 |
| 1413 | cetuximab-naïve | 1 |
| 1414 | bortezomib-naïve | 1 |
| 1415 | biologic-naïve | 5 |
| 1416 | analgesic-naïve | 1 |
| 1417 | antipsychotic-naïve | 33 |
| 1418 | glucocorticoid-naïve | 3 |
| 1419 | opioid-naïve | 15 |
| 1420 | corticosteroid-naïve | 1 |
| 1421 | dmard-naïve | 15 |
| 1422 | nucleoside-naïve | 5 |
| 1423 | olanzapine-naïve | 2 |
| 1424 | opiate-naïve | 1 |
| 1425 | drug-naïve | 157 |
| 1426 | pi-naïve | 1 |
| 1427 | antiretroviral-naïve | 48 |
| 1428 | pen-naïve | 5 |
| 1429 | insulin-naïve | 39 |
| 1430 | statin-naïve | 24 |
| 1431 | transfusion-naïve | 2 |
| 1432 | medication-naïve | 45 |
| 1433 | -non-naïve | 1 |
| 1434 | chemo-naïve | 10 |
| 1435 | beta-blocker-naïve | 2 |
| 1436 | α-blocker-naïve | 1 |
| 1437 | stimulant-naïve | 7 |
| 1438 | treatment-naïve | 343 |
| 1439 | pi-treatment-naïve | 1 |
| 1440 | ifnβ-treatment-naïve | 2 |
| 1441 | tnfα-antagonist-naïve | 1 |
| 1442 | mtx-naïve | 12 |
| 1443 | study-naïve | 2 |
| 1444 | therapy-naïve | 12 |
| 1445 | radiotherapy-naïve | 1 |
| 1446 | chemotherapy-naïve | 62 |
| 1447 | chemonaïve | 11 |
| 1448 | cisplatin-naοve | 1 |
| 1449 | amio-off | 4 |
| 1450 | non-korsakoff | 1 |
| 1451 | psvf-hf | 2 |
| 1452 | r-tof | 5 |
| 1453 | s-ipf | 4 |
| 1454 | no-prior-cabg | 1 |
| 1455 | non-mg | 1 |
| 1456 | erythroid-responding | 1 |
| 1457 | long-responding | 1 |
| 1458 | normal-responding | 1 |
| 1459 | poor-responding | 1 |
| 1460 | spanish-only-speaking | 2 |
| 1461 | insulin-taking | 2 |
| 1462 | panicking | 2 |
| 1463 | low-functioning | 11 |
| 1464 | denture-wearing | 2 |
| 1465 | hypofiltering | 1 |
| 1466 | weight-losing | 10 |
| 1467 | non-relapsing | 6 |
| 1468 | skilled-nursing | 1 |
| 1469 | non-progressing | 5 |
| 1470 | non-tegaserod-using | 1 |
| 1471 | olmesartan-using | 1 |
| 1472 | insulin-using | 5 |
| 1473 | non-cannabis-using | 1 |
| 1474 | methamphetamine-abusing | 3 |
| 1475 | designer-drug-abusing | 6 |
| 1476 | hypnotics/anxiolytics-abusing | 3 |
| 1477 | non-fluctuating | 2 |
| 1478 | binge-eating/vomiting | 2 |
| 1479 | teriparatide-receiving | 1 |
| 1480 | urban-living | 3 |
| 1481 | 700young | 1 |
| 1482 | nonyoung | 3 |
| 1483 | scorpion-stung | 1 |
| 1484 | tbi/sah | 1 |
| 1485 | entecavir-switch | 6 |
| 1486 | khalesseh | 1 |
| 1487 | periostin-high | 1 |
| 1488 | non-breakthrough | 2 |
| 1489 | hyperoh | 6 |
| 1490 | dtth-ish | 1 |
| 1491 | pa-with | 1 |
| 1492 | irs-i | 1 |
| 1493 | non-crai | 5 |
| 1494 | elective-pci | 3 |
| 1495 | non-ci-aki | 1 |
| 1496 | non-ami | 6 |
| 1497 | non-abmi | 2 |
| 1498 | non-qatari | 3 |
| 1499 | altri | 1 |
| 1500 | non-uri | 2 |
| 1501 | not-weak | 3 |
| 1502 | asian/black | 1 |
| 1503 | less-sick | 1 |
| 1504 | septic-shock | 1 |
| 1505 | non-shock | 10 |
| 1506 | dgf-risk | 1 |
| 1507 | high/very-high-risk | 1 |
| 1508 | high-cardiovascular-risk | 4 |
| 1509 | polypathological | 7 |
| 1510 | non-cardiological | 2 |
| 1511 | onco-hematological | 9 |
| 1512 | cardio-surgical | 1 |
| 1513 | neurology/neurosurgical | 1 |
| 1514 | cardioswrgical | 1 |
| 1515 | eugonadal/hypogonadal | 1 |
| 1516 | 'non-trial | 3 |
| 1517 | non-sdldl | 5 |
| 1518 | non-t-all | 1 |
| 1519 | somatically-ill | 2 |
| 1520 | critically-ill | 40 |
| 1521 | ap-cml | 2 |
| 1522 | working/in-school | 1 |
| 1523 | td2m | 2 |
| 1524 | cfs/fm | 9 |
| 1525 | malignant-neoplasm | 1 |
| 1526 | novasospasm | 1 |
| 1527 | normal-magnesium | 2 |
| 1528 | low-potassium | 9 |
| 1529 | non-dan | 3 |
| 1530 | dutch-antillean | 2 |
| 1531 | difficult-to-wean | 11 |
| 1532 | chinese-canadian | 2 |
| 1533 | hypothyroidian | 1 |
| 1534 | djiboutian | 2 |
| 1535 | snakebitten | 1 |
| 1536 | placebo-given | 1 |
| 1537 | amenorrhea-in | 1 |
| 1538 | amio-on | 5 |
| 1539 | asian-region | 5 |
| 1540 | no-fixation | 1 |
| 1541 | treatment-option | 4 |
| 1542 | uk-born | 2 |
| 1543 | folfox/placebo | 1 |
| 1544 | kikyo | 5 |
| 1545 | pin/asap | 1 |
| 1546 | non-vap | 7 |
| 1547 | stent/dep | 2 |
| 1548 | an-fep | 5 |
| 1549 | post-pkp | 1 |
| 1550 | ventilated-group | 1 |
| 1551 | mild-group | 1 |
| 1552 | olanzapine-group | 3 |
| 1553 | ni-group | 2 |
| 1554 | ocd-bipolar | 4 |
| 1555 | poor-responder | 3 |
| 1556 | non-transfer | 5 |
| 1557 | non-abuser | 2 |
| 1558 | front-door | 4 |
| 1559 | low-qor | 1 |
| 1560 | non-inhibitor | 3 |
| 1561 | non-isr | 1 |
| 1562 | t2dm.fourty-four | 1 |
| 1563 | non-rvr | 9 |
| 1564 | misleads | 1 |
| 1565 | non-ces | 1 |
| 1566 | disqualifies | 1 |
| 1567 | spondylarthroses | 1 |
| 1568 | non-is | 2 |
| 1569 | non-amyloidosis | 1 |
| 1570 | non-dialysis | 46 |
| 1571 | nondialysis | 44 |
| 1572 | non-hemodialysis | 2 |
| 1573 | tnbs-colitis | 3 |
| 1574 | non-rheumatoid-arthritis | 3 |
| 1575 | migraine/rls | 1 |
| 1576 | nonextractions | 1 |
| 1577 | bon-bos | 1 |
| 1578 | non-ps | 2 |
| 1579 | difficult-access | 1 |
| 1580 | numberless | 1 |
| 1581 | brcaness | 4 |
| 1582 | low-ts | 2 |
| 1583 | nondelirious | 2 |
| 1584 | lipedematous | 1 |
| 1585 | near-lepromatous | 1 |
| 1586 | good-performance-status | 1 |
| 1587 | sjögren׳s | 9 |
| 1588 | harder-to-treat | 1 |
| 1589 | non-hct | 4 |
| 1590 | younger/fit | 3 |
| 1591 | older/unfit | 3 |
| 1592 | elderly/unfit | 1 |
| 1593 | direct-admit | 4 |
| 1594 | non-bmt | 2 |
| 1595 | met-comt | 4 |
| 1596 | immunodiscordant | 4 |
| 1597 | organ-transplant | 1 |
| 1598 | opioid-tolerant | 17 |
| 1599 | benzodiazepine-tolerant | 1 |
| 1600 | penicillin-tolerant | 1 |
| 1601 | metformin-tolerant | 2 |
| 1602 | sunitinib-intolerant | 1 |
| 1603 | ace-intolerant | 7 |
| 1604 | sulfasalazine-intolerant | 2 |
| 1605 | uf-intolerant | 1 |
| 1606 | acei-intolerant | 2 |
| 1607 | statin-intolerant | 33 |
| 1608 | imatinib-resistant/intolerant | 1 |
| 1609 | cpib-resistant | 2 |
| 1610 | hydroxyflutamide-resistant | 1 |
| 1611 | fludarabine-resistant | 1 |
| 1612 | duloxetine-resistant | 1 |
| 1613 | calcitriol-resistant | 4 |
| 1614 | lam-resistant | 10 |
| 1615 | insulin-resistant | 211 |
| 1616 | metformin-resistant | 1 |
| 1617 | aspirin-resistant | 17 |
| 1618 | divalproex-resistant | 1 |
| 1619 | cocaine/methamphetamine-dependent | 1 |
| 1620 | inotrope-dependent | 6 |
| 1621 | ethanol-dependent | 2 |
| 1622 | pacemaker-dependent | 17 |
| 1623 | non-pacemaker-dependent | 2 |
| 1624 | is-dependent | 1 |
| 1625 | nondialysis-dependent | 7 |
| 1626 | non-hemodialysis-dependent | 2 |
| 1627 | transfusion-independent | 3 |
| 1628 | growth-hormone-deficient | 1 |
| 1629 | mbl-deficient | 2 |
| 1630 | non-hdl-deficient | 1 |
| 1631 | hl-deficient | 2 |
| 1632 | insulin-deficient | 9 |
| 1633 | aat-deficient | 6 |
| 1634 | kidney-recipient | 1 |
| 1635 | aggressive-treatment | 1 |
| 1636 | naïve-to-treatment | 3 |
| 1637 | immunecompetent | 1 |
| 1638 | deep-burnt | 1 |
| 1639 | hiv/haart | 3 |
| 1640 | premanifest | 6 |
| 1641 | 100-out | 1 |
| 1642 | non-gout | 2 |
| 1643 | post-bltx | 1 |
| 1644 | intensive-pathway | 2 |
| 1645 | gonadotropin-deficiency | 1 |
| 1646 | hematopathy | 3 |
| 1647 | gly/gly | 33 |
| 1648 | screening-only | 1 |
| 1649 | posthaemorrhoidectomy | 2 |
| 1650 | post-gastrectomy | 6 |
| 1651 | post-coarctectomy | 3 |
| 1652 | postcoarctectomy | 1 |
| 1653 | post-cardiac-surgery | 1 |
| 1654 | knee-surgery | 1 |
| 1655 | nonsurgery | 1 |
| 1656 | non-ambulatory | 16 |
| 1657 | interferon-alpha-refractory | 1 |
| 1658 | ra-refractory | 1 |
| 1659 | lvd-refractory | 1 |
| 1660 | lamivudine-refractory | 7 |
| 1661 | anti-vegf-refractory | 2 |
| 1662 | bcg-refractory | 2 |
| 1663 | paclitaxel-refractory | 1 |
| 1664 | mixed-ancestry | 1 |
| 1665 | first-biopsy | 4 |
| 1666 | high-anxiety | 7 |
| 1667 | higher-acuity | 1 |
| 1668 | csr.sixty | 1 |
| 1669 | efficacy.sixty | 1 |